{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:16:37Z","timestamp":1791497797157,"version":"4.3.4"},"reference-count":1343,"publisher":"Georg Thieme Verlag KG","issue":"06","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Z Gastroenterol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1055\/a-2769-2192","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T23:41:03Z","timestamp":1782258063000},"page":"689-827","source":"Crossref","is-referenced-by-count":2,"title":["Aktualisierte S3-Leitlinie Colitis ulcerosa (Version 7.0)"],"prefix":"10.1055","volume":"64","author":[{"given":"Irina","family":"Blumenstein","sequence":"additional","affiliation":[{"name":"Goethe-Universit\u00e4t Frankfurt, Universit\u00e4tsklinikum Frankfurt, Medizinische Klinik 1, Gastroenterologie und Hepatologie, Frankfurt am Main, Deutschland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Schnoy","sequence":"additional","affiliation":[{"name":"III. Medizinische Klinik, Universit\u00e4tsklinikum Augsburg, Augsburg, Deutschland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raja","family":"Atreya","sequence":"additional","affiliation":[{"name":"Medizinische Klinik 1 Gastroent., Pneumologie, Endokrin., Universit\u00e4tsklinikum Erlangen, Erlangen, Deutschland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"Bettenworth","sequence":"additional","affiliation":[{"name":"Praxis f\u00fcr Innere Medizin\/CED Schwerpunktpraxis M\u00fcnster, M\u00fcnster, Deutschland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"de Laffolie","sequence":"additional","affiliation":[{"name":"Allgemeinp\u00e4diatrie und Neonatologie Zentrum f\u00fcr Kinderheilkunde und Jugendmedizin, Universit\u00e4tsklinikum Gie\u00dfen, Gie\u00dfen, Deutschland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit","family":"Kaltz","sequence":"additional","affiliation":[{"name":"Bundesgesch\u00e4ftsstelle DCCV e.V., Berlin, Deutschland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Kienle","sequence":"additional","affiliation":[{"name":"Abteilung f\u00fcr Allgemein- und Viszeralchirurgie, Theresienkrankenhaus, Mannheim, Deutschland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jost","family":"Langhorst","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Integrative Medizin und Naturheilkunde, Sozialstiftung Bamberg Klinikum Bamberg, Bamberg, Deutschland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Maaser","sequence":"additional","affiliation":[{"name":"Gastroenterologie, Ambulanzzentrum L\u00fcneburg, L\u00fcneburg, Deutschland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann","family":"Ockenga","sequence":"additional","affiliation":[{"name":"Medizinische Klinik II, Klinikum Bremen Mitte \u2013 Gesundheit Nord, Bremen, Deutschland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Posovszky","sequence":"additional","affiliation":[{"name":"Universit\u00e4ts-Kinderspital Z\u00fcrich, Z\u00fcrich, Schweiz"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Britta","family":"Siegmund","sequence":"additional","affiliation":[{"name":"Medizinische Klinik f\u00fcr Gastroenterologie, Infektiologie und Rheumatologie, Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin, Campus Benjamin Franklin, Berlin, Deutschland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Sonnenberg","sequence":"additional","affiliation":[{"name":"Medizinische Klinik f\u00fcr Gastroenterologie, Infektiologie und Rheumatologie, Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin, Campus Benjamin Franklin, Berlin, Deutschland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Stallmach","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Innere Medizin IV (Gastroenterologie, Hepatologie, Infektiologie, Zentrale Endoskopie), Universit\u00e4tsklinikum Jena, Jena, Deutschland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Sturm","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Innere Medizin mit Schwerpunkt Gastroenterologie, DRK Kliniken Berlin Westend, Berlin, Deutschland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Zei\u00dfig","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Gastroenterologie, Inselspital Bern, Schweiz"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Dignass","sequence":"additional","affiliation":[{"name":"Medizinische Klinik I Gastroenterologie, Hepatologie, Onkologie, Pneumologie und Allgemeine Innere Medizin Agaplesion Markus Krankenhaus Frankfurt, Frankfurt am Main, Deutschland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torsten","family":"Kucharzik","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Allgemeine Innere Medizin und Gastroenterologie, St\u00e4dtisches Klinikum L\u00fcneburg, L\u00fcneburg, Deutschland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"f\u00fcr die Autoren des DGVS Leitlinienkomitees\/for the authors of the DGVS guideline committee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Collaborators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2026,6,22]]},"reference":[{"key":"ref2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1155\/2005\/269076","article-title":"Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology","volume":"19 Suppl A","author":"M S Silverberg","year":"2005","journal-title":"Can J Gastroenterol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1136\/gutjnl-2016-311970","article-title":"Ulcerative proctitis is a frequent location of paediatric-onset UC and not a minor disease: a population-based study","volume":"66","author":"A Hochart","year":"2017","journal-title":"Gut"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1056\/NEJM199011013231802","article-title":"Ulcerative colitis and colorectal cancer. A population-based study","volume":"323","author":"A Ekbom","year":"1990","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1067\/mge.2002.125367","article-title":"Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis","volume":"56","author":"R M Soetikno","year":"2002","journal-title":"Gastrointest Endosc"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1053\/j.gastro.2020.05.049","article-title":"Effects of Primary Sclerosing Cholangitis on Risks of Cancer and Death in People With Inflammatory Bowel Disease, Based on Sex, Race, and Age","volume":"159","author":"P J Trivedi","year":"2020","journal-title":"Gastroenterology"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1111\/j.1365-2036.2004.02270.x","article-title":"Systematic review: is ingestion of paracetamol or non-steroidal anti-inflammatory drugs associated with exacerbations of inflammatory bowel disease?","volume":"20","author":"K Forrest","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S1542-3565(05)00980-8","article-title":"Prevalence and mechanism of nonsteroidal anti-inflammatory drug-induced clinical relapse in patients with inflammatory bowel disease","volume":"4","author":"K Takeuchi","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.cgh.2005.12.002","article-title":"Safety of celecoxib in patients with ulcerative colitis in remission: a randomized, placebo-controlled, pilot study","volume":"4","author":"W J Sandborn","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.cgh.2005.11.007","article-title":"Selective use of selective nonsteroidal anti-inflammatory drugs in inflammatory bowel disease","volume":"4","author":"J R Korzenik","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1111\/apt.14606","article-title":"Systematic review with meta-analysis: association between acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs) and risk of Crohn\u2019s disease and ulcerative colitis exacerbation","volume":"47","author":"O O Moninuola","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.14309\/ajg.0000000000001932","article-title":"The Association Between Nonsteroidal Anti-Inflammatory Drug Use and Inflammatory Bowel Disease Exacerbations: A True Association or Residual Bias?","volume":"117","author":"S Cohen-Mekelburg","year":"2022","journal-title":"Am J Gastroenterol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1365-2036.2006.02974.x","article-title":"The efficacy of corticosteroid therapy in inflammatory bowel disease: analysis of a 5-year UK inception cohort","volume":"24","author":"G T Ho","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1053\/gast.2001.26279","article-title":"The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study","volume":"121","author":"W A Faubion Jr.","year":"2001","journal-title":"Gastroenterology"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1053\/j.gastro.2008.01.012","article-title":"Risk factors for opportunistic infections in patients with inflammatory bowel disease","volume":"134","author":"M Toruner","year":"2008","journal-title":"Gastroenterology"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1093\/ecco-jcc\/jjab052","article-title":"ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease","volume":"15","author":"T Kucharzik","year":"2021","journal-title":"J Crohns Colitis"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.4065\/81.11.1462","article-title":"Smoking and inflammatory bowel disease: a meta-analysis","volume":"81","author":"S S Mahid","year":"2006","journal-title":"Mayo Clin Proc"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1111\/j.1572-0241.2007.01265.x","article-title":"Ulcerative colitis: patient characteristics may predict 10-yr disease recurrence in a European-wide population-based cohort","volume":"102","author":"O Hoie","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1111\/j.1572-0241.2001.03944.x","article-title":"Impact of cessation of smoking on the course of ulcerative colitis","volume":"96","author":"L Beaugerie","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1097\/00054725-200411000-00019","article-title":"Inflammatory bowel disease and smoking: a review of epidemiology, pathophysiology, and therapeutic implications","volume":"10","author":"T Birrenbach","year":"2004","journal-title":"Inflamm Bowel Dis"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1136\/gut.2003.036483","article-title":"Epidemiology of appendicectomy in primary sclerosing cholangitis and ulcerative colitis: its influence on the clinical behaviour of these diseases","volume":"53","author":"T H Florin","year":"2004","journal-title":"Gut"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1365-2036.2006.03052.x","article-title":"Review article: genetic susceptibility and application of genetic testing in clinical management of inflammatory bowel disease","volume":"24 Suppl 3","author":"S Vermeire","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.crohns.2014.05.008","article-title":"Family history of inflammatory bowel disease among patients with ulcerative colitis: a systematic review and meta-analysis","volume":"8","author":"R E Childers","year":"2014","journal-title":"J Crohns Colitis"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1111\/j.1572-0241.2007.01368.x","article-title":"Are there any differences in phenotype or disease course between familial and sporadic cases of inflammatory bowel disease? Results of a population-based follow-up study","volume":"102","author":"M Henriksen","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"109622","DOI":"10.1016\/j.jnutbio.2024.109622","article-title":"Dietary polyphenols represent a phytotherapeutic alternative for gut dysbiosis associated neurodegeneration: A systematic review","volume":"129","author":"A Chatterjee","year":"2024","journal-title":"J Nutr Biochem"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1053\/j.gastro.2021.07.042","article-title":"Extraintestinal Manifestations of Inflammatory Bowel Disease: Current Concepts, Treatment, and Implications for Disease Management","volume":"161","author":"G Rogler","year":"2021","journal-title":"Gastroenterology"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0016-5085(94)90054-X","article-title":"Course of ulcerative colitis: analysis of changes in disease activity over years","volume":"107","author":"E Langholz","year":"1994","journal-title":"Gastroenterology"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1111\/apt.17754","article-title":"Systematic review with meta-analysis: Diagnostic performance of faecal calprotectin in distinguishing inflammatory bowel disease from irritable bowel syndrome in adults","volume":"58","author":"E Dajti","year":"2023","journal-title":"Aliment Pharmacol Ther"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1080\/00365520600554527","article-title":"Change of diagnosis during the first five years after onset of inflammatory bowel disease: results of a prospective follow-up study (the IBSEN Study)","volume":"41","author":"M Henriksen","year":"2006","journal-title":"Scand J Gastroenterol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1136\/jcp.31.6.567","article-title":"Overlap in the spectrum of non-specific inflammatory bowel disease \u2013 \u201ccolitis indeterminate\u201d","volume":"31","author":"A B Price","year":"1978","journal-title":"J Clin Pathol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"299","DOI":"10.15403\/jgld.2014.1121.273.pti","article-title":"Fecal calprotectin in assessing inflammatory bowel disease endoscopic activity: a diagnostic accuracy meta-analysis","volume":"27","author":"T Rokkas","year":"2018","journal-title":"J Gastrointestin Liver Dis"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1007\/s10620-006-9691-2","article-title":"CRP correlates with clinical score in ulcerative colitis but not in Crohn\u2019s disease","volume":"52","author":"A D Rodgers","year":"2007","journal-title":"Dig Dis Sci"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1097\/00054725-200409000-00026","article-title":"C-reactive protein as a marker for inflammatory bowel disease","volume":"10","author":"S Vermeire","year":"2004","journal-title":"Inflamm Bowel Dis"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/00004836-198802000-00010","article-title":"Clinical and laboratory indicators of extent of ulcerative colitis. Serum C-reactive protein helps the most","volume":"10","author":"C Prantera","year":"1988","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1080\/00365520410007971","article-title":"Normalization of faecal calprotectin: a predictor of mucosal healing in patients with inflammatory bowel disease","volume":"39","author":"A G Roseth","year":"2004","journal-title":"Scand J Gastroenterol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1002\/ibd.20986","article-title":"Ulcerative colitis: Correlation of the Rachmilewitz endoscopic activity index with fecal calprotectin, clinical activity, C-reactive protein, and blood leukocytes","volume":"15","author":"A M Schoepfer","year":"2009","journal-title":"Inflamm Bowel Dis"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1002\/ibd.22861","article-title":"Fecal calprotectin in predicting relapse of inflammatory bowel diseases: a meta-analysis of prospective studies","volume":"18","author":"R Mao","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1097\/MIB.0000000000000057","article-title":"Meta-analysis: fecal calprotectin for assessment of inflammatory bowel disease activity","volume":"20","author":"J F Lin","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"892","DOI":"10.5152\/tjg.2023.22812","article-title":"Evaluation of Mucosal Healing in Ulcerative Colitis by Fecal Calprotectin vs. Fecal Immunochemical Test: A Systematic Review and Meta-analysis","volume":"34","author":"T Hu","year":"2023","journal-title":"Turk J Gastroenterol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1651-2227.2004.tb00700.x","article-title":"Serum procalcitonin and C-reactive protein in children with diarrhoea of various aetiologies","volume":"93","author":"B Korczowski","year":"2004","journal-title":"Acta Paediatr"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/00054725-200405000-00008","article-title":"Serum procalcitonin differentiates inflammatory bowel disease and self-limited colitis","volume":"10","author":"K R Herrlinger","year":"2004","journal-title":"Inflamm Bowel Dis"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1097\/01.meg.0000131040.38607.09","article-title":"Enteric infection in relapse of inflammatory bowel disease: importance of microbiological examination of stool","volume":"16","author":"M Mylonaki","year":"2004","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref43","first-page":"121","article-title":"Search for enteric microbial pathogens in patients with ulcerative colitis","volume":"53","author":"W J Brown","year":"1992","journal-title":"Digestion"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1097\/01.mcg.0000124026.92823.fc","article-title":"Do serological markers and cytokines determine the indeterminate?","volume":"38","author":"S Plevy","year":"2004","journal-title":"J Clin Gastroenterol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/ibd.20047","article-title":"The prevalence of genetic and serologic markers in an unselected European population-based cohort of IBD patients","volume":"13","author":"L Riis","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1373\/clinchem.2004.032318","article-title":"Interassay and interobserver variability in the detection of anti-neutrophil cytoplasmic antibodies in patients with ulcerative colitis","volume":"50","author":"S Joossens","year":"2004","journal-title":"Clin Chem"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1111\/j.1572-0241.2006.00840.x","article-title":"Diagnostic precision of anti-Saccharomyces cerevisiae antibodies and perinuclear antineutrophil cytoplasmic antibodies in inflammatory bowel disease","volume":"101","author":"G E Reese","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/00004836-199206000-00008","article-title":"Microbic superinfection in relapse of inflammatory bowel disease","volume":"14","author":"P Weber","year":"1992","journal-title":"J Clin Gastroenterol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/MOG.0000000000000739","article-title":"Diagnosis and management of Clostridioides difficile infection in patients with inflammatory bowel disease","volume":"37","author":"R S Dalal","year":"2021","journal-title":"Curr Opin Gastroenterol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1093\/ecco-jcc\/jjaa036","article-title":"Ulcerative Colitis and Cytomegalovirus Infection: From A to Z","volume":"14","author":"F H Mourad","year":"2020","journal-title":"J Crohns Colitis"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s00384-018-3170-z","article-title":"Accuracy of diagnostic tests and a new algorithm for diagnosing cytomegalovirus colitis in inflammatory bowel diseases: a diagnostic study","volume":"34","author":"L I Kredel","year":"2019","journal-title":"Int J Colorectal Dis"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1046\/j.1365-2036.2002.01196.x","article-title":"Review article: faecal markers in the assessment of activity in inflammatory bowel disease","volume":"16","author":"A Poullis","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1097\/01.MIB.0000187980.08686.18","article-title":"Comparison of 4 neutrophil-derived proteins in feces as indicators of disease activity in ulcerative colitis","volume":"11","author":"J Langhorst","year":"2005","journal-title":"Inflamm Bowel Dis"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/ajg.2015.6","article-title":"A meta-analysis of the utility of C-reactive protein, erythrocyte sedimentation rate, fecal calprotectin, and fecal lactoferrin to exclude inflammatory bowel disease in adults with IBS","volume":"110","author":"S B Menees","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/ajg.2015.120","article-title":"C-Reactive Protein, Fecal Calprotectin, and Stool Lactoferrin for Detection of Endoscopic Activity in Symptomatic Inflammatory Bowel Disease Patients: A Systematic Review and Meta-Analysis","volume":"110","author":"M H Mosli","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1111\/j.1572-0241.2008.01870.x","article-title":"Can calprotectin predict relapse risk in inflammatory bowel disease?","volume":"103","author":"R D\u2019Inca","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/S1590-8658(03)00381-5","article-title":"Role of faecal calprotectin as non-invasive marker of intestinal inflammation","volume":"35","author":"F Costa","year":"2003","journal-title":"Dig Liver Dis"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0021-9673(00)94843-X","article-title":"Application of clomiphene photolysis to assays based on analysis of the derived phenanthrenes","volume":"367","author":"R G Frith","year":"1986","journal-title":"J Chromatogr"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/apt.15662","article-title":"Review article: faecal calprotectin and histologic remission in ulcerative colitis","volume":"51","author":"F D\u2019Amico","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1097\/MIB.0000000000001082","article-title":"Clinical Utility of Fecal Calprotectin Monitoring in Asymptomatic Patients with Inflammatory Bowel Disease: A Systematic Review and Practical Guide","volume":"23","author":"A Heida","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1053\/j.gastro.2020.12.031","article-title":"STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD","volume":"160","author":"D Turner","year":"2021","journal-title":"Gastroenterology"},{"key":"ref62","first-page":"1550","article-title":"Colonoscopy of acute colitis. A safe and reliable tool for assessment of severity","volume":"39","author":"F Carbonnel","year":"1994","journal-title":"Dig Dis Sci"},{"key":"ref63","first-page":"187","article-title":"Colonoscopy during an attack of severe ulcerative colitis is a safe procedure and of great value in clinical decision making","volume":"86","author":"G Alemayehu","year":"1991","journal-title":"Am J Gastroenterol"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S1542-3565(04)00441-0","article-title":"Endoscopy in inflammatory bowel disease: indications, surveillance, and use in clinical practice","volume":"3","author":"D S Fefferman","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref65","first-page":"26","article-title":"Colonoscopy or sigmoidoscopy as the initial evaluation of pediatric patients with colitis: a survey of physician behavior and a cost analysis","volume":"25","author":"D E Deutsch","year":"1997","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.cgh.2007.02.015","article-title":"Predicting a change in diagnosis from ulcerative colitis to Crohn\u2019s disease: a nested, case-control study","volume":"5","author":"G Y Melmed","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.cgh.2016.01.015","article-title":"Mucosal Healing Is Associated With Improved Long-term Outcomes of Patients With Ulcerative Colitis: A Systematic Review and Meta-analysis","volume":"14","author":"S C Shah","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1097\/MIB.0000000000000816","article-title":"Endoscopic Mucosal Healing Predicts Favorable Clinical Outcomes in Inflammatory Bowel Disease: A Meta-analysis","volume":"22","author":"A R Reinink","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/ecco-jcc\/jjy113","article-title":"ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications","volume":"13","author":"C Maaser","year":"2019","journal-title":"J Crohns Colitis"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjaf106","article-title":"ECCO-ESGAR-ESP-IBUS Giudeline on Diagnostics and Monitoring of Patients with IBD Part 1","author":"T Kucharzik","year":"2025","journal-title":"JCC"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.cgh.2016.01.015","article-title":"Mucosal Healing Is Associated With Improved Long-term Outcomes of Patients With Ulcerative Colitis: A Systematic Review and Meta-analysis","volume":"14","author":"S C Shah","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.gie.2017.07.028","article-title":"Impact of mucosal inflammation on risk of colorectal neoplasia in patients with ulcerative colitis: a systematic review and meta-analysis","volume":"86","author":"B M Flores","year":"2017","journal-title":"Gastrointest Endosc"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1053\/j.gastro.2020.06.043","article-title":"Incremental Benefit of Achieving Endoscopic and Histologic Remission in Patients With Ulcerative Colitis: A Systematic Review and Meta-Analysis","volume":"159","author":"H Yoon","year":"2020","journal-title":"Gastroenterology"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1136\/gutjnl-2014-308839","article-title":"An endoscopic Mayo score of 0 is associated with a lower risk of colectomy than a score of 1 in ulcerative colitis","volume":"64","author":"C Manginot","year":"2015","journal-title":"Gut"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/apt.15577","article-title":"Prevalence of endoscopic improvement and remission according to patient-reported outcomes in ulcerative colitis","volume":"51","author":"P S Dulai","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgast-2023-001218","article-title":"Determining the optimal treatment target in patients with ulcerative colitis: rationale, design, protocol and interim analysis for the randomised controlled VERDICT trial","volume":"11","author":"V Jairath","year":"2024","journal-title":"BMJ Open Gastroenterol"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1053\/j.gastro.2020.06.043","article-title":"Incremental Benefit of Achieving Endoscopic and Histologic Remission in Patients With Ulcerative Colitis: A Systematic Review and Meta-Analysis","volume":"159","author":"H Yoon","year":"2020","journal-title":"Gastroenterology"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1093\/ibd\/izad159","article-title":"Disease Clearance as a New Outcome in Ulcerative Colitis: a Systematic Review and Expert Consensus","volume":"30","author":"F D\u2019Amico","year":"2024","journal-title":"Inflamm Bowel Dis"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/j.cgh.2020.09.046","article-title":"Treat to Target: The Role of Histologic Healing in Inflammatory Bowel Diseases: A Systematic Review and Meta-analysis","volume":"19","author":"A Gupta","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/ibd\/izad119","article-title":"Histological Disease Activity as Predictor of Clinical Relapse, Hospitalization, and Surgery in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis","volume":"30","author":"M Shehab","year":"2024","journal-title":"Inflamm Bowel Dis"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.cgh.2013.07.022","article-title":"Histologic remission: the ultimate therapeutic goal in ulcerative colitis?","volume":"12","author":"L Peyrin-Biroulet","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1093\/ecco-jcc\/jjy092","article-title":"Histological Risk Factors to Predict Clinical Relapse in Ulcerative Colitis With Endoscopically Normal Mucosa","volume":"12","author":"R Ozaki","year":"2018","journal-title":"J Crohns Colitis"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.cgh.2017.02.016","article-title":"Histologic Normalization Occurs in Ulcerative Colitis and Is Associated With Improved Clinical Outcomes","volume":"15","author":"B Christensen","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/j.cgh.2020.09.046","article-title":"Treat to Target: The Role of Histologic Healing in Inflammatory Bowel Diseases: A Systematic Review and Meta-analysis","volume":"19","author":"A Gupta","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1093\/ecco-jcc\/jjaa110","article-title":"ECCO Position Paper: Harmonization of the Approach to Ulcerative Colitis Histopathology","volume":"14","author":"F Magro","year":"2020","journal-title":"J Crohns Colitis"},{"key":"ref86","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1093\/ecco-jcc\/jjab135","article-title":"Systematic Review and Meta-Analysis: Clinical, Endoscopic, Histological and Safety Placebo Rates in Induction and Maintenance Trials of Ulcerative Colitis","volume":"16","author":"R Sedano","year":"2022","journal-title":"J Crohns Colitis"},{"key":"ref87","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.dld.2024.04.005","article-title":"Artificial intelligence-assisted colonoscopy to identify histologic remission and predict the outcomes of patients with ulcerative colitis: A systematic review","volume":"56","author":"Y Maeda","year":"2024","journal-title":"Dig Liver Dis"},{"key":"ref88","first-page":"1229","article-title":"Aktualisierte S3-Leitlinie \u201eDiagnostik und Therapie des Morbus Crohn\u201c der Deutschen Gesellschaft f\u00fcr Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) (Version 4.1) \u2013 living guideline. M\u00e4rz 2024 \u2013 AWMF-Registernummer: 021-004","volume":"62","author":"A Sturm","year":"2024","journal-title":"AWMF"},{"key":"ref89","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1053\/j.gastro.2022.08.038","article-title":"Intestinal Ultrasound Is Accurate to Determine Endoscopic Response and Remission in Patients With Moderate to Severe Ulcerative Colitis: A Longitudinal Prospective Cohort Study","volume":"163","author":"F de Voogd","year":"2022","journal-title":"Gastroenterology"},{"key":"ref90","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1093\/ecco-jcc\/jjab173","article-title":"Defining Transabdominal Intestinal Ultrasound Treatment Response and Remission in Inflammatory Bowel Disease: Systematic Review and Expert Consensus Statement","volume":"16","author":"J Ilvemark","year":"2022","journal-title":"J Crohns Colitis"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1136\/gutjnl-2019-319451","article-title":"Intestinal ultrasound for monitoring therapeutic response in patients with ulcerative colitis: results from the TRUST&UC study","volume":"69","author":"C Maaser","year":"2020","journal-title":"Gut"},{"key":"ref92","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/jcu.1870150302","article-title":"Ultrasound findings in Crohn\u2019s disease and ulcerative colitis: a prospective study","volume":"15","author":"H Worlicek","year":"1987","journal-title":"J Clin Ultrasound"},{"key":"ref93","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/jcu.1870220204","article-title":"Ultrasonography as a primary diagnostic tool in patients with inflammatory disease and tumors of the small intestine and large bowel","volume":"22","author":"T Bozkurt","year":"1994","journal-title":"J Clin Ultrasound"},{"key":"ref94","first-page":"2163","article-title":"Management of severe ulcerative colitis with the help of high resolution ultrasonography","volume":"91","author":"V Arienti","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"ref95","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0022-3476(97)70325-1","article-title":"Ultrasonographic assessment of inflammatory bowel disease in children: comparison with ileocolonoscopy","volume":"130","author":"C Faure","year":"1997","journal-title":"J Pediatr"},{"key":"ref96","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s002619900164","article-title":"Sonographic assessment of the normal and abnormal bowel wall in nondiverticular ileitis and colitis","volume":"22","author":"J A Pradel","year":"1997","journal-title":"Abdom Imaging"},{"key":"ref97","doi-asserted-by":"crossref","first-page":"375","DOI":"10.7863\/jum.2002.21.4.375","article-title":"Ultrasonographic findings correspond to clinical, endoscopic, and histologic findings in inflammatory bowel disease and other enterocolitides","volume":"21","author":"H P Haber","year":"2002","journal-title":"J Ultrasound Med"},{"key":"ref98","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/00054725-200407000-00008","article-title":"Clinical relevance of transabdominal ultrasonography and magnetic resonance imaging in patients with inflammatory bowel disease of the terminal ileum and large bowel","volume":"10","author":"M Pascu","year":"2004","journal-title":"Inflamm Bowel Dis"},{"key":"ref99","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2009.672","article-title":"Are Colonoscopy and Bowel Ultrasound Useful for Assessing Response to Short-Term Therapy and Predicting Disease Outcome of Moderate-to-Severe Forms of Ulcerative Colitis?: A Prospective Study","author":"F Parente","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"ref100","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1093\/ecco-jcc\/jjac083","article-title":"Early Intestinal Ultrasound Predicts Intravenous Corticosteroid Response in Hospitalised Patients With Severe Ulcerative Colitis","volume":"16","author":"J Ilvemark","year":"2022","journal-title":"J Crohns Colitis"},{"key":"ref101","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjae101","article-title":"Early intestinal ultrasound in severe ulcerative colitis identifies patients at increased risk of 1-year treatment failure and colectomy","author":"J Ilvemark","year":"2024","journal-title":"J Crohns Colitis"},{"key":"ref102","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2025.06.002","article-title":"Role of non-invasive imaging in the diagnosis and management of patients with suspected and established IBD","author":"T Kucharzik","year":"2025","journal-title":"Gastroenterology"},{"key":"ref103","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1136\/gut.2003.038505","article-title":"Cancer surveillance in longstanding ulcerative colitis: endoscopic appearances help predict cancer risk","volume":"53","author":"M D Rutter","year":"2004","journal-title":"Gut"},{"key":"ref104","doi-asserted-by":"publisher","DOI":"10.1055\/a-1018-2516","article-title":"MMe. S3-Leitlinie Diagnostik und Therapie der Adenokarzinome des Magens und \u00f6sophagogastralen \u00dcbergangs (Version 2)","author":"M Moehler","year":"2019","journal-title":"AWMF"},{"key":"ref105","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1136\/gut.33.7.938","article-title":"Benign and malignant colorectal strictures in ulcerative colitis","volume":"33","author":"V Gumaste","year":"1992","journal-title":"Gut"},{"key":"ref106","first-page":"119","article-title":"Adenocarcinoma in strictures of ulcerative colitis without antecedent dysplasia by colonoscopy","volume":"89","author":"J R Reiser","year":"1994","journal-title":"Am J Gastroenterol"},{"key":"ref107","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ejrad.2005.11.004","article-title":"Multi-detector CT-colonography in inflammatory bowel disease: prospective analysis of CT-findings to high-resolution video colonoscopy","volume":"58","author":"K Andersen","year":"2006","journal-title":"Eur J Radiol"},{"key":"ref108","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1148\/radiol.2471070611","article-title":"Inflammatory bowel disease diagnosed with US, MR, scintigraphy, and CT: meta-analysis of prospective studies","volume":"247","author":"K Horsthuis","year":"2008","journal-title":"Radiology"},{"key":"ref109","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1016\/j.cgh.2015.04.185","article-title":"Detection of Dysplasia or Cancer in 3.5% of Patients With Inflammatory Bowel Disease and Colonic Strictures","volume":"13","author":"M Fumery","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref110","first-page":"985","article-title":"The value of rectal biopsy in distinguishing self-limited colitis from early inflammatory bowel disease","volume":"65","author":"M C Allison","year":"1987","journal-title":"Q J Med"},{"key":"ref111","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1136\/jcp.55.12.955","article-title":"How could pathologists improve the initial diagnosis of colitis? Evidence from an international workshop","volume":"55","author":"E Bentley","year":"2002","journal-title":"J Clin Pathol"},{"key":"ref112","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1055\/s-2003-44593","article-title":"Diagnosing colitis: a prospective study on essential parameters for reaching a diagnosis","volume":"35","author":"C Dejaco","year":"2003","journal-title":"Endoscopy"},{"key":"ref113","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1136\/jcp.51.5.378","article-title":"Audit of the histopathological diagnosis of non-neoplastic colorectal biopsies: achievable standards for the diagnosis of inflammatory bowel disease","volume":"51","author":"A K Dube","year":"1998","journal-title":"J Clin Pathol"},{"key":"ref114","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1046\/j.1365-2559.1997.5810818.x","article-title":"Reliability of rectal biopsy in distinguishing between chronic inflammatory bowel disease and acute self-limiting colitis","volume":"31","author":"S A Dundas","year":"1997","journal-title":"Histopathology"},{"key":"ref115","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1136\/jcp.50.2.93","article-title":"Guidelines for the initial biopsy diagnosis of suspected chronic idiopathic inflammatory bowel disease. The British Society of Gastroenterology Initiative","volume":"50","author":"D Jenkins","year":"1997","journal-title":"J Clin Pathol"},{"key":"ref116","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/0016-5085(87)90124-7","article-title":"Histopathology differentiates acute self-limited colitis from ulcerative colitis","volume":"92","author":"T T Nostrant","year":"1987","journal-title":"Gastroenterology"},{"key":"ref117","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3109\/00365529409094843","article-title":"A prospective study of first attacks of inflammatory bowel disease and infectious colitis. Histologic course during the 1st year after presentation","volume":"29","author":"G Schumacher","year":"1994","journal-title":"Scand J Gastroenterol"},{"key":"ref118","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1136\/gut.32.12.1514","article-title":"Histopathological evaluation of colonic mucosal biopsy specimens in chronic inflammatory bowel disease: diagnostic implications","volume":"32","author":"C A Seldenrijk","year":"1991","journal-title":"Gut"},{"key":"ref119","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/0016-5085(84)90595-X","article-title":"Rectal biopsy helps to distinguish acute self-limited colitis from idiopathic inflammatory bowel disease","volume":"86","author":"C M Surawicz","year":"1984","journal-title":"Gastroenterology"},{"key":"ref120","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1046\/j.1440-1746.2001.02638.x","article-title":"Observer variation of diagnoses based on simple biopsy criteria differentiating among Crohn\u2019s disease, ulcerative colitis, and other forms of colitis","volume":"16","author":"M Tanaka","year":"2001","journal-title":"J Gastroenterol Hepatol"},{"key":"ref121","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/00365529950172844","article-title":"Morphologic criteria applicable to biopsy specimens for effective distinction of inflammatory bowel disease from other forms of colitis and of Crohn\u2019s disease from ulcerative colitis","volume":"34","author":"M Tanaka","year":"1999","journal-title":"Scand J Gastroenterol"},{"key":"ref122","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1080\/003655200750024155","article-title":"Simple mucosal biopsy criteria differentiating among Crohn disease, ulcerative colitis, and other forms of colitis: measurement of validity","volume":"35","author":"M Tanaka","year":"2000","journal-title":"Scand J Gastroenterol"},{"key":"ref123","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1136\/gut.35.7.961","article-title":"Observer variation and discriminatory value of biopsy features in inflammatory bowel disease","volume":"35","author":"A Theodossi","year":"1994","journal-title":"Gut"},{"key":"ref124","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1111\/j.1572-0241.2007.01194.x","article-title":"The diagnostic value of endoscopic terminal ileum biopsies","volume":"102","author":"J B McHugh","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"ref125","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1111\/j.1572-0241.2004.40730.x","article-title":"Is routine ileoscopy useful? An observational study of procedure times, diagnostic yield, and learning curve","volume":"99","author":"S Cherian","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"ref126","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1572-0241.1998.00201.x","article-title":"Is ileoscopy with biopsy worthwhile in patients presenting with symptoms of inflammatory bowel disease?","volume":"93","author":"K Geboes","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"ref127","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1111\/j.1440-1746.2005.03954.x","article-title":"Role of esophagogastroduodenoscopy in the initial assessment of children with inflammatory bowel disease","volume":"20","author":"D A Lemberg","year":"2005","journal-title":"J Gastroenterol Hepatol"},{"key":"ref128","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/BF01295652","article-title":"Serial sectioning of a portion of a rectal biopsy detects more focal abnormalities: a prospective study of patients with inflammatory bowel disease","volume":"27","author":"C M Surawicz","year":"1982","journal-title":"Dig Dis Sci"},{"key":"ref129","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/0016-5085(81)90192-X","article-title":"Rectal biopsy in the diagnosis of Crohn\u2019s disease: value of multiple biopsies and serial sectioning","volume":"80","author":"C M Surawicz","year":"1981","journal-title":"Gastroenterology"},{"key":"ref130","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3109\/00365528909093031","article-title":"The final outcome of patients presenting with their first episode of acute diarrhoea and an inflamed rectal mucosa with preserved crypt architecture. A clinicopathologic study","volume":"24","author":"M H Therkildsen","year":"1989","journal-title":"Scand J Gastroenterol"},{"key":"ref131","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1097\/00000478-200211000-00006","article-title":"Histopathology of ulcerative colitis in initial rectal biopsy in children","volume":"26","author":"K Washington","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"ref132","doi-asserted-by":"crossref","first-page":"III37","DOI":"10.1136\/gut.50.suppl_3.iii37","article-title":"Influence of treatment on morphological features of mucosal inflammation","volume":"50 Suppl 3","author":"K Geboes","year":"2002","journal-title":"Gut"},{"key":"ref133","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1097\/00000478-199309000-00002","article-title":"Effect of topical 5-aminosalicylic acid (5-ASA) therapy on rectal mucosal biopsy morphology in chronic ulcerative colitis","volume":"17","author":"R Odze","year":"1993","journal-title":"Am J Surg Pathol"},{"key":"ref134","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1097\/00000478-199808000-00008","article-title":"Ulcerative colitis: patterns of involvement in colorectal biopsies and changes with time","volume":"22","author":"C G Kleer","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"ref135","first-page":"110","volume-title":"Chronisch entz\u00fcndliche Darmerkrankungen Das CED-Handbuch f\u00fcr Klinik und Praxis","author":"F Autschbach","year":"2004"},{"key":"ref136","first-page":"110","article-title":"[Differential diagnosis of colitis]","volume":"83","author":"F Borchard","year":"1999","journal-title":"Verh Dtsch Ges Pathol"},{"key":"ref137","first-page":"276","article-title":"Histopathologische Diagnostik chronischentz\u00fcndlicher Darmerkrankungen. Historischer R\u00fcckblick und aktuelle \u00dcbersicht","volume":"20","author":"A vH","year":"1999","journal-title":"Pathologe"},{"key":"ref138","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1136\/gut.27.1.92","article-title":"Relationship between disease activity indices and colonoscopic findings in patients with colonic inflammatory bowel disease","volume":"27","author":"P Gomes","year":"1986","journal-title":"Gut"},{"key":"ref139","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/S0016-5085(99)70005-3","article-title":"Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn\u2019s disease: A European multicenter trial","volume":"116","author":"G D\u2019Haens","year":"1999","journal-title":"Gastroenterology"},{"key":"ref140","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1136\/gut.32.2.174","article-title":"Microscopic activity in ulcerative colitis: what does it mean?","volume":"32","author":"S A Riley","year":"1991","journal-title":"Gut"},{"key":"ref141","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1053\/gast.2001.20912","article-title":"Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis","volume":"120","author":"A Bitton","year":"2001","journal-title":"Gastroenterology"},{"key":"ref142","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1136\/gut.2005.086900","article-title":"Pit patterns in rectal mucosa assessed by magnifying colonoscope are predictive of relapse in patients with quiescent ulcerative colitis","volume":"55","author":"Y Nishio","year":"2006","journal-title":"Gut"},{"key":"ref143","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1136\/gutjnl-2015-310187","article-title":"Development and validation of the Nancy histological index for UC","volume":"66","author":"A Marchal-Bressenot","year":"2017","journal-title":"Gut"},{"key":"ref144","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1136\/gutjnl-2015-310393","article-title":"Development and validation of a histological index for UC","volume":"66","author":"M H Mosli","year":"2017","journal-title":"Gut"},{"key":"ref145","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S0046-8177(83)80175-0","article-title":"Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications","volume":"14","author":"R H Riddell","year":"1983","journal-title":"Hum Pathol"},{"key":"ref146","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1002\/(SICI)1097-0142(19961201)78:11<2261::AID-CNCR1>3.0.CO;2-Q","article-title":"Significance and detection of dysplasia in chronic colitis","volume":"78","author":"H Goldman","year":"1996","journal-title":"Cancer"},{"key":"ref147","first-page":"57","article-title":"Chronic inflammatory bowel disease and cancer","volume":"47","author":"C Pohl","year":"2000","journal-title":"Hepatogastroenterology"},{"key":"ref148","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/0046-8177(89)90273-6","article-title":"Observer study of the grading of dysplasia in ulcerative colitis: comparison with clinical outcome","volume":"20","author":"D M Melville","year":"1989","journal-title":"Hum Pathol"},{"key":"ref149","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/path.876","article-title":"Inter-observer variation between general and specialist gastrointestinal pathologists when grading dysplasia in ulcerative colitis","volume":"194","author":"J Eaden","year":"2001","journal-title":"J Pathol"},{"key":"ref150","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/modpathol.3880534","article-title":"Interobserver variability in the diagnosis of ulcerative colitis-associated dysplasia by telepathology","volume":"15","author":"R D Odze","year":"2002","journal-title":"Mod Pathol"},{"key":"ref151","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1046\/j.1440-1827.1999.00965.x","article-title":"p53 immunohistochemistry of ulcerative colitis-associated with dysplasia and carcinoma","volume":"49","author":"A Sato","year":"1999","journal-title":"Pathol Int"},{"key":"ref152","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/modpathol.2013.133","article-title":"Diagnostic utility of TP53 and cytokeratin 7 immunohistochemistry in idiopathic inflammatory bowel disease-associated neoplasia","volume":"27","author":"H Xie","year":"2014","journal-title":"Mod Pathol"},{"key":"ref153","first-page":"107","article-title":"Usefulness of analysis of p53 alteration and observation of surface microstructure for diagnosis of ulcerative colitis-associated colorectal neoplasia","volume":"22","author":"S Fujii","year":"2003","journal-title":"J Exp Clin Cancer Res"},{"key":"ref154","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.crohns.2012.09.003","article-title":"Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part\u00a01: definitions and diagnosis","volume":"6","author":"A Dignass","year":"2012","journal-title":"J Crohns Colitis"},{"key":"ref155","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1093\/ecco-jcc\/jjx008","article-title":"Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders","volume":"11","author":"F Magro","year":"2017","journal-title":"J Crohns Colitis"},{"key":"ref156","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.gie.2014.12.009","article-title":"SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease","volume":"81","author":"L Laine","year":"2015","journal-title":"Gastrointest Endosc"},{"key":"ref157","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1053\/j.gastro.2009.12.037","article-title":"AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease","volume":"138","author":"F A Farraye","year":"2010","journal-title":"Gastroenterology"},{"key":"ref158","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/S0016-5107(04)01710-9","article-title":"Most dysplasia in ulcerative colitis is visible at colonoscopy","volume":"60","author":"M D Rutter","year":"2004","journal-title":"Gastrointest Endosc"},{"key":"ref159","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/0016-5085(81)90727-7","article-title":"Dysplasia-associated lesion or mass (DALM) detected by colonoscopy in long-standing ulcerative colitis: an indication for colectomy","volume":"80","author":"M O Blackstone","year":"1981","journal-title":"Gastroenterology"},{"key":"ref160","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1136\/gut.31.7.800","article-title":"Precancer and cancer in extensive ulcerative colitis: findings among 401 patients over 22 years","volume":"31","author":"J E Lennard-Jones","year":"1990","journal-title":"Gut"},{"key":"ref161","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/BF01393356","article-title":"Macroscopic lesions in dysplasia and carcinoma complicating ulcerative colitis","volume":"28","author":"J H Butt","year":"1983","journal-title":"Dig Dis Sci"},{"key":"ref162","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1038\/s41395-018-0354-7","article-title":"Strategies for Detecting Colorectal Cancer in Patients with Inflammatory Bowel Disease: A Cochrane Systematic Review and Meta-Analysis","volume":"113","author":"W A Bye","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"ref163","doi-asserted-by":"publisher","first-page":"CD000279","DOI":"10.1002\/14651858.CD000279.pub3","article-title":"Strategies for detecting colon cancer and\/or dysplasia in patients with inflammatory bowel disease","author":"P D Collins","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"ref164","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/S1542-3565(04)00543-9","article-title":"Long-term risk of cancer in ulcerative colitis: a population-based cohort study from Copenhagen County","volume":"2","author":"K V Winther","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref165","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1136\/gut.2007.143453","article-title":"High frequency of early colorectal cancer in inflammatory bowel disease","volume":"57","author":"M W Lutgens","year":"2008","journal-title":"Gut"},{"key":"ref166","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1038\/sj.bjc.6605359","article-title":"Colonoscopic surveillance improves survival after colorectal cancer diagnosis in inflammatory bowel disease","volume":"101","author":"M W Lutgens","year":"2009","journal-title":"Br J Cancer"},{"key":"ref167","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/apt.12651","article-title":"Systematic review with meta-analysis: the declining risk of colorectal cancer in ulcerative colitis","volume":"39","author":"C Casta\u00f1o-Milla","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"ref168","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0140-6736(19)32545-0","article-title":"Colorectal cancer in ulcerative colitis: a Scandinavian population-based cohort study","volume":"395","author":"O Ol\u00e9n","year":"2020","journal-title":"Lancet"},{"key":"ref169","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1053\/j.gastro.2012.04.016","article-title":"Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years","volume":"143","author":"T Jess","year":"2012","journal-title":"Gastroenterology"},{"key":"ref170","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.crohns.2013.09.016","article-title":"European evidence based consensus for endoscopy in inflammatory bowel disease","volume":"7","author":"V Annese","year":"2013","journal-title":"J Crohns Colitis"},{"key":"ref171","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1053\/j.gastro.2012.04.054","article-title":"Incidence and mortality of colorectal adenocarcinoma in persons with inflammatory bowel disease from 1998 to 2010","volume":"143","author":"L J Herrinton","year":"2012","journal-title":"Gastroenterology"},{"key":"ref172","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1093\/ecco-jcc\/jjaa040","article-title":"Reappraising Risk Factors for Inflammatory Bowel Disease-associated Neoplasia: Implications for Colonoscopic Surveillance in IBD","volume":"14","author":"S C Shah","year":"2020","journal-title":"J Crohns Colitis"},{"key":"ref173","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1136\/gutjnl-2017-314190","article-title":"Cumulative burden of inflammation predicts colorectal neoplasia risk in ulcerative colitis: a large single-centre study","volume":"68","author":"C R Choi","year":"2019","journal-title":"Gut"},{"key":"ref174","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3748\/wjg.v23.i3.472","article-title":"Incidental adenocarcinoma in patients undergoing surgery for stricturing Crohn\u2019s disease","volume":"23","author":"I Kristo","year":"2017","journal-title":"World J Gastroenterol"},{"key":"ref175","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.3390\/cancers15133361","article-title":"Frequency and predictors of dysplasia in pseudopolyp-like colorectal lesions in patients with long-standing inflammatory bowel disease","volume":"15","author":"E De Cristafaro","year":"2023","journal-title":"Cancers"},{"key":"ref176","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/ajg.2010.428","article-title":"The risk of inflammatory bowel disease-related colorectal carcinoma is limited: results from a nationwide nested case-control study","volume":"106","author":"J E Baars","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"ref177","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1053\/j.gastro.2006.03.028","article-title":"Predictive and protective factors associated with colorectal cancer in ulcerative colitis: A case-control study","volume":"130","author":"F S Velayos","year":"2006","journal-title":"Gastroenterology"},{"key":"ref178","doi-asserted-by":"crossref","first-page":"8783","DOI":"10.3748\/wjg.v20.i27.8783","article-title":"Primary sclerosing cholangitis as an independent risk factor for colorectal cancer in the context of inflammatory bowel disease: a review of the literature","volume":"20","author":"R Wang","year":"2014","journal-title":"World J Gastroenterol"},{"key":"ref179","doi-asserted-by":"crossref","first-page":"e319","DOI":"10.1097\/SLA.0000000000005339","article-title":"Survival Outcomes and Clinicopathological Features in Inflammatory Bowel Disease-associated Colorectal Cancer: A Systematic Review and Meta-analysis","volume":"276","author":"C Lu","year":"2022","journal-title":"Ann Surg"},{"key":"ref180","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/ajg.2013.249","article-title":"Cancer risk in inflammatory bowel disease according to patient phenotype and treatment: a Danish population-based cohort study","volume":"108","author":"T Jess","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"ref181","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1053\/j.gastro.2020.12.036","article-title":"Prognostic Factors for Advanced Colorectal Neoplasia in Inflammatory Bowel Disease: Systematic Review and Meta-analysis","volume":"160","author":"A M Wijnands","year":"2021","journal-title":"Gastroenterology"},{"key":"ref182","first-page":"Cd000279","article-title":"Strategies for detecting colon cancer in patients with inflammatory bowel disease","volume":"9","author":"W A Bye","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"ref183","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1111\/j.1572-0241.1999.01145.x","article-title":"Change in the extent of colonoscopic and histological involvement in ulcerative colitis over time","volume":"94","author":"B Moum","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"ref184","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/00042737-199606000-00011","article-title":"Progression of ulcerative proctosigmoiditis: incidence and factors influencing progression","volume":"8","author":"R C Ayres","year":"1996","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref185","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3109\/00365529609004876","article-title":"Changes in extent of ulcerative colitis: a study on the course and prognostic factors","volume":"31","author":"E Langholz","year":"1996","journal-title":"Scand J Gastroenterol"},{"key":"ref186","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1080\/00365520802600961","article-title":"Clinical course during the first 10\u00a0years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study)","volume":"44","author":"I C Solberg","year":"2009","journal-title":"Scand J Gastroenterol"},{"key":"ref187","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1111\/apt.14063","article-title":"Systematic review with meta-analysis: proximal disease extension in limited ulcerative colitis","volume":"45","author":"G Roda","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"ref188","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.cgh.2014.07.018","article-title":"Colonoscopy is associated with a reduced risk for colon cancer and mortality in patients with inflammatory bowel diseases","volume":"13","author":"A N Ananthakrishnan","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref189","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1055\/s-2006-925259","article-title":"Judgement of the quality of bowel preparation at screening flexible sigmoidoscopy is associated with variability in adenoma detection rates","volume":"38","author":"S Thomas-Gibson","year":"2006","journal-title":"Endoscopy"},{"key":"ref190","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/01.MIB.0000158951.54388.3a","article-title":"Endoscopic factors in the diagnosis of colorectal dysplasia in chronic inflammatory bowel disease","volume":"11","author":"M Toruner","year":"2005","journal-title":"Inflamm Bowel Dis"},{"key":"ref191","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1097\/MIB.0b013e31828029c0","article-title":"Declining risk of colorectal cancer in inflammatory bowel disease: an updated meta-analysis of population-based cohort studies","volume":"19","author":"M W Lutgens","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"ref192","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.cgh.2016.11.025","article-title":"Incidence, Risk Factors, and Outcomes of Colorectal Cancer in Patients With Ulcerative Colitis With Low-Grade Dysplasia: A Systematic Review and Meta-analysis","volume":"15","author":"M Fumery","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref193","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1097\/MIB.0000000000001214","article-title":"Clinical Predictors and Natural History of Disease Extension in Patients with Ulcerative Proctitis","volume":"23","author":"E Walsh","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"ref194","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/gut.48.4.526","article-title":"The risk of colorectal cancer in ulcerative colitis: a meta-analysis","volume":"48","author":"J A Eaden","year":"2001","journal-title":"Gut"},{"key":"ref195","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1053\/gast.2001.22434","article-title":"Backwash ileitis is strongly associated with colorectal carcinoma in ulcerative colitis","volume":"120","author":"U A Heuschen","year":"2001","journal-title":"Gastroenterology"},{"key":"ref196","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1002\/ibd.20886","article-title":"More right-sided IBD-associated colorectal cancer in patients with primary sclerosing cholangitis","volume":"15","author":"M M Claessen","year":"2009","journal-title":"Inflamm Bowel Dis"},{"key":"ref197","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/MEG.0000000000000576","article-title":"Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease: a meta-analysis of 16 observational studies","volume":"28","author":"H H Zheng","year":"2016","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref198","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1136\/gutjnl-2016-311892","article-title":"Are random biopsies still useful for the detection of neoplasia in patients with IBD undergoing surveillance colonoscopy with chromoendoscopy?","volume":"67","author":"D Moussata","year":"2018","journal-title":"Gut"},{"key":"ref199","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.cgh.2024.05.045","article-title":"Additional Yield of Random Biopsy in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis","volume":"23","author":"L Gao","year":"2025","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref200","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1093\/ecco-jcc\/jjad189","article-title":"Cancer Biology or Ineffective Surveillance? A Multicentre Retrospective Analysis of Colitis-Associated Post-Colonoscopy Colorectal Cancers","volume":"18","author":"M Kabir","year":"2024","journal-title":"J Crohns Colitis"},{"key":"ref201","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izae274","article-title":"Undetected Dysplasia at Colectomy in Patients With Inflammatory Bowel Diseases. What Are We Missing?","author":"E Centorrino","year":"2024","journal-title":"Inflamm Bowel Dis"},{"key":"ref202","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1053\/j.gastro.2013.04.008","article-title":"The detection of nonpolypoid (flat and depressed) colorectal neoplasms in patients with inflammatory bowel disease","volume":"144","author":"R Soetikno","year":"2013","journal-title":"Gastroenterology"},{"key":"ref203","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1016\/j.cgh.2020.04.049","article-title":"High-Definition Chromoendoscopy Superior to High-Definition White-Light Endoscopy in Surveillance of Inflammatory Bowel Diseases in a Randomized Trial","volume":"18","author":"B Alexandersson","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref204","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ijsu.2018.02.028","article-title":"Detecting dysplasia using white light endoscopy or chromoendoscopy in ulcerative colitis patients without primary sclerosing cholangitis: A systematic review and meta-analysis","volume":"52","author":"S Azizi","year":"2018","journal-title":"Int J Surg"},{"key":"ref205","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1093\/ibd\/izy188","article-title":"Comparison of Endoscopic Dysplasia Detection Techniques in Patients With Ulcerative Colitis: A Systematic Review and Network Meta-analysis","volume":"24","author":"T Bessissow","year":"2018","journal-title":"Inflamm Bowel Dis"},{"key":"ref206","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1136\/gutjnl-2016-313213","article-title":"Chromoendoscopy versus narrow band imaging in UC: a prospective randomised controlled trial","volume":"67","author":"R Bisschops","year":"2018","journal-title":"Gut"},{"key":"ref207","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1093\/ibd\/izaa011","article-title":"Meta-analysis of Virtual-based Chromoendoscopy Compared With Dye-spraying Chromoendoscopy Standard and High-definition White Light Endoscopy in Patients With Inflammatory Bowel Disease at Increased Risk of Colon Cancer","volume":"26","author":"M El-Dallal","year":"2020","journal-title":"Inflamm Bowel Dis"},{"key":"ref208","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.gie.2019.04.219","article-title":"Meta-analysis of dye-based chromoendoscopy compared with standard- and high-definition white-light endoscopy in patients with inflammatory bowel disease at increased risk of colon cancer","volume":"90","author":"J D Feuerstein","year":"2019","journal-title":"Gastrointest Endosc"},{"key":"ref209","doi-asserted-by":"crossref","first-page":"159","DOI":"10.4253\/wjge.v12.i5.159","article-title":"Efficacy of various endoscopic modalities in detecting dysplasia in ulcerative colitis: A systematic review and network meta-analysis","volume":"12","author":"B Gondal","year":"2020","journal-title":"World J Gastrointest Endosc"},{"key":"ref210","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1093\/ibd\/izaa291","article-title":"Chromoendoscopy With Indigo Carmine vs Virtual Chromoendoscopy (iSCAN 1) for Neoplasia Screening in Patients With Inflammatory Bowel Disease: A Prospective Randomized Study","volume":"27","author":"O Gonz\u00e1lez-Bernardo","year":"2021","journal-title":"Inflamm Bowel Dis"},{"key":"ref211","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1007\/s10620-017-4772-y","article-title":"Chromoendoscopy, Narrow-Band Imaging or White Light Endoscopy for Neoplasia Detection in Inflammatory Bowel Diseases","volume":"62","author":"O Har-Noy","year":"2017","journal-title":"Dig Dis Sci"},{"key":"ref212","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/ajg.2017.417","article-title":"A Randomized Trial Comparing High Definition Colonoscopy Alone With High Definition Dye Spraying and Electronic Virtual Chromoendoscopy for Detection of Colonic Neoplastic Lesions During IBD Surveillance Colonoscopy","volume":"113","author":"M Iacucci","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"ref213","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1111\/apt.15493","article-title":"Systematic review with network meta-analysis: endoscopic techniques for dysplasia surveillance in inflammatory bowel disease","volume":"50","author":"A Iannone","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"ref214","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1016\/j.cgh.2016.11.021","article-title":"Chromoendoscopy for Surveillance in Ulcerative Colitis and Crohn\u2019s Disease: A Systematic Review of Randomized Trials","volume":"15","author":"A Iannone","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref215","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1093\/ecco-jcc\/jjy218","article-title":"Augmented Endoscopy for Surveillance of Colonic Inflammatory Bowel Disease: Systematic Review With Network Meta-analysis","volume":"13","author":"N Imperatore","year":"2019","journal-title":"J Crohns Colitis"},{"key":"ref216","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1136\/gutjnl-2020-320980","article-title":"Multicentre randomised controlled trial on virtual chromoendoscopy in the detection of neoplasia during colitis surveillance high-definition colonoscopy (the VIRTUOSO trial)","volume":"70","author":"K Kandiah","year":"2021","journal-title":"Gut"},{"key":"ref217","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1053\/j.gastro.2017.01.008","article-title":"Full-Spectrum Endoscopy Improves Surveillance for Dysplasia in Patients With Inflammatory Bowel Diseases","volume":"152","author":"R W Leong","year":"2017","journal-title":"Gastroenterology"},{"key":"ref218","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/MCG.0000000000001101","article-title":"Narrow Band Imaging for Surveillance in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis","volume":"53","author":"X H Lv","year":"2019","journal-title":"J Clin Gastroenterol"},{"key":"ref219","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1136\/gutjnl-2016-311892","article-title":"Are random biopsies still useful for the detection of neoplasia in patients with IBD undergoing surveillance colonoscopy with chromoendoscopy?","volume":"67","author":"D Moussata","year":"2018","journal-title":"Gut"},{"key":"ref220","doi-asserted-by":"crossref","first-page":"E578","DOI":"10.1055\/a-1120-8376","article-title":"Surveillance in inflammatory bowel disease: is chromoendoscopy the only way to go? A systematic review and meta-analysis of randomized clinical trials","volume":"8","author":"R H Resende","year":"2020","journal-title":"Endosc Int Open"},{"key":"ref221","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S2468-1253(18)30055-4","article-title":"Chromoendoscopy versus autofluorescence imaging for neoplasia detection in patients with longstanding ulcerative colitis (FIND-UC): an international, multicentre, randomised controlled trial","volume":"3","author":"J LA Vleugels","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref222","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/1751-2980.12714","article-title":"Systematic review with meta-analysis: Chromoendoscopy versus white light endoscopy in detection of dysplasia in patients with inflammatory bowel disease","volume":"20","author":"J Wan","year":"2019","journal-title":"J Dig Dis"},{"key":"ref223","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/ibd.23002","article-title":"Comparison of high definition with standard white light endoscopy for detection of dysplastic lesions during surveillance colonoscopy in patients with colonic inflammatory bowel disease","volume":"19","author":"V Subramanian","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"ref224","doi-asserted-by":"crossref","first-page":"otae020","DOI":"10.1093\/crocol\/otae020","article-title":"Longer Colonoscopy Withdrawal Time Is Associated With the Detection of Visible Dysplasia in Patients With Inflammatory Bowel Disease","volume":"6","author":"C McMillan","year":"2024","journal-title":"Crohns Colitis 360"},{"key":"ref225","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.cgh.2022.12.010","article-title":"Quality of Surveillance Impacts the Colitis-Associated Advanced Neoplasia Risk: A Multicenter Case-Control Study","volume":"22","author":"M Te Groen","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref226","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S2468-1253(19)30194-3","article-title":"Improving the quality of surveillance colonoscopy in inflammatory bowel disease","volume":"4","author":"M Iacucci","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref227","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1136\/gutjnl-2024-333446","article-title":"Surveillance in inflammatory bowel disease: white light endoscopy with segmental re-inspection versus dye-based chromoendoscopy \u2013 a multi-arm randomised controlled trial (HELIOS)","volume":"74","author":"M Te Groen","year":"2025","journal-title":"Gut"},{"key":"ref228","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1053\/j.gastro.2016.08.002","article-title":"Comparison of Targeted vs Random Biopsies for Surveillance of Ulcerative Colitis-Associated Colorectal Cancer","volume":"151","author":"T Watanabe","year":"2016","journal-title":"Gastroenterology"},{"key":"ref229","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.gie.2017.09.024","article-title":"Pit pattern analysis with high-definition chromoendoscopy and narrow-band imaging for optical diagnosis of dysplasia in patients with ulcerative colitis","volume":"86","author":"R Bisschops","year":"2017","journal-title":"Gastrointest Endosc"},{"key":"ref230","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/ecco-jcc\/jjac187","article-title":"ECCO Guidelines on Inflammatory Bowel Disease and Malignancies","volume":"17","author":"H Gordon","year":"2023","journal-title":"J Crohns Colitis"},{"key":"ref231","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1365-2036.2007.03241.x","article-title":"Meta-analysis: cancer risk of low-grade dysplasia in chronic ulcerative colitis","volume":"25","author":"T Thomas","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"ref232","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1016\/j.cgh.2019.05.062","article-title":"Risk of Development of More-advanced Lesions in Patients With Inflammatory Bowel Diseases and Dysplasia","volume":"18","author":"A Cremer","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref233","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.cgh.2013.07.024","article-title":"Cancer risk after resection of polypoid dysplasia in patients with longstanding ulcerative colitis: a meta-analysis","volume":"12","author":"L K Wanders","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref234","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/apt.15778","article-title":"Systematic review with meta-analysis: IBD-associated colonic dysplasia prognosis in the videoendoscopic era (1990 to present)","volume":"52","author":"M Kabir","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"ref235","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1053\/j.gastro.2005.12.035","article-title":"Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis","volume":"130","author":"M D Rutter","year":"2006","journal-title":"Gastroenterology"},{"key":"ref236","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1136\/gut.2009.179804","article-title":"Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002)","volume":"59","author":"S R Cairns","year":"2010","journal-title":"Gut"},{"key":"ref237","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.gie.2018.01.013","article-title":"Endoscopic submucosal dissection for nonpolypoid colorectal dysplasia in patients with inflammatory bowel disease: in medias res","volume":"87","author":"R Soetikno","year":"2018","journal-title":"Gastrointest Endosc"},{"key":"ref238","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.gastro.2003.08.023","article-title":"Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis","volume":"125","author":"T Ullman","year":"2003","journal-title":"Gastroenterology"},{"key":"ref239","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1136\/gut.52.8.1127","article-title":"Ten year follow up of ulcerative colitis patients with and without low grade dysplasia","volume":"52","author":"C H Lim","year":"2003","journal-title":"Gut"},{"key":"ref240","first-page":"161","article-title":"Clinical implications of low grade dysplasia found during inflammatory bowel disease surveillance: a retrospective study comparing chromoendoscopy and white-light endoscopy","volume":"49","author":"J R Ten Hove","year":"2017","journal-title":"Endoscopy"},{"key":"ref241","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1002\/ibd.22912","article-title":"Prospective study of the progression of low-grade dysplasia in ulcerative colitis using current cancer surveillance guidelines","volume":"18","author":"T L Zisman","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"ref242","doi-asserted-by":"crossref","first-page":"E994","DOI":"10.1055\/a-0953-2021","article-title":"Outcome of endoscopic resection of colonic polyps larger than 10\u200amm in patients with inflammatory bowel disease","volume":"7","author":"S Yadav","year":"2019","journal-title":"Endosc Int Open"},{"key":"ref243","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1093\/ibd\/izx113","article-title":"Outcomes of Endoscopic Resections of Large Laterally Spreading Colorectal Lesions in Inflammatory Bowel Disease: a Single United Kingdom Center Experience","volume":"24","author":"S Gulati","year":"2018","journal-title":"Inflamm Bowel Dis"},{"key":"ref244","doi-asserted-by":"crossref","first-page":"e684","DOI":"10.1016\/j.crohns.2013.06.006","article-title":"Progression of low-grade dysplasia to advanced neoplasia based on the location and morphology of dysplasia in ulcerative colitis patients with extensive colitis under colonoscopic surveillance","volume":"7","author":"U Navaneethan","year":"2013","journal-title":"J Crohns Colitis"},{"key":"ref245","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1136\/gut.2005.075531","article-title":"Sporadic adenoma in ulcerative colitis: endoscopic resection is an adequate treatment","volume":"55","author":"M Vieth","year":"2006","journal-title":"Gut"},{"key":"ref246","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1053\/gast.2003.50156","article-title":"Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis","volume":"124","author":"D S Pardi","year":"2003","journal-title":"Gastroenterology"},{"key":"ref247","doi-asserted-by":"crossref","first-page":"89","DOI":"10.7326\/0003-4819-134-2-200101160-00008","article-title":"Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis","volume":"134","author":"B Y Tung","year":"2001","journal-title":"Ann Intern Med"},{"key":"ref248","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/hep.23082","article-title":"High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis","volume":"50","author":"K D Lindor","year":"2009","journal-title":"Hepatology"},{"key":"ref249","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/ecco-jcc\/jjv081","article-title":"The Impact of Endoscopic Inflammation and Mucosal Healing on Health-related Quality of Life in Ulcerative Colitis Patients","volume":"9","author":"K Theede","year":"2015","journal-title":"J Crohns Colitis"},{"key":"ref250","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1007\/s12325-023-02488-z","article-title":"A Systematic Review of the Economic and Health-Related Quality of Life Impact of Advanced Therapies Used to Treat Moderate-to-Severe Ulcerative Colitis","volume":"40","author":"A Cichewicz","year":"2023","journal-title":"Adv Ther"},{"key":"ref251","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1053\/j.gastro.2020.10.065","article-title":"Selecting End Points for Disease-Modification Trials in Inflammatory Bowel Disease: the SPIRIT Consensus From the IOIBD","volume":"160","author":"C Le Berre","year":"2021","journal-title":"Gastroenterology"},{"key":"ref252","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1111\/apt.13387","article-title":"Randomised clinical study: discrepancies between patient-reported outcomes and endoscopic appearance in moderate to severe ulcerative colitis","volume":"42","author":"B Jharap","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"ref253","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.cgh.2018.08.001","article-title":"AGA Clinical Practice Update on Functional Gastrointestinal Symptoms in Patients With Inflammatory Bowel Disease: Expert Review","volume":"17","author":"J F Colombel","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref254","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S2468-1253(20)30300-9","article-title":"Prevalence of irritable bowel syndrome-type symptoms in patients with inflammatory bowel disease in remission: a systematic review and meta-analysis","volume":"5","author":"K M Fairbrass","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref255","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/ecco-jcc\/jjx152","article-title":"Irritable Bowel-like Symptoms in Ulcerative Colitis are as Common in Patients in Deep Remission as in Inflammation: Results From a Population-based Study [the IBSEN Study]","volume":"12","author":"M Henriksen","year":"2018","journal-title":"J Crohns Colitis"},{"key":"ref256","doi-asserted-by":"publisher","first-page":"CD008655","DOI":"10.1002\/14651858.CD008655.pub3","article-title":"The impact of biological interventions for ulcerative colitis on health-related quality of life","author":"K Le Blanc","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"ref257","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/ajg.2011.67","article-title":"Efficacy of 5-aminosalicylates in ulcerative colitis: systematic review and meta-analysis","volume":"106","author":"A C Ford","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"ref258","doi-asserted-by":"publisher","first-page":"CD000478","DOI":"10.1002\/14651858.CD000478.pub4","article-title":"Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis","author":"A Timmer","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"ref259","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1053\/j.gastro.2011.06.054","article-title":"Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis","volume":"141","author":"J F Colombel","year":"2011","journal-title":"Gastroenterology"},{"key":"ref260","doi-asserted-by":"publisher","first-page":"CD004115","DOI":"10.1002\/14651858.CD004115.pub2","article-title":"Rectal 5-aminosalicylic acid for induction of remission in ulcerative colitis","author":"J K Marshall","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"ref261","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1097\/MIB.0000000000000141","article-title":"Drug therapies for ulcerative proctitis: systematic review and meta-analysis","volume":"20","author":"M R Lie","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"ref262","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1097\/MIB.0000000000000379","article-title":"Systematic Review: Rectal Therapies for the Treatment of Distal Forms of Ulcerative Colitis","volume":"21","author":"R D Cohen","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"ref263","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1093\/ecco-jcc\/jjab218","article-title":"Efficacy of Pharmacological Agents for Ulcerative Proctitis: A Systematic Literature Review","volume":"16","author":"B Caron","year":"2022","journal-title":"J Crohns Colitis"},{"key":"ref264","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1002\/ibd.21258","article-title":"Clinical trial: a novel high-dose 1g mesalamine suppository (Salofalk) once daily is as efficacious as a 500-mg suppository thrice daily in active ulcerative proctitis","volume":"16","author":"T Andus","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"ref265","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1002\/ibd.22939","article-title":"High mucosal healing rates in 5-ASA-treated ulcerative colitis patients: results of a meta-analysis of clinical trials","volume":"18","author":"T E Romkens","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"ref266","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s10620-010-1334-y","article-title":"A multicenter, randomized study to evaluate the efficacy and safety of mesalamine suppositories 1g at bedtime and 500 mg Twice daily in patients with active mild-to-moderate ulcerative proctitis","volume":"56","author":"M Lamet","year":"2011","journal-title":"Dig Dis Sci"},{"key":"ref267","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1097\/00054725-200411000-00006","article-title":"Oral mesalazine (5-ASA) treatment may protect against proximal extension of mucosal inflammation in ulcerative proctitis","volume":"10","author":"R Pica","year":"2004","journal-title":"Inflamm Bowel Dis"},{"key":"ref268","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/BF02236902","article-title":"Comparison of oral with rectal mesalazine in the treatment of ulcerative proctitis","volume":"41","author":"P Gionchetti","year":"1998","journal-title":"Dis Colon Rectum"},{"key":"ref269","first-page":"677","article-title":"Mesalazine foam (Salofalk foam) in the treatment of active distal ulcerative colitis. A comparative trial vs Salofalk enema. The SAF-3 study group","volume":"31","author":"S Ardizzone","year":"1999","journal-title":"Ital J Gastroenterol Hepatol"},{"key":"ref270","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1111\/j.1572-0241.2008.02152.x","article-title":"Mesalamine foam enema versus mesalamine liquid enema in active left-sided ulcerative colitis","volume":"103","author":"A Cortot","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"ref271","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.cgh.2018.04.027","article-title":"Budesonide Suppositories Are Effective and Safe for Treating Acute Ulcerative Proctitis","volume":"17","author":"W Kruis","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref272","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1093\/ecco-jcc\/jjac081","article-title":"Novel Budesonide Suppository and Standard Budesonide Rectal Foam Induce High Rates of Clinical Remission and Mucosal Healing in Active Ulcerative Proctitis: a Randomised, Controlled, Non-inferiority Trial","volume":"16","author":"W Kruis","year":"2022","journal-title":"J Crohns Colitis"},{"key":"ref273","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.crohns.2009.08.003","article-title":"Mesalazine vanishing time from rectal mucosa following its topical administration","volume":"4","author":"M T Pimpo","year":"2010","journal-title":"J Crohns Colitis"},{"key":"ref274","first-page":"CD000543","article-title":"Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis","volume":"4","author":"Y Wang","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"ref275","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1002\/ibd.23024","article-title":"Once daily oral mesalamine compared to conventional dosing for induction and maintenance of remission in ulcerative colitis: a systematic review and meta-analysis","volume":"18","author":"B G Feagan","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"ref276","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1053\/j.gastro.2015.01.037","article-title":"Budesonide foam induces remission in patients with mild to moderate ulcerative proctitis and ulcerative proctosigmoiditis","volume":"148","author":"W J Sandborn","year":"2015","journal-title":"Gastroenterology"},{"key":"ref277","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1097\/MIB.0000000000000860","article-title":"Baseline Oral 5-ASA Use and Efficacy and Safety of Budesonide Foam in Patients with Ulcerative Proctitis and Ulcerative Proctosigmoiditis: Analysis of 2 Phase 3 Studies","volume":"22","author":"B P Bosworth","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"ref278","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/ibd.20263","article-title":"Efficacy and safety of tacrolimus in refractory ulcerative colitis and Crohn\u2019s disease: a single-center experience","volume":"14","author":"A Benson","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"ref279","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.cgh.2017.02.027","article-title":"Efficacy of Rectal Tacrolimus for Induction Therapy in Patients With Resistant Ulcerative Proctitis","volume":"15","author":"I C Lawrance","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref280","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1093\/ecco-jcc\/jjx032","article-title":"Budesonide Multimatrix Is Efficacious for Mesalamine-refractory, Mild to Moderate Ulcerative Colitis: A Randomised, Placebo-controlled Trial","volume":"11","author":"D T Rubin","year":"2017","journal-title":"J Crohns Colitis"},{"key":"ref281","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/j.1365-2036.2011.04620.x","article-title":"Randomised clinical trial: early assessment after 2 weeks of high-dose mesalazine for moderately active ulcerative colitis \u2013 new light on a familiar question","volume":"33","author":"T R Orchard","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"ref282","doi-asserted-by":"publisher","first-page":"CD007698","DOI":"10.1002\/14651858.CD007698.pub3","article-title":"Oral budesonide for induction of remission in ulcerative colitis","author":"M E Sherlock","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"ref283","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1053\/j.gastro.2012.08.003","article-title":"Once-daily budesonide MMX(R) extended-release tablets induce remission in patients with mild to moderate ulcerative colitis: results from the CORE I study","volume":"143","author":"W J Sandborn","year":"2012","journal-title":"Gastroenterology"},{"key":"ref284","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1136\/gutjnl-2012-304258","article-title":"Once-daily budesonide MMX in active, mild-to-moderate ulcerative colitis: results from the randomised CORE II study","volume":"63","author":"S P Travis","year":"2014","journal-title":"Gut"},{"key":"ref285","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/apt.13076","article-title":"Induction of clinical and colonoscopic remission of mild-to-moderate ulcerative colitis with budesonide MMX 9 mg: pooled analysis of two phase 3 studies","volume":"41","author":"W J Sandborn","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"ref286","doi-asserted-by":"publisher","first-page":"CD007698","DOI":"10.1002\/14651858.CD007698.pub3","article-title":"Oral budesonide for induction of remission in ulcerative colitis","author":"M E Sherlock","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"ref287","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1136\/gut.2004.060103","article-title":"Combined oral and enema treatment with Pentasa (mesalazine) is superior to oral therapy alone in patients with extensive mild\/moderate active ulcerative colitis: a randomised, double blind, placebo controlled study","volume":"54","author":"P Marteau","year":"2005","journal-title":"Gut"},{"key":"ref288","first-page":"2031","article-title":"Are there any differences in the efficacy and safety of different formulations of Oral 5-ASA used for induction and maintenance of remission in ulcerative colitis? evidence from cochrane reviews","volume":"19","author":"B G Feagan","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"ref289","first-page":"CD004118","article-title":"Rectal 5-aminosalicylic acid for maintenance of remission in ulcerative colitis","volume":"11","author":"J K Marshall","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"ref290","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1111\/j.1365-2036.1997.tb00001.x","article-title":"Oral or rectal administration of drugs in IBD?","volume":"11","author":"G A Moody","year":"1997","journal-title":"Aliment Pharmacol Ther"},{"key":"ref291","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1080\/14656566.2016.1187132","article-title":"Maintenance therapy options for ulcerative colitis","volume":"17","author":"M Chaparro","year":"2016","journal-title":"Expert Opin Pharmacother"},{"key":"ref292","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1136\/gut.40.6.775","article-title":"Rectal corticosteroids versus alternative treatments in ulcerative colitis: a meta-analysis","volume":"40","author":"J K Marshall","year":"1997","journal-title":"Gut"},{"key":"ref293","first-page":"1143","article-title":"Combined therapy with 5-aminosalicylic acid tablets and enemas for maintaining remission in ulcerative colitis: a randomized double-blind study","volume":"92","author":"G d\u2019Albasio","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"ref294","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1002\/ibd.20158","article-title":"Effect of weekend 5-aminosalicylic acid (mesalazine) enema as maintenance therapy for ulcerative colitis: results from a randomized controlled study","volume":"13","author":"H Yokoyama","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"ref295","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1080\/00365520310008133","article-title":"Long-term intermittent treatment with low-dose 5-aminosalicylic enemas is efficacious for remission maintenance in ulcerative colitis","volume":"39","author":"L P Piodi","year":"2004","journal-title":"Scand J Gastroenterol"},{"key":"ref296","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.crohns.2011.10.006","article-title":"Mesalazine in left-sided ulcerative colitis: efficacy analyses from the PODIUM trial on maintenance of remission and mucosal healing","volume":"6","author":"B Bokemeyer","year":"2012","journal-title":"J Crohns Colitis"},{"key":"ref297","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1136\/gut.2007.138248","article-title":"Randomised trial of once- or twice-daily MMX mesalazine for maintenance of remission in ulcerative colitis","volume":"57","author":"M A Kamm","year":"2008","journal-title":"Gut"},{"key":"ref298","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1111\/j.1365-2036.2011.04840.x","article-title":"Mesalazine granules are superior to Eudragit-L-coated mesalazine tablets for induction of remission in distal ulcerative colitis \u2013 a pooled analysis","volume":"34","author":"L Leifeld","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"ref299","first-page":"CD000544","article-title":"Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis","volume":"10","author":"B G Feagan","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"ref300","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.cgh.2009.04.004","article-title":"Mesalamine once daily is more effective than twice daily in patients with quiescent ulcerative colitis","volume":"7","author":"A U Dignass","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref301","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/MCG.0000000000000414","article-title":"Once-daily Mesalamine Formulation for Maintenance of Remission in Ulcerative Colitis: A Randomized, Placebo-controlled Clinical Trial","volume":"50","author":"G L Gordon","year":"2016","journal-title":"J Clin Gastroenterol"},{"key":"ref302","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1365-2036.2010.04537.x","article-title":"Randomised clinical trial: a comparative dose-finding study of three arms of dual release mesalazine for maintaining remission in ulcerative colitis","volume":"33","author":"W Kruis","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"ref303","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1053\/j.gastro.2009.12.054","article-title":"Once-daily dosing of delayed-release oral mesalamine (400-mg tablet) is as effective as twice-daily dosing for maintenance of remission of ulcerative colitis","volume":"138","author":"W J Sandborn","year":"2010","journal-title":"Gastroenterology"},{"key":"ref304","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1002\/ibd.21256","article-title":"Efficacy and safety of mesalamine suppositories for treatment of ulcerative proctitis in children and adolescents","volume":"16","author":"M B Heyman","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"ref305","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.crohns.2014.05.005","article-title":"A randomized clinical trial of mesalazine suppository: the usefulness and problems of central review of evaluations of colonic mucosal findings","volume":"8","author":"K Kobayashi","year":"2014","journal-title":"J Crohns Colitis"},{"key":"ref306","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/apt.12362","article-title":"Randomised clinical trial: evaluation of the efficacy of mesalazine (mesalamine) suppositories in patients with ulcerative colitis and active rectal inflammation -- a placebo-controlled study","volume":"38","author":"M Watanabe","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"ref307","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1365-2036.2010.04537.x","article-title":"Randomised clinical trial: a comparative dose-finding study of three arms of dual release mesalazine for maintaining remission in ulcerative colitis","volume":"33","author":"W Kruis","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"ref308","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1002\/ibd.20158","article-title":"Effect of weekend 5-aminosalicylic acid (mesalazine) enema as maintenance therapy for ulcerative colitis: results from a randomized controlled study","volume":"13","author":"H Yokoyama","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"ref309","doi-asserted-by":"publisher","DOI":"10.1055\/a-2596-8934","article-title":"From guidelines to evidence-based practice \u2013 A German perspective on mesalazine as first-line therapy for mild-to-moderate ulcerative colitis","author":"E Schnoy","year":"2025","journal-title":"Z Gastroenterol"},{"key":"ref310","doi-asserted-by":"crossref","first-page":"499","DOI":"10.15403\/jgld.2014.1121.244.ecn","article-title":"Escherichia coli Nissle 1917 in Ulcerative Colitis Treatment: Systematic Review and Meta-analysis","volume":"24","author":"G Losurdo","year":"2015","journal-title":"J Gastrointestin Liver Dis"},{"key":"ref311","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1111\/j.1572-0241.2005.41442.x","article-title":"Effect of 5-aminosalicylate use on colorectal cancer and dysplasia risk: a systematic review and metaanalysis of observational studies","volume":"100","author":"F S Velayos","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"ref312","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s00464-022-09462-w","article-title":"Colorectal cancer risk of flat low-grade dysplasia in inflammatory bowel disease: a systematic review and proportion meta-analysis","volume":"37","author":"S Lauricella","year":"2023","journal-title":"Surg Endosc"},{"key":"ref313","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.crohns.2007.12.001","article-title":"European evidence-based Consensus on the management of ulcerative colitis: Special situations","volume":"2","author":"L Biancone","year":"2008","journal-title":"J Crohns Colitis"},{"key":"ref314","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1136\/gut.2009.179804","article-title":"Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002)","volume":"59","author":"S R Cairns","year":"2010","journal-title":"Gut"},{"key":"ref315","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1053\/j.gastro.2003.11.010","article-title":"Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis","volume":"126","author":"M Rutter","year":"2004","journal-title":"Gastroenterology"},{"key":"ref316","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1053\/j.gastro.2007.08.001","article-title":"Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study","volume":"133","author":"R B Gupta","year":"2007","journal-title":"Gastroenterology"},{"key":"ref317","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.cgh.2013.06.023","article-title":"Inflammation is an independent risk factor for colonic neoplasia in patients with ulcerative colitis: a case-control study","volume":"11","author":"D T Rubin","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref318","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/00054725-200311000-00002","article-title":"Gross versus microscopic pancolitis and the occurrence of neoplasia in ulcerative colitis","volume":"9","author":"C Mathy","year":"2003","journal-title":"Inflamm Bowel Dis"},{"key":"ref319","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/ajg.2015.248","article-title":"Low-grade dysplasia in ulcerative colitis: risk factors for developing high-grade dysplasia or colorectal cancer","volume":"110","author":"C H Choi","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"ref320","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BF02234825","article-title":"Proximal colorectal dysplasia or cancer in ulcerative colitis. The impact of primary sclerosing cholangitis and sulfasalazine: results from a 20-year surveillance study","volume":"44","author":"B U Lindberg","year":"2001","journal-title":"Dis Colon Rectum"},{"key":"ref321","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1053\/j.gastro.2004.03.025","article-title":"Diagnosis and management of dysplasia in patients with inflammatory bowel diseases","volume":"126","author":"S H Itzkowitz","year":"2004","journal-title":"Gastroenterology"},{"key":"ref322","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1365-2036.2009.04195.x","article-title":"Systematic review: molecular chemoprevention of colorectal malignancy by mesalazine","volume":"31","author":"A Lyakhovich","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"ref323","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.cgh.2008.05.020","article-title":"Progression to colorectal neoplasia in ulcerative colitis: effect of mesalamine","volume":"6","author":"T Ullman","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref324","first-page":"693","article-title":"Azathioprine [AZA] is associated with less histological inflammation of the colon in inactive IBD","volume":"138","author":"V N-LI Bergeron","year":"2010","journal-title":"Gastroenterology"},{"key":"ref325","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0016-5085(97)70215-4","article-title":"The effect of folic acid supplementation on the risk for cancer or dysplasia in ulcerative colitis","volume":"112","author":"B A Lashner","year":"1997","journal-title":"Gastroenterology"},{"key":"ref326","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/ibd.20074","article-title":"5-Aminosalicylic acid therapy and the risk of colorectal cancer among patients with inflammatory bowel disease","volume":"13","author":"J P Terdiman","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"ref327","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S1542-3565(05)00738-X","article-title":"Chemoprevention of colorectal neoplasia in ulcerative colitis: the effect of 6-mercaptopurine","volume":"3","author":"S Matula","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref328","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1136\/gut.2011.237412","article-title":"Thiopurines prevent advanced colorectal neoplasia in patients with inflammatory bowel disease","volume":"61","author":"F D van Schaik","year":"2012","journal-title":"Gut"},{"key":"ref329","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1053\/j.gastro.2013.03.044","article-title":"Risk of colorectal high-grade dysplasia and cancer in a prospective observational cohort of patients with inflammatory bowel disease","volume":"145","author":"L Beaugerie","year":"2013","journal-title":"Gastroenterology"},{"key":"ref330","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1111\/bcp.14051","article-title":"Comparative assessment of budesonide-MMX and mesalamine in active, mild-to-moderate ulcerative colitis: A systematic review and network meta-analysis","volume":"85","author":"S Bonovas","year":"2019","journal-title":"Br J Clin Pharmacol"},{"key":"ref331","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S0140-6736(23)00061-2","article-title":"Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE): two randomised, double-blind, placebo-controlled, phase 3 studies","volume":"401","author":"W J Sandborn","year":"2023","journal-title":"Lancet"},{"key":"ref332","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1053\/j.gastro.2023.08.038","article-title":"Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: QUASAR Phase 2b Induction Study","volume":"165","author":"L Peyrin-Biroulet","year":"2023","journal-title":"Gastroenterology"},{"key":"ref333","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1093\/ecco-jcc\/jjad123","article-title":"Withdrawal and Re-treatment with Filgotinib in Ulcerative Colitis: Post Hoc Analyses of the Phase 2b\/3 SELECTION and SELECTIONLTE Studies","volume":"18","author":"S Vermeire","year":"2024","journal-title":"J Crohns Colitis"},{"key":"ref334","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00011-023-01829-6","article-title":"Sphingosine 1-phosphate (S1P) receptor modulators as an induction and maintenance therapy for ulcerative colitis: a systematic review and meta-analysis of randomized controlled trials","volume":"73","author":"H A Suilik","year":"2024","journal-title":"Inflamm Res"},{"key":"ref335","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0140-6736(24)01927-5","article-title":"Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies","volume":"405","author":"D T Rubin","year":"2025","journal-title":"Lancet"},{"key":"ref336","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1080\/00365520212512","article-title":"Effect of budesonide enema on remission and relapse rate in distal ulcerative colitis and proctitis","volume":"37","author":"S Lindgren","year":"2002","journal-title":"Scand J Gastroenterol"},{"key":"ref337","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/00004836-198702000-00013","article-title":"Predicting the outcome of corticoid therapy for acute ulcerative colitis. Results of a prospective, randomized, double-blind clinical trial","volume":"9","author":"S Meyers","year":"1987","journal-title":"J Clin Gastroenterol"},{"key":"ref338","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1038\/ajg.2012.218","article-title":"Serious infection and mortality in patients with Crohn\u2019s disease: more than 5 years of follow-up in the TREAT registry","volume":"107","author":"G R Lichtenstein","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"ref339","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1136\/gut.4.4.299","article-title":"The Course and Prognosis of Ulcerative Colitis","volume":"4","author":"F C Edwards","year":"1963","journal-title":"Gut"},{"key":"ref340","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1136\/bmj.2.4947.1041","article-title":"Cortisone in ulcerative colitis; final report on a therapeutic trial","volume":"2","author":"S C Truelove","year":"1955","journal-title":"Br Med J"},{"key":"ref341","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1136\/gut.2009.192765","article-title":"Management of acute severe ulcerative colitis","volume":"60","author":"G Van Assche","year":"2011","journal-title":"Gut"},{"key":"ref342","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/bmb\/ldl001","article-title":"Management of acute severe colitis","volume":"75\u201376","author":"S L Jakobovits","year":"2005","journal-title":"Br Med Bull"},{"key":"ref343","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.cgh.2006.09.033","article-title":"Response to corticosteroids in severe ulcerative colitis: a systematic review of the literature and a meta-regression","volume":"5","author":"D Turner","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref344","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1111\/apt.12473","article-title":"Outcomes of rescue therapy in acute severe ulcerative colitis: data from the United Kingdom inflammatory bowel disease audit","volume":"38","author":"R W Lynch","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"ref345","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1136\/bmj.2.5302.441","article-title":"Out-patient treatment of ulcerative colitis. Comparison between three doses of oral prednisone","volume":"2","author":"J H Baron","year":"1962","journal-title":"Br Med J"},{"key":"ref346","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1136\/gut.1.3.217","article-title":"An assessment of prednisone, salazopyrin, and topical hydrocortisone hemisuccinate used as out-patient treatment for ulcerative colitis","volume":"1","author":"J E Lennard-Jones","year":"1960","journal-title":"Gut"},{"key":"ref347","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/S0140-6736(74)90552-2","article-title":"Intensive intravenous regimen for severe attacks of ulcerative colitis","volume":"1","author":"S C Truelove","year":"1974","journal-title":"Lancet"},{"key":"ref348","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1136\/bmj.2.4884.375","article-title":"Cortisone in ulcerative colitis; preliminary report on a therapeutic trial","volume":"2","author":"S C Truelove","year":"1954","journal-title":"Br Med J"},{"key":"ref349","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1136\/bmj.1.5119.387","article-title":"Cortisone and corticotrophin in ulcerative colitis","volume":"1","author":"S C Truelove","year":"1959","journal-title":"Br Med J"},{"key":"ref350","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/00004836-199002000-00011","article-title":"High-dose methylprednisolone in the treatment of active ulcerative colitis","volume":"12","author":"W Rosenberg","year":"1990","journal-title":"J Clin Gastroenterol"},{"key":"ref351","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1111\/codi.12328","article-title":"Prolonged preoperative hospital stay is a risk factor for complications after emergency colectomy for severe colitis","volume":"15","author":"S A Bartels","year":"2013","journal-title":"Colorectal Dis"},{"key":"ref352","first-page":"2001","article-title":"A review of mortality and surgery in ulcerative colitis: milestones of the seriousness of the disease","volume":"19","author":"C N Bernstein","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"ref353","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/bjs.6874","article-title":"Delayed surgery for acute severe colitis is associated with increased risk of postoperative complications","volume":"97","author":"J Randall","year":"2010","journal-title":"Br J Surg"},{"key":"ref354","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1136\/bmj.39345.714039.55","article-title":"Mortality in patients with and without colectomy admitted to hospital for ulcerative colitis and Crohn\u2019s disease: record linkage studies","volume":"335","author":"S E Roberts","year":"2007","journal-title":"BMJ"},{"key":"ref355","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/ecco-jcc\/jju009","article-title":"European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases","volume":"9","author":"A U Dignass","year":"2015","journal-title":"J Crohns Colitis"},{"key":"ref356","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/ibd.21847","article-title":"Toxic megacolon","volume":"18","author":"D M Autenrieth","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"ref357","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1111\/j.1572-0241.2003.07696.x","article-title":"A new look at toxic megacolon: an update and review of incidence, etiology, pathogenesis, and management","volume":"98","author":"S I Gan","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"ref358","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3109\/00365521.2014.966753","article-title":"Nonsteroidal anti-inflammatory drugs and exacerbations of inflammatory bowel disease","volume":"50","author":"C L Kvasnovsky","year":"2015","journal-title":"Scand J Gastroenterol"},{"key":"ref359","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/ibd.21806","article-title":"Narcotic use for inflammatory bowel disease and risk factors during hospitalization","volume":"18","author":"M D Long","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"ref360","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1002\/ibd.20498","article-title":"Cytomegalovirus infection in ulcerative colitis: a prospective, comparative study on prevalence and diagnostic strategy","volume":"14","author":"E Domenech","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"ref361","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1099\/jmm.0.45629-0","article-title":"Infection with cytomegalovirus in patients with inflammatory bowel disease: prevalence, clinical significance and outcome","volume":"53","author":"J Kishore","year":"2004","journal-title":"J Med Microbiol"},{"key":"ref362","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1097\/MIB.0000000000000675","article-title":"Risk Factors and Clinical Outcomes Associated with Cytomegalovirus Colitis in Patients with Acute Severe Ulcerative Colitis","volume":"22","author":"H S Lee","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"ref363","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1111\/j.1572-0241.2001.03949.x","article-title":"Outcome of cytomegalovirus infections in patients with inflammatory bowel disease","volume":"96","author":"K A Papadakis","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"ref364","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.crohns.2013.12.013","article-title":"Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease","volume":"8","author":"J F Rahier","year":"2014","journal-title":"J Crohns Colitis"},{"key":"ref365","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S2468-1253(16)30159-5","article-title":"Cytomegalovirus infection associated with inflammatory bowel disease","volume":"2","author":"B Siegmund","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref366","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/ibd.22964","article-title":"Clostridium difficile infection in the inflammatory bowel disease patient","volume":"19","author":"A M Berg","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"ref367","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1002\/ibd.20500","article-title":"Clostridium difficile and inflammatory bowel disease","volume":"14","author":"M Issa","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"ref368","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.cgh.2006.12.028","article-title":"Impact of Clostridium difficile on inflammatory bowel disease","volume":"5","author":"M Issa","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref369","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1111\/j.1365-2036.2011.04661.x","article-title":"Increased health burden associated with Clostridium difficile diarrhoea in patients with inflammatory bowel disease","volume":"33","author":"M H Jen","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"ref370","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1111\/apt.12073","article-title":"Impact of Clostridium difficile colitis on 5-year health outcomes in patients with ulcerative colitis","volume":"36","author":"S K Murthy","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"ref371","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1155\/2014\/914303","article-title":"Clostridium difficile infection worsens the prognosis of ulcerative colitis","volume":"28","author":"M E Negron","year":"2014","journal-title":"Can J Gastroenterol Hepatol"},{"key":"ref372","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1111\/j.1572-0241.2007.01780.x","article-title":"A national survey of the prevalence and impact of Clostridium difficile infection among hospitalized inflammatory bowel disease patients","volume":"103","author":"G C Nguyen","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"ref373","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.cgh.2009.05.031","article-title":"Combination immunomodulator and antibiotic treatment in patients with inflammatory bowel disease and clostridium difficile infection","volume":"7","author":"S Ben-Horin","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref374","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.crohns.2009.02.010","article-title":"European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease","volume":"3","author":"J F Rahier","year":"2009","journal-title":"J Crohns Colitis"},{"key":"ref375","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0140-6736(09)61963-2","article-title":"Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study","volume":"375","author":"M J Grainge","year":"2010","journal-title":"Lancet"},{"key":"ref376","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/ecco-jcc\/jjv213","article-title":"The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease","volume":"10","author":"M Harbord","year":"2016","journal-title":"J Crohns Colitis"},{"key":"ref377","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1136\/gut.2010.228585","article-title":"Thromboembolic risk among Danish children and adults with inflammatory bowel diseases: a population-based nationwide study","volume":"60","author":"M D Kappelman","year":"2011","journal-title":"Gut"},{"key":"ref378","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1053\/j.gastro.2014.01.042","article-title":"Consensus statements on the risk, prevention, and treatment of venous thromboembolism in inflammatory bowel disease: Canadian Association of Gastroenterology","volume":"146","author":"G C Nguyen","year":"2014","journal-title":"Gastroenterology"},{"key":"ref379","first-page":"227","article-title":"Enteral versus parenteral nutrition as adjunct therapy in acute ulcerative colitis","volume":"88","author":"F Gonzalez-Huix","year":"1993","journal-title":"Am J Gastroenterol"},{"key":"ref380","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/gut.27.5.481","article-title":"Controlled trial of bowel rest in the treatment of severe acute colitis","volume":"27","author":"P B McIntyre","year":"1986","journal-title":"Gut"},{"key":"ref381","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1001\/jama.2024.12414","article-title":"Risankizumab for Ulcerative Colitis: Two Randomized Clinical Trials","volume":"332","author":"E Louis","year":"2024","journal-title":"Jama"},{"key":"ref382","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1056\/NEJMoa1905725","article-title":"Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis","volume":"381","author":"B E Sands","year":"2019","journal-title":"N Engl J Med"},{"key":"ref383","doi-asserted-by":"crossref","first-page":"4446","DOI":"10.1007\/s12325-024-03003-8","article-title":"Efficacy and Safety of Advanced Therapies in Moderately-to-Severely Active Ulcerative Colitis: a Systematic Review and Network Meta-analysis","volume":"41","author":"A Dignass","year":"2024","journal-title":"Adv Ther"},{"key":"ref384","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/phar.4611","article-title":"Efficacy and safety of mirikizumab compared with currently approved biologic drugs for the treatment of ulcerative colitis: A systematic review and network meta-analysis","volume":"44","author":"P Mo\u0107ko","year":"2024","journal-title":"Pharmacotherapy"},{"key":"ref385","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1053\/j.gastro.2024.07.046","article-title":"Comparative Efficacy of Advanced Therapies for Management of Moderate-to-Severe Ulcerative Colitis: 2024 American Gastroenterological Association Evidence Synthesis","volume":"167","author":"A N Ananthakrishnan","year":"2024","journal-title":"Gastroenterology"},{"key":"ref386","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.cgh.2024.07.033","article-title":"Comparative Efficacy of Biologics and Small Molecule in Ulcerative Colitis: A Systematic Review and Network Meta-analysis","volume":"23","author":"M Shehab","year":"2025","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref387","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1097\/MEG.0000000000002751","article-title":"Comparative maintenance performance of all biologic agents and Small Molecules in ulcerative colitis: a network meta-analysis","volume":"36","author":"T Rokkas","year":"2024","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref388","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1186\/s12876-023-02938-6","article-title":"Network meta-analysis on efficacy and safety of different biologics for ulcerative colitis","volume":"23","author":"X Chu","year":"2023","journal-title":"BMC Gastroenterol"},{"key":"ref389","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s11096-022-01509-1","article-title":"Comparative efficacy of advanced treatments in biologic-na\u00efve or biologic-experienced patients with ulcerative colitis: a systematic review and network meta-analysis","volume":"45","author":"X Lu","year":"2023","journal-title":"Int J Clin Pharm"},{"key":"ref390","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2021-326390","article-title":"Efficacy of biological therapies and Small Molecules in moderate to severe ulcerative colitis: systematic review and network meta-analysis","author":"N E Burr","year":"2021","journal-title":"Gut"},{"key":"ref391","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S2468-1253(21)00377-0","article-title":"Efficacy and safety of biologics and Small Molecule drugs for patients with moderate-to-severe ulcerative colitis: a systematic review and network meta-analysis","volume":"7","author":"J S Lasa","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref392","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1080\/17474124.2021.1880319","article-title":"Integrating efficacy and safety of vedolizumab compared with other advanced therapies to assess net clinical benefit of ulcerative colitis treatments: a network meta-analysis","volume":"15","author":"V Jairath","year":"2021","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"ref393","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1007\/s11096-018-0743-4","article-title":"Systematic review and network meta-analysis of treatment for moderate-to-severe ulcerative colitis","volume":"40","author":"C Trigo-Vicente","year":"2018","journal-title":"Int J Clin Pharm"},{"key":"ref394","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1111\/apt.15005","article-title":"Systematic review with network meta-analysis: the impact of medical interventions for moderate-to-severe ulcerative colitis on health-related quality of life","volume":"48","author":"P Paschos","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"ref395","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/apt.14449","article-title":"Systematic review with network meta-analysis: comparative assessment of tofacitinib and biological therapies for moderate-to-severe ulcerative colitis","volume":"47","author":"S Bonovas","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"ref396","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/apt.14422","article-title":"Systematic review with network meta-analysis: first- and second-line pharmacotherapy for moderate-severe ulcerative colitis","volume":"47","author":"S Singh","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"ref397","doi-asserted-by":"crossref","first-page":"e079839","DOI":"10.1136\/bmj-2024-079839","article-title":"Risk of Bias in Network Meta-Analysis (RoB NMA) tool","volume":"388","author":"C Lunny","year":"2025","journal-title":"Bmj"},{"key":"ref398","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13643-023-02388-x","article-title":"Methodological review of NMA bias concepts provides groundwork for the development of a list of concepts for potential inclusion in a new risk of bias tool for network meta-analysis (RoB NMA Tool)","volume":"13","author":"C Lunny","year":"2024","journal-title":"Syst Rev"},{"key":"ref399","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1093\/ecco-jcc\/jjae091","article-title":"ECCO Guidelines on Therapeutics in Crohn\u2019s Disease: Medical Treatment","volume":"18","author":"H Gordon","year":"2024","journal-title":"J Crohns Colitis"},{"key":"ref400","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1093\/ecco-jcc\/jjaa226","article-title":"Ciclosporin or Infliximab as Rescue Therapy in Acute Glucorticosteroid-Refractory Ulcerative Colitis: Systematic Review and Network Meta-Analysis","volume":"15","author":"B Barberio","year":"2021","journal-title":"J Crohns Colitis"},{"key":"ref401","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/apt.17938","article-title":"Effectiveness and safety of a third-line rescue treatment for acute severe ulcerative colitis refractory to infliximab or ciclosporin (REASUC study)","volume":"59","author":"M J Garc\u00eda","year":"2024","journal-title":"Aliment Pharmacol Ther"},{"key":"ref402","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1136\/gut.38.6.905","article-title":"Predicting outcome in severe ulcerative colitis","volume":"38","author":"S P Travis","year":"1996","journal-title":"Gut"},{"key":"ref403","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1136\/gut.16.8.579","article-title":"Assessment of severity in colitis: a preliminary study","volume":"16","author":"J E Lennard-Jones","year":"1975","journal-title":"Gut"},{"key":"ref404","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1136\/gut.32.12.1535","article-title":"Small bowel gas in severe ulcerative colitis","volume":"32","author":"C N Chew","year":"1991","journal-title":"Gut"},{"key":"ref405","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1046\/j.1365-2036.2000.00705.x","article-title":"Predictive factors of outcome of intensive intravenous treatment for attacks of ulcerative colitis","volume":"14","author":"F Carbonnel","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"ref406","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1093\/ecco-jcc\/jjv047","article-title":"Association between the ulcerative colitis endoscopic index of severity (UCEIS) and outcomes in acute severe ulcerative colitis","volume":"9","author":"C Corte","year":"2015","journal-title":"J Crohns Colitis"},{"key":"ref407","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/j.1365-2036.2004.01945.x","article-title":"Predicting the outcome of severe ulcerative colitis: development of a novel risk score to aid early selection of patients for second-line medical therapy or surgery","volume":"19","author":"G T Ho","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"ref408","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1056\/NEJM199406303302601","article-title":"Ciclosporine in severe ulcerative colitis refractory to steroid therapy","volume":"330","author":"S Lichtiger","year":"1994","journal-title":"N Engl J Med"},{"key":"ref409","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1053\/gast.2001.23983","article-title":"Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis","volume":"120","author":"G D\u2019Haens","year":"2001","journal-title":"Gastroenterology"},{"key":"ref410","first-page":"1025","article-title":"Randomized, double-blind comparison of 4 mg\/kg versus 2 mg\/kg intravenous cyclosporine in severe ulcerative colitis","volume":"125","author":"G Van Assche","year":"2003","journal-title":"Gastroenterology"},{"key":"ref411","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1016\/S0140-6736(12)61084-8","article-title":"Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial","volume":"380","author":"D Laharie","year":"2012","journal-title":"Lancet"},{"key":"ref412","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S2468-1253(16)30003-6","article-title":"Infliximab versus ciclosporin for steroid-resistant acute severe ulcerative colitis (CONSTRUCT): a mixed methods, open-label, pragmatic randomised trial","volume":"1","author":"J G Williams","year":"2016","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref413","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1111\/j.1572-0241.1999.01149.x","article-title":"Intravenous cyclosporin in ulcerative colitis: a five-year experience","volume":"94","author":"R D Cohen","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"ref414","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.cgh.2006.04.001","article-title":"Incidence of colectomy during long-term follow-up after cyclosporine-induced remission of severe ulcerative colitis","volume":"4","author":"D N Moskovitz","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref415","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1440-1746.2009.06119.x","article-title":"Factors affecting the efficacy of cyclosporin A therapy for refractory ulcerative colitis","volume":"25","author":"S Bamba","year":"2010","journal-title":"J Gastroenterol Hepatol"},{"key":"ref416","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.crohns.2010.01.001","article-title":"Long-term outcome in patients with ulcerative colitis treated with intravenous cyclosporine A is determined by previous exposure to thiopurines","volume":"4","author":"A Walch","year":"2010","journal-title":"J Crohns Colitis"},{"key":"ref417","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1136\/gut.2005.081794","article-title":"A randomised dose finding study of oral tacrolimus (FK506) therapy in refractory ulcerative colitis","volume":"55","author":"H Ogata","year":"2006","journal-title":"Gut"},{"key":"ref418","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/ibd.21853","article-title":"Double-blind, placebo-controlled trial of oral tacrolimus (FK506) in the management of hospitalized patients with steroid-refractory ulcerative colitis","volume":"18","author":"H Ogata","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"ref419","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1093\/ecco-jcc\/jjv221","article-title":"Efficacy and Safety of Tacrolimus Therapy for Active Ulcerative Colitis; A Systematic Review and Meta-analysis","volume":"10","author":"Y Komaki","year":"2016","journal-title":"J Crohns Colitis"},{"key":"ref420","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/apt.12118","article-title":"Short-term efficacy of tacrolimus in steroid-refractory ulcerative colitis \u2013 experience in 130\u00a0patients","volume":"37","author":"K J Schmidt","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"ref421","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/apt.13531","article-title":"Tacrolimus vs. anti-tumour necrosis factor agents for moderately to severely active ulcerative colitis: a retrospective observational study","volume":"43","author":"T Yamamoto","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"ref422","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1053\/j.gastro.2005.03.003","article-title":"Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study","volume":"128","author":"G Jarnerot","year":"2005","journal-title":"Gastroenterology"},{"key":"ref423","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1111\/j.1365-2036.2010.04435.x","article-title":"Clinical trial: colectomy after rescue therapy in ulcerative colitis \u2013 3-year follow-up of the Swedish-Danish controlled infliximab study","volume":"32","author":"A Gustavsson","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"ref424","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/apt.12387","article-title":"Infliximab as rescue therapy in hospitalised patients with steroid-refractory acute ulcerative colitis: a long-term follow-up of 211 Swedish patients","volume":"38","author":"M Sjoberg","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"ref425","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/S2468-1253(24)00200-0","article-title":"Intensified versus standard dose infliximab induction therapy for steroid-refractory acute severe ulcerative colitis (PREDICT-UC): an open-label, multicentre, randomised controlled trial","volume":"9","author":"M C Choy","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref426","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.14309\/ajg.0000000000002635","article-title":"Tofacitinib in Acute Severe Ulcerative Colitis (TACOS): A Randomized Controlled Trial","volume":"119","author":"A Singh","year":"2024","journal-title":"Am J Gastroenterol"},{"key":"ref427","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjae111","article-title":"Rescue Therapies for Steroid-Refractory Acute Severe Ulcerative Colitis: A Systemic Review and Network Meta-analysis","author":"C W Huang","year":"2024","journal-title":"J Crohns Colitis"},{"key":"ref428","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1093\/ecco-jcc\/jjad036","article-title":"Tofacitinib for Acute Severe Ulcerative Colitis: A Systematic Review","volume":"17","author":"C Steenholdt","year":"2023","journal-title":"J Crohns Colitis"},{"key":"ref429","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izae191","article-title":"Upadacitinib for Acute Severe Ulcerative Colitis: A Systematic Review","author":"J A Damianos","year":"2024","journal-title":"Inflamm Bowel Dis"},{"key":"ref430","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.3748\/wjg.v25.i13.1603","article-title":"Performance of tacrolimus in hospitalized patients with steroid-refractory acute severe ulcerative colitis","volume":"25","author":"P Hoffmann","year":"2019","journal-title":"World J Gastroenterol"},{"key":"ref431","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1007\/BF02100145","article-title":"Intravenous cyclosporine in attacks of ulcerative colitis: short-term and long-term responses","volume":"41","author":"F Carbonnel","year":"1996","journal-title":"Dig Dis Sci"},{"key":"ref432","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-230X-7-13","article-title":"Colectomy rate in steroid-refractory colitis initially responsive to cyclosporin: a long-term retrospective cohort study","volume":"7","author":"G C Actis","year":"2007","journal-title":"BMC Gastroenterol"},{"key":"ref433","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1093\/ibd\/izab328","article-title":"A Prospective Trial with Long Term Follow-up of Patients With Severe, Steroid-Resistant Ulcerative Colitis Who Received Induction Therapy With Ciclosporine and Were Maintained With Vedolizumab","volume":"28","author":"D Tarabar","year":"2022","journal-title":"Inflamm Bowel Dis"},{"key":"ref434","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.cgh.2018.04.060","article-title":"Safety and Efficacy of Combination Treatment With Calcineurin Inhibitors and Vedolizumab in Patients With Refractory Inflammatory Bowel Disease","volume":"17","author":"B Christensen","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref435","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00384-021-04072-9","article-title":"The outcome of patients with inflammatory bowel disease-associated colorectal cancer is not worse than that of patients with sporadic colorectal cancer-a matched-pair analysis of survival","volume":"37","author":"F Vitali","year":"2022","journal-title":"Int J Colorectal Dis"},{"key":"ref436","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.cgh.2022.03.008","article-title":"Efficacy of Induction Therapy With Calcineurin Inhibitors in Combination With Ustekinumab for Acute Severe Ulcerative Colitis","volume":"21","author":"P Veyrard","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref437","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/ecco-jcc\/jjab178","article-title":"ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment","volume":"16","author":"T Raine","year":"2022","journal-title":"J Crohns Colitis"},{"key":"ref438","doi-asserted-by":"crossref","first-page":"s1","DOI":"10.1136\/gutjnl-2019-318484","article-title":"British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults","volume":"68","author":"C A Lamb","year":"2019","journal-title":"Gut"},{"key":"ref439","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0140-6736(65)90973-6","article-title":"PREDNISONE AS MAINTENANCE TREATMENT FOR ULCERATIVE COLITIS IN REMISSION","volume":"1","author":"J E Lennard-Jones","year":"1965","journal-title":"Lancet"},{"key":"ref440","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1093\/ecco-jcc\/jjz032","article-title":"Ciclosporin Therapy After Infliximab Failure in Hospitalized Patients With Acute Severe Colitis is Effective and Safe","volume":"13","author":"R Weisshof","year":"2019","journal-title":"J Crohns Colitis"},{"key":"ref441","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1053\/j.gastro.2013.05.048","article-title":"Subcutaneous golimumab induces clinical response and remission in patients with moderate-to-severe ulcerative colitis","volume":"146","author":"W J Sandborn","year":"2014","journal-title":"Gastroenterology"},{"key":"ref442","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.crohns.2014.01.009","article-title":"Trough s-infliximab and antibodies towards infliximab in a cohort of 79 IBD patients with maintenance infliximab treatment","volume":"8","author":"P Marits","year":"2014","journal-title":"J Crohns Colitis"},{"key":"ref443","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/apt.12869","article-title":"Adalimumab drug and antibody levels as predictors of clinical and laboratory response in patients with Crohn\u2019s disease","volume":"40","author":"Y Mazor","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"ref444","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1136\/gutjnl-2012-304094","article-title":"Postinduction serum infliximab trough level and decrease of C-reactive protein level are associated with durable sustained response to infliximab: a retrospective analysis of the ACCENT I trial","volume":"63","author":"F Cornillie","year":"2014","journal-title":"Gut"},{"key":"ref445","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1136\/annrheumdis-2013-204172","article-title":"Key findings towards optimising adalimumab treatment: the concentration-effect curve","volume":"74","author":"M F Pouw","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"ref446","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1136\/gut.2009.183095","article-title":"Trough serum infliximab: a predictive factor of clinical outcome for infliximab treatment in acute ulcerative colitis","volume":"59","author":"C H Seow","year":"2010","journal-title":"Gut"},{"key":"ref447","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1093\/ecco-jcc\/jjw007","article-title":"Systematic Review and Meta-Analysis: Serum Infliximab Levels During Maintenance Therapy and Outcomes in Inflammatory Bowel Disease","volume":"10","author":"C Moore","year":"2016","journal-title":"J Crohns Colitis"},{"key":"ref448","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.cgh.2013.07.010","article-title":"Association between pharmacokinetics of adalimumab and mucosal healing in patients with inflammatory bowel diseases","volume":"12","author":"X Roblin","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref449","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1177\/1756283X16676194","article-title":"Golimumab pharmacokinetics in ulcerative colitis: a literature review","volume":"10","author":"I Harzallah","year":"2017","journal-title":"Therap Adv Gastroenterol"},{"key":"ref450","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/ajg.2010.9","article-title":"Clinical utility of measuring infliximab and human anti-chimeric antibody concentrations in patients with inflammatory bowel disease","volume":"105","author":"W Afif","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"ref451","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1097\/MIB.0000000000000138","article-title":"Antibodies against infliximab are associated with de novo development of antibodies to adalimumab and therapeutic failure in infliximab-to-adalimumab switchers with IBD","volume":"20","author":"M T Frederiksen","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"ref452","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1136\/gutjnl-2019-319758","article-title":"Addition of azathioprine to the switch of anti-TNF in patients with IBD in clinical relapse with undetectable anti-TNF trough levels and antidrug antibodies: a prospective randomised trial","volume":"69","author":"X Roblin","year":"2020","journal-title":"Gut"},{"key":"ref453","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.MIB.0000436951.80898.6d","article-title":"Antibodies to infliximab and risk of infusion reactions in patients with inflammatory bowel disease: a systematic review and meta-analysis","volume":"20","author":"S O\u2019Meara","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"ref454","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1136\/gutjnl-2013-305259","article-title":"The temporal evolution of antidrug antibodies in patients with inflammatory bowel disease treated with infliximab","volume":"63","author":"B Ungar","year":"2014","journal-title":"Gut"},{"key":"ref455","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1002\/ibd.22910","article-title":"Clinical implications of variations in anti-infliximab antibody levels in patients with inflammatory bowel disease","volume":"18","author":"C Steenholdt","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"ref456","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.cgh.2014.07.029","article-title":"Levels of drug and antidrug antibodies are associated with outcome of interventions after loss of response to infliximab or adalimumab","volume":"13","author":"H Yanai","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref457","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1215734","article-title":"Vedolizumab as induction and maintenance therapy for ulcerative colitis","volume":"369","author":"B G Feagan","year":"2013","journal-title":"N Engl J Med"},{"key":"ref458","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15030972","article-title":"Therapeutic Drug Monitoring of Vedolizumab in Inflammatory Bowel Disease Patients during Maintenance Treatment-TUMMY Study","volume":"15","author":"M Sivrida\u015f","year":"2023","journal-title":"Pharmaceutics"},{"key":"ref459","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/j.1572-0241.2006.00524.x","article-title":"Tacrolimus is safe and effective in patients with severe steroid-refractory or steroid-dependent inflammatory bowel disease--a long-term follow-up","volume":"101","author":"D C Baumgart","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"ref460","first-page":"28","article-title":"[Management of patients with AMS 800 urinary artificial sphincter]","volume":"6","author":"J A Nel","year":"1991","journal-title":"Nurs RSA"},{"key":"ref461","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/0016-5085(94)90394-8","article-title":"A placebo-controlled trial of cyclosporine enemas for mildly to moderately active left-sided ulcerative colitis","volume":"106","author":"W J Sandborn","year":"1994","journal-title":"Gastroenterology"},{"key":"ref462","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1007\/BF02071409","article-title":"Treatment of distal ulcerative colitis with short-chain fatty acid enemas. A placebo-controlled trial. German-Austrian SCFA Study Group","volume":"41","author":"W Scheppach","year":"1996","journal-title":"Dig Dis Sci"},{"key":"ref463","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/ibd.20644","article-title":"Local application of tacrolimus in distal colitis: feasible and safe","volume":"15","author":"J M van Dieren","year":"2009","journal-title":"Inflamm Bowel Dis"},{"key":"ref464","first-page":"Cd007216","article-title":"Tacrolimus (FK506) for induction of remission in corticosteroid-refractory ulcerative colitis","volume":"4","author":"M Gordon","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"ref465","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1016\/j.cgh.2019.09.049","article-title":"No Superiority of Tacrolimus Suppositories vs Beclomethasone Suppositories in a Randomized Trial of Patients With Refractory Ulcerative Proctitis","volume":"18","author":"M Lie","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref466","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1111\/apt.17666","article-title":"Systematic review with meta-analysis: Medical therapies for treatment of ulcerative proctitis","volume":"58","author":"A Aruljothy","year":"2023","journal-title":"Aliment Pharmacol Ther"},{"key":"ref467","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1056\/NEJMoa2207940","article-title":"Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis","volume":"388","author":"G D\u2019Haens","year":"2023","journal-title":"N Engl J Med"},{"key":"ref468","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjae038","article-title":"Efficacy and Safety of Etrasimod in Patients with Moderately to Severely Active Isolated Proctitis: Results From the Phase 3 ELEVATE UC Clinical Programme","author":"L Peyrin-Biroulet","year":"2024","journal-title":"J Crohns Colitis"},{"key":"ref469","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1016\/S0140-6736(24)01762-8","article-title":"Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn\u2019s disease: a phase 3, multicentre, randomised, double-blind, placebo-controlled and active-controlled, treat-through study","volume":"404","author":"M Ferrante","year":"2024","journal-title":"Lancet"},{"key":"ref470","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1056\/NEJMoa050516","article-title":"Infliximab for induction and maintenance therapy for ulcerative colitis","volume":"353","author":"P Rutgeerts","year":"2005","journal-title":"N Engl J Med"},{"key":"ref471","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1053\/j.gastro.2011.10.032","article-title":"Adalimumab induces and maintains clinical remission in patients with moderate-to-severe ulcerative colitis","volume":"142","author":"W J Sandborn","year":"2012","journal-title":"Gastroenterology"},{"key":"ref472","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1038\/ajg.2014.242","article-title":"Four-year maintenance treatment with adalimumab in patients with moderately to severely active ulcerative colitis: Data from ULTRA 1, 2, and 3","volume":"109","author":"J F Colombel","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"ref473","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1053\/j.gastro.2013.06.010","article-title":"Subcutaneous golimumab maintains clinical response in patients with moderate-to-severe ulcerative colitis","volume":"146","author":"W J Sandborn","year":"2014","journal-title":"Gastroenterology"},{"key":"ref474","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1056\/NEJMoa1900750","article-title":"Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis","volume":"381","author":"B E Sands","year":"2019","journal-title":"N Engl J Med"},{"key":"ref475","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1056\/NEJMoa2033617","article-title":"Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis","volume":"385","author":"W J Sandborn","year":"2021","journal-title":"N Engl J Med"},{"key":"ref476","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1016\/S0140-6736(21)00666-8","article-title":"Filgotinib as induction and maintenance therapy for ulcerative colitis (SELECTION): a phase 2b\/3 double-blind, randomised, placebo-controlled trial","volume":"397","author":"B G Feagan","year":"2021","journal-title":"Lancet"},{"key":"ref477","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMoa1606910","article-title":"Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis","volume":"376","author":"W J Sandborn","year":"2017","journal-title":"N Engl J Med"},{"key":"ref478","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1093\/ecco-jcc\/jjaa087","article-title":"Relapse From Deep Remission After Therapeutic De-escalation in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis","volume":"14","author":"B Zhang","year":"2020","journal-title":"J Crohns Colitis"},{"key":"ref479","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1136\/bmj.305.6844.20","article-title":"Randomised controlled trial of azathioprine withdrawal in ulcerative colitis","volume":"305","author":"A B Hawthorne","year":"1992","journal-title":"Bmj"},{"key":"ref480","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S2468-1253(21)00062-5","article-title":"Discontinuation of infliximab in patients with ulcerative colitis in remission (HAYABUSA): a multicentre, open-label, randomised controlled trial","volume":"6","author":"T Kobayashi","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref481","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1136\/gutjnl-2024-333385","article-title":"Withdrawal of antitumour necrosis factor in inflammatory bowel disease patients in remission: a randomised placebo-controlled clinical trial of GETECCU","volume":"74","author":"J P Gisbert","year":"2025","journal-title":"Gut"},{"key":"ref482","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1093\/ecco-jcc\/jjy020","article-title":"Second N-ECCO Consensus Statements on the European Nursing Roles in Caring for Patients with Crohn\u2019s Disease or Ulcerative Colitis","volume":"12","author":"K Kemp","year":"2018","journal-title":"J Crohns Colitis"},{"key":"ref483","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1136\/flgastro-2016-100696","article-title":"The impact of an inflammatory bowel disease nurse-led biologics service","volume":"7","author":"N S Taylor","year":"2016","journal-title":"Frontline Gastroenterol"},{"key":"ref484","doi-asserted-by":"crossref","first-page":"S358","DOI":"10.1016\/S1873-9946(14)60808-4","article-title":"N010 A review of nursing consultancy to control patients with inflammatory bowel disease treated with thiopurines: Analysis and implementation of improvements","volume":"8","author":"M L\u00f3pez-Parra","year":"2014","journal-title":"Journal of Crohn\u2019s and Colitis"},{"key":"ref485","doi-asserted-by":"publisher","first-page":"Cd006597","DOI":"10.1002\/14651858.CD006597.pub2","article-title":"Specialist nursing interventions for inflammatory bowel disease","author":"R Belling","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"ref486","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.crohns.2010.08.009","article-title":"Contribution of nurses to the quality of care in management of inflammatory bowel disease: a synthesis of the evidence","volume":"4","author":"P Hern\u00e1ndez-Sampelayo","year":"2010","journal-title":"J Crohns Colitis"},{"key":"ref487","doi-asserted-by":"crossref","first-page":"A34","DOI":"10.1136\/gutjnl-2013-304907.077","article-title":"Cost savings and outpatient clinic appointments saved: A 2 year review of a nurse led telephone advice line inflammatory bowel disease","volume":"62","author":"T Price","year":"2013","journal-title":"Gut"},{"key":"ref488","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1046\/j.1365-2214.2002.00302.x","article-title":"The meaning of parental illness to children: the case of inflammatory bowel disease","volume":"28","author":"S Mukherjee","year":"2002","journal-title":"Child Care Health Dev"},{"key":"ref489","doi-asserted-by":"crossref","first-page":"24","DOI":"10.12968\/gasn.2012.10.5.24","article-title":"Audit of an inflammatory bowel disease (IBD) telephone helpline set up and managed by IBD specialist nurses","volume":"10","author":"G Anderson","year":"2012","journal-title":"Gastrointestinal Nurs"},{"key":"ref490","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1093\/ecco-jcc\/jjv085","article-title":"Optimising the Inflammatory Bowel Disease Unit to Improve Quality of Care: Expert Recommendations","volume":"9","author":"E Louis","year":"2015","journal-title":"J Crohns Colitis"},{"key":"ref491","first-page":"1057","article-title":"Inviting patients with inflammatory bowel disease to active involvement in their own care: a randomized controlled trial","volume":"20","author":"A Hueppe","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"ref493","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.crohns.2012.02.015","article-title":"Infection-related hospitalizations are associated with increased mortality in patients with inflammatory bowel diseases","volume":"7","author":"A N Ananthakrishnan","year":"2013","journal-title":"J Crohns Colitis"},{"key":"ref494","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s11938-014-0023-x","article-title":"Risks of Infection among the Older Inflammatory Bowel Disease Patients","volume":"12","author":"C Y Ha","year":"2014","journal-title":"Curr Treat Options Gastroenterol"},{"key":"ref495","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1053\/j.gastro.2018.04.012","article-title":"Risk of Serious and Opportunistic Infections Associated With Treatment of Inflammatory Bowel Diseases","volume":"155","author":"J Kirchgesner","year":"2018","journal-title":"Gastroenterology"},{"key":"ref496","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1136\/ard.2011.151043","article-title":"Treatment benefit or survival of the fittest: what drives the time-dependent decrease in serious infection rates under TNF inhibition and what does this imply for the individual patient?","volume":"70","author":"A Strangfeld","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"ref497","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1111\/apt.13195","article-title":"Diabetes and the risk of infections with immunomodulator therapy in inflammatory bowel diseases","volume":"41","author":"A N Ananthakrishnan","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"ref498","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/ecco-jcc\/jjac133","article-title":"Opportunistic Infections in Patients with Inflammatory Bowel Disease Treated with Advanced Therapies: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","volume":"17","author":"P A Olivera","year":"2023","journal-title":"J Crohns Colitis"},{"key":"ref499","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1111\/apt.17379","article-title":"Systematic review with network meta-analysis: Risk of Herpes zoster with biological therapies and Small Molecules in inflammatory bowel disease","volume":"57","author":"S Din","year":"2023","journal-title":"Aliment Pharmacol Ther"},{"key":"ref500","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1093\/ecco-jcc\/jjad100","article-title":"Efficacy and Safety of Advanced Oral Small Molecules for Inflammatory Bowel Disease: Systematic Review and Meta-Analysis","volume":"17","author":"V Solitano","year":"2023","journal-title":"J Crohns Colitis"},{"key":"ref501","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1038\/ajg.2014.313","article-title":"Oral corticosteroids and the risk of serious infections in patients with elderly-onset inflammatory bowel diseases","volume":"109","author":"P Brassard","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"ref502","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1093\/clinids\/11.6.954","article-title":"Risk of infectious complications in patients taking glucocorticosteroids","volume":"11","author":"A E Stuck","year":"1989","journal-title":"Rev Infect Dis"},{"key":"ref503","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1136\/ard.2010.144741","article-title":"The influence of systemic glucocorticoid therapy upon the risk of non-serious infection in older patients with rheumatoid arthritis: a nested case-control study","volume":"70","author":"W G Dixon","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"ref504","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/art.21705","article-title":"Glucocorticoid use, other associated factors, and the risk of tuberculosis","volume":"55","author":"S S Jick","year":"2006","journal-title":"Arthritis Rheum"},{"key":"ref505","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1136\/gutjnl-2015-311079","article-title":"The safety of vedolizumab for ulcerative colitis and Crohn\u2019s disease","volume":"66","author":"J F Colombel","year":"2017","journal-title":"Gut"},{"key":"ref506","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s40264-019-00797-3","article-title":"Ustekinumab Safety in Psoriasis, Psoriatic Arthritis, and Crohn\u2019s Disease: An Integrated Analysis of Phase II\/III Clinical Development Programs","volume":"42","author":"S Ghosh","year":"2019","journal-title":"Drug Saf"},{"key":"ref507","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1056\/NEJMoa2109927","article-title":"Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis","volume":"386","author":"S R Ytterberg","year":"2022","journal-title":"N Engl J Med"},{"key":"ref508","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjad100","article-title":"Efficacy and safety of advanced oral Small Molecules for inflammatory bowel disease: Systematic review and meta-analysis","author":"V Solitano","year":"2023","journal-title":"J Crohns Colitis"},{"key":"ref509","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/apt.15297","article-title":"Systematic review with meta-analysis: efficacy and safety of oral Janus kinase inhibitors for inflammatory bowel disease","volume":"50","author":"C Ma","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"ref510","doi-asserted-by":"crossref","first-page":"1241954","DOI":"10.3389\/fphar.2023.1241954","article-title":"Risk of herpes zoster associated with JAK inhibitors in immune-mediated inflammatory diseases: a systematic review and network meta-analysis","volume":"14","author":"Q Xu","year":"2023","journal-title":"Front Pharmacol"},{"key":"ref511","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1093\/ecco-jcc\/jjae060","article-title":"Etrasimod for the Treatment of Ulcerative Colitis: Analysis of Infection Events from the ELEVATE UC Clinical Programme","volume":"18","author":"M Regueiro","year":"2024","journal-title":"J Crohns Colitis"},{"key":"ref512","doi-asserted-by":"crossref","first-page":"e0293655","DOI":"10.1371\/journal.pone.0293655","article-title":"An indirect comparison of efficacy including histologic assessment and safety in biologic therapy in ulcerative colitis: Systemic review and network meta-analysis","volume":"18","author":"K Chae","year":"2023","journal-title":"PLoS One"},{"key":"ref513","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.cgh.2022.07.032","article-title":"Comparative Risk of Serious Infections With Biologic Agents and Oral Small Molecules in Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis","volume":"21","author":"V Solitano","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref514","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cgh.2019.02.044","article-title":"Comparative Risk of Serious Infections With Biologic and\/or Immunosuppressive Therapy in Patients With Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis","volume":"18","author":"S Singh","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref515","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11894-023-00914-4","article-title":"Managing IBD Patients with Concomitant HIV Infection \u2013 a Systematic Review","volume":"26","author":"H Sousa","year":"2024","journal-title":"Curr Gastroenterol Rep"},{"key":"ref516","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/01.MIB.0000437736.91712.a1","article-title":"Efficacy of hepatitis A vaccination and factors impacting on seroconversion in patients with inflammatory bowel disease","volume":"20","author":"S H Park","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"ref517","doi-asserted-by":"crossref","first-page":"396","DOI":"10.5009\/gnl210081","article-title":"Clinical Course of Hepatitis B Viral Infection in Patients Undergoing Anti-Tumor Necrosis Factor \u03b1 Therapy for Inflammatory Bowel Disease","volume":"16","author":"J M Lee","year":"2022","journal-title":"Gut Liver"},{"key":"ref518","first-page":"871","article-title":"[Prophylaxis, diagnosis and therapy of hepatitis B virus infection \u2013 the German guideline]","volume":"49","author":"M Cornberg","year":"2011","journal-title":"Z Gastroenterol"},{"key":"ref519","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1097\/QAD.0000000000002985","article-title":"TNF-\u03b1 inhibition in the setting of undiagnosed HIV infection: a call for enhanced screening guidelines","volume":"35","author":"J D Claytor","year":"2021","journal-title":"Aids"},{"key":"ref520","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.jaad.2015.11.043","article-title":"Use of tumor necrosis factor (TNF) inhibitors in patients with HIV\/AIDS","volume":"74","author":"S M Gallitano","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"ref521","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1177\/0956462416675109","article-title":"Systematic review of the efficacy and safety of biological therapy for inflammatory conditions in HIV-infected individuals","volume":"28","author":"D L Fink","year":"2017","journal-title":"Int J STD AIDS"},{"key":"ref522","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jaci.2005.05.038","article-title":"EBV the prototypical human tumor virus--just how bad is it?","volume":"116","author":"D A Thorley-Lawson","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"ref523","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1158\/1078-0432.CCR-0670-3","article-title":"Epstein-Barr virus and cancer","volume":"10","author":"M P Thompson","year":"2004","journal-title":"Clin Cancer Res"},{"key":"ref524","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1111\/j.1600-6143.2005.01115.x","article-title":"Ganciclovir and acyclovir reduce the risk of post-transplant lymphoproliferative disorder in renal transplant recipients","volume":"5","author":"D P Funch","year":"2005","journal-title":"Am J Transplant"},{"key":"ref525","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.bbmt.2010.08.007","article-title":"Strategies to prevent EBV reactivation and posttransplant lymphoproliferative disorders (PTLD) after allogeneic stem cell transplantation in high-risk patients","volume":"17","author":"N Reddy","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"ref526","first-page":"103","article-title":"Complement-fixing antibodies against cytomegalovirus in different parts of the world","volume":"49","author":"U Krech","year":"1973","journal-title":"Bull World Health Organ"},{"key":"ref527","doi-asserted-by":"crossref","first-page":"511","DOI":"10.2147\/IDR.S149784","article-title":"Is cytomegalovirus infection related to inflammatory bowel disease, especially steroid-resistant inflammatory bowel disease? A meta-analysis","volume":"10","author":"Y L Lv","year":"2017","journal-title":"Infect Drug Resist"},{"key":"ref528","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics11111952","article-title":"Risk Factors of Cytomegalovirus Reactivation in Ulcerative Colitis Patients: A Meta-Analysis","volume":"11","author":"Y Qin","year":"2021","journal-title":"Diagnostics"},{"key":"ref529","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1055\/s-2007-959219","article-title":"Empfehlungen f\u00fcr die Umgebungsuntersuchungen bei Tuberkulose","volume":"61","author":"R Diel","year":"2007","journal-title":"Pneumologie"},{"key":"ref530","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1111\/j.1572-0241.2008.02050.x","article-title":"Comparison of interferon-gamma release assay versus tuberculin skin test for tuberculosis screening in inflammatory bowel disease","volume":"103","author":"A M Schoepfer","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"ref531","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2147\/CEG.S42514","article-title":"Hospitalizations for vaccine preventable pneumonias in patients with inflammatory bowel disease: a 6-year analysis of the Nationwide Inpatient Sample","volume":"6","author":"D J Stobaugh","year":"2013","journal-title":"Clin Exp Gastroenterol"},{"key":"ref532","first-page":"105","article-title":"Vaccination coverage in immunosuppressed patients: results of a regional health services research study","volume":"108","author":"N Teich","year":"2011","journal-title":"Dtsch Arztebl Int"},{"key":"ref533","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/rheumatology\/ken436","article-title":"Efficacy of measles, mumps and rubella revaccination in children with juvenile idiopathic arthritis treated with methotrexate and etanercept","volume":"48","author":"S Borte","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"ref534","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1007\/s10620-015-3631-y","article-title":"Effect of Immunosuppressive Therapies for the Treatment of Inflammatory Bowel Disease on Response to Routine Vaccinations: A Meta-Analysis","volume":"60","author":"D L Nguyen","year":"2015","journal-title":"Dig Dis Sci"},{"key":"ref535","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000542353","article-title":"Antibody Response to SARS-CoV-2 before and after the Third Vaccination in Patients with Inflammatory Bowel Disease","volume":"43","author":"J M Classen","year":"2025","journal-title":"Dig Dis"},{"key":"ref536","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/apt.18318","article-title":"Consensus Statements on Assessments and Vaccinations Prior to Commencement of Advanced Therapies for the Treatment of Inflammatory Bowel Diseases","volume":"61","author":"R W Leong","year":"2025","journal-title":"Aliment Pharmacol Ther"},{"key":"ref537","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines12091061","article-title":"Methotrexate and Tumor Necrosis Factor Inhibitors Independently Decrease Neutralizing Antibodies after SARS-CoV-2 Vaccination: Updated Results from the SUCCEED Study","volume":"12","author":"C A Hitchon","year":"2024","journal-title":"Vaccines (Basel)"},{"key":"ref538","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00296-013-2907-9","article-title":"Comparison of national clinical practice guidelines and recommendations on vaccination of adult patients with autoimmune rheumatic diseases","volume":"34","author":"D Papadopoulou","year":"2014","journal-title":"Rheumatol Int"},{"key":"ref539","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.jaad.2023.12.070","article-title":"Vaccination recommendations for adults receiving biologics and oral therapies for psoriasis and psoriatic arthritis: Delphi consensus from the medical board of the National Psoriasis Foundation","volume":"90","author":"V S Chat","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"ref541","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1093\/ecco-jcc\/jjae008","article-title":"Recombinant Zoster Vaccine [RZV] is Effective in Patients with Inflammatory Bowel Disease: A US Propensity Matched Cohort Study","volume":"18","author":"A Desai","year":"2024","journal-title":"J Crohns Colitis"},{"key":"ref542","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1111\/apt.17454","article-title":"Cost-effectiveness of an adjuvanted recombinant zoster vaccine in adults with inflammatory bowel disease","volume":"57","author":"F Caldera","year":"2023","journal-title":"Aliment Pharmacol Ther"},{"key":"ref543","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1111\/apt.17490","article-title":"Editorial: adjuvanted recombinant zoster vaccine in adults with inflammatory bowel disease-time for universal recommendation?","volume":"57","author":"F S Macaluso","year":"2023","journal-title":"Aliment Pharmacol Ther"},{"key":"ref544","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1111\/apt.17519","article-title":"Editorial: adjuvanted recombinant zoster vaccine in adults with inflammatory bowel disease-time for universal recommendation? Authors\u2019 reply","volume":"57","author":"F Caldera","year":"2023","journal-title":"Aliment Pharmacol Ther"},{"key":"ref545","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/ibd.20261","article-title":"Prophylaxis against Pneumocystis pneumonia in patients with inflammatory bowel disease: toward a standard of care","volume":"14","author":"D M Poppers","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"ref546","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.cgh.2016.11.037","article-title":"Low Risk of Pneumonia From Pneumocystis jirovecii Infection in Patients With Inflammatory Bowel Disease Receiving Immune Suppression","volume":"15","author":"T G Cotter","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref547","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1097\/MIB.0b013e3182802a9b","article-title":"Increased risk of pneumocystis jiroveci pneumonia among patients with inflammatory bowel disease","volume":"19","author":"M D Long","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"ref548","doi-asserted-by":"publisher","first-page":"CD005590","DOI":"10.1002\/14651858.CD005590.pub3","article-title":"Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients","author":"A Stern","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"ref549","doi-asserted-by":"publisher","DOI":"10.1111\/tid.12651","article-title":"The role of CD4 cell count as discriminatory measure to guide chemoprophylaxis against Pneumocystis jirovecii pneumonia in human immunodeficiency virus-negative immunocompromised patients: A systematic review","volume":"19","author":"P E Messiaen","year":"2017","journal-title":"Transpl Infect Dis"},{"key":"ref550","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1001\/archinte.1996.00440020081010","article-title":"A meta-analysis of the relative efficacy and toxicity of Pneumocystis carinii prophylactic regimens","volume":"156","author":"J P Ioannidis","year":"1996","journal-title":"Arch Intern Med"},{"key":"ref551","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1111\/apt.15770","article-title":"Systematic review: gastrointestinal infection and incident inflammatory bowel disease","volume":"51","author":"J E Axelrad","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"ref552","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1136\/gut.2007.128231","article-title":"Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease","volume":"57","author":"A N Ananthakrishnan","year":"2008","journal-title":"Gut"},{"key":"ref553","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1038\/ajg.2010.142","article-title":"Glucocorticoids are associated with increased risk of short-term mortality in hospitalized patients with clostridium difficile-associated disease","volume":"105","author":"R Das","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"ref554","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1365-2036.2009.04037.x","article-title":"Infliximab and other immunomodulating drugs in patients with inflammatory bowel disease and the risk of serious bacterial infections","volume":"30","author":"S Schneeweiss","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"ref555","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1053\/j.gastro.2017.04.044","article-title":"Higher Incidence of Clostridium difficile Infection Among Individuals With Inflammatory Bowel Disease","volume":"153","author":"H Singh","year":"2017","journal-title":"Gastroenterology"},{"key":"ref556","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/00000658-200203000-00008","article-title":"Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications","volume":"235","author":"R M Dallal","year":"2002","journal-title":"Ann Surg"},{"key":"ref557","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1128\/JCM.00165-06","article-title":"Comparative analysis of prevalence, risk factors, and molecular epidemiology of antibiotic-associated diarrhea due to Clostridium difficile, Clostridium perfringens, and Staphylococcus aureus","volume":"44","author":"N J Asha","year":"2006","journal-title":"J Clin Microbiol"},{"key":"ref558","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1111\/jgh.16265","article-title":"Fidaxomicin treatment for Clostridioides difficile infection in patients with inflammatory bowel disease","volume":"38","author":"A H Koop","year":"2023","journal-title":"J Gastroenterol Hepatol"},{"key":"ref559","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12071396","article-title":"Comparative Efficacy of Fecal Microbiota Transplantation in Treating Refractory or Recurrent Clostridioides difficile Infection among Patients with and without Inflammatory Bowel Disease: A Retrospective Cohort Study","volume":"12","author":"J H Chen","year":"2024","journal-title":"Biomedicines"},{"key":"ref560","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1055\/a-2240-1428","article-title":"S2k-Leitlinie Gastrointestinale Infektionen der Deutschen Gesellschaft f\u00fcr Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS)","volume":"62","author":"C F Manthey","year":"2024","journal-title":"Z Gastroenterol"},{"key":"ref561","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1056\/NEJMoa0910812","article-title":"Fidaxomicin versus vancomycin for Clostridium difficile infection","volume":"364","author":"T J Louie","year":"2011","journal-title":"N Engl J Med"},{"key":"ref562","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1093\/cid\/cis499","article-title":"Fidaxomicin versus vancomycin for Clostridium difficile infection: meta-analysis of pivotal randomized controlled trials","volume":"55 Suppl 2","author":"D W Crook","year":"2012","journal-title":"Clin Infect Dis"},{"key":"ref563","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S1473-3099(11)70374-7","article-title":"Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial","volume":"12","author":"O A Cornely","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"ref564","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.cgh.2006.12.027","article-title":"Incidence of Clostridium difficile infection in inflammatory bowel disease","volume":"5","author":"J F Rodemann","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref565","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1080\/00365521.2018.1492012","article-title":"Clostridium difficile infection in patients with inflammatory bowel disease: a case control study","volume":"53","author":"K Vitikainen","year":"2018","journal-title":"Scand J Gastroenterol"},{"key":"ref566","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/MEG.0000000000001414","article-title":"Prevalence of Clostridium difficile infection among hospitalized inflammatory bowel disease patients in Greece","volume":"31","author":"N Viazis","year":"2019","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref567","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/ibd\/izy308","article-title":"Escalation of Immunosuppressive Therapy for Inflammatory Bowel Disease Is Not Associated With Adverse Outcomes After Infection With Clostridium difficile","volume":"25","author":"D J Lukin","year":"2019","journal-title":"Inflamm Bowel Dis"},{"key":"ref568","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1056\/NEJMoa1602615","article-title":"Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection","volume":"376","author":"M H Wilcox","year":"2017","journal-title":"N Engl J Med"},{"key":"ref569","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1053\/j.gastro.2018.06.080","article-title":"Bezlotoxumab for Clostridium difficile Infection Complicating Inflammatory Bowel Disease","volume":"155","author":"C P Kelly","year":"2018","journal-title":"Gastroenterology"},{"key":"ref570","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S1473-3099(17)30751-X","article-title":"Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients 60\u00a0years and older (EXTEND): a randomised, controlled, open-label, phase 3b\/4 trial","volume":"18","author":"B Guery","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"ref571","first-page":"543","article-title":"Efficacy and safety of fecal microbiota transplant for recurrent Clostridium difficile infection in inflammatory bowel disease: a systematic review and meta-analysis","volume":"114","author":"F Cheng","year":"2022","journal-title":"Rev Esp Enferm Dig"},{"key":"ref572","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1093\/ecco-jcc\/jjab202","article-title":"Efficacy and Outcomes of Faecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection in Children with Inflammatory Bowel Disease","volume":"16","author":"M R Nicholson","year":"2022","journal-title":"Journal of Crohn\u2019s & colitis"},{"key":"ref573","doi-asserted-by":"crossref","DOI":"10.1177\/17562848231156285","article-title":"Short- and long-term follow-up after fecal microbiota transplantation as treatment for recurrent Clostridioides difficile infection in patients with inflammatory bowel disease","volume":"16","author":"E E van Lingen","year":"2023","journal-title":"Therap Adv Gastroenterol"},{"key":"ref574","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1093\/ecco-jcc\/jjw081","article-title":"First Occurrence of Severe Extraintestinal Manifestations of Crohn\u2019s Disease Following Faecal Microbiota Transplantation","volume":"10","author":"N Teich","year":"2016","journal-title":"J Crohns Colitis"},{"key":"ref575","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/S0140-6736(09)61302-7","article-title":"Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study","volume":"374","author":"L Beaugerie","year":"2009","journal-title":"Lancet"},{"key":"ref576","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1136\/gut.36.2.311","article-title":"Fatal infectious mononucleosis: a severe complication in the treatment of Crohn\u2019s disease with azathioprine","volume":"36","author":"E F Posthuma","year":"1995","journal-title":"Gut"},{"key":"ref577","first-page":"7","article-title":"[Fatal infectious mononucleosis during azathioprine treatment in Crohn\u2019s disease]","volume":"23","author":"A Garrido Serrano","year":"2000","journal-title":"Gastroenterol Hepatol"},{"key":"ref578","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1128\/JCM.02052-08","article-title":"Fatal Epstein-Barr virus primo infection in a 25-year-old man treated with azathioprine for Crohn\u2019s disease","volume":"47","author":"Y N\u2019Guyen","year":"2009","journal-title":"J Clin Microbiol"},{"key":"ref579","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/j.1572-0241.2001.03620.x","article-title":"Prevalence of cytomegalovirus infection in severe refractory ulcerative and Crohn\u2019s colitis","volume":"96","author":"M Cottone","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"ref580","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/00000478-200403000-00009","article-title":"Cytomegalovirus infection in steroid-refractory ulcerative colitis: a case-control study","volume":"28","author":"N Kambham","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"ref581","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/MIB.0000000000001073","article-title":"Diagnostic Accuracy of Blood-Based Tests and Histopathology for Cytomegalovirus Reactivation in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis","volume":"23","author":"P Tandon","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"ref582","doi-asserted-by":"crossref","first-page":"e34463","DOI":"10.1097\/MD.0000000000034463","article-title":"Tissue quantitative RT-PCR test for diagnostic significance of cytomegalovirus infection in patients with inflammatory bowel disease and treatment response: Cytomegalovirus infection in patients with inflammatory bowel disease","volume":"102","author":"B Ozdemir","year":"2023","journal-title":"Medicine (Baltimore)"},{"key":"ref583","doi-asserted-by":"crossref","first-page":"38","DOI":"10.4103\/JLP.JLP_94_17","article-title":"Diagnostic utility of quantitative cytomegalovirus DNA polymerase chain reaction in intestinal biopsies from patients with inflammatory bowel disease","volume":"10","author":"M Paul","year":"2018","journal-title":"J Lab Physicians"},{"key":"ref584","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.cgh.2014.09.042","article-title":"Effects of antiviral therapy for patients with inflammatory bowel disease and a positive intestinal biopsy for cytomegalovirus","volume":"13","author":"A Jones","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref585","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00384-018-3210-8","article-title":"The detection of the cytomegalovirus DNA in the colonic mucosa of patients with ulcerative colitis is associated with increased long-term risk of proctocolectomy: results from an outpatient IBD clinic","volume":"34","author":"W Schenk","year":"2019","journal-title":"Int J Colorectal Dis"},{"key":"ref586","first-page":"230","article-title":"Cytomegalovirus complicating inflammatory bowel disease: a 10-year experience in a community-based, university-affiliated hospital","volume":"8","author":"R Al-Zafiri","year":"2012","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"ref587","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1093\/ibd\/izy045","article-title":"CMV Disease in IBD: Comparison of Diagnostic Tests and Correlation with Disease Outcome","volume":"24","author":"J Johnson","year":"2018","journal-title":"Inflamm Bowel Dis"},{"key":"ref588","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/modpathol.2017.149","article-title":"Identification of clinically relevant cytomegalovirus infections in patients with inflammatory bowel disease","volume":"31","author":"N Wethkamp","year":"2018","journal-title":"Mod Pathol"},{"key":"ref589","doi-asserted-by":"publisher","DOI":"10.3390\/v16050691","article-title":"Diagnostic Utility of Cytomegalovirus (CMV) DNA Quantitation in Ulcerative Colitis","volume":"16","author":"S Esen","year":"2024","journal-title":"Viruses"},{"key":"ref590","doi-asserted-by":"crossref","first-page":"e0183951","DOI":"10.1371\/journal.pone.0183951","article-title":"Colonic cytomegalovirus detection by mucosal PCR and antiviral therapy in ulcerative colitis","volume":"12","author":"K Okahara","year":"2017","journal-title":"PLoS One"},{"key":"ref591","doi-asserted-by":"crossref","first-page":"246","DOI":"10.3164\/jcbn.18-14","article-title":"Cytomegalovirus infection in ulcerative colitis assessed by quantitative polymerase chain reaction: risk factors and effects of immunosuppressants","volume":"63","author":"Y Henmi","year":"2018","journal-title":"J Clin Biochem Nutr"},{"key":"ref592","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1111\/apt.12650","article-title":"The impact of cytomegalovirus reactivation and its treatment on the course of inflammatory bowel disease","volume":"39","author":"M Delvincourt","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"ref593","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1038\/ajg.2011.202","article-title":"Cytomegalovirus load in inflamed intestinal tissue is predictive of resistance to immunosuppressive therapy in ulcerative colitis","volume":"106","author":"X Roblin","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"ref594","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s00428-015-1741-8","article-title":"Diagnosing cytomegalovirus in patients with inflammatory bowel disease--by immunohistochemistry or polymerase chain reaction?","volume":"466","author":"N Zidar","year":"2015","journal-title":"Virchows Arch"},{"key":"ref595","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.3109\/00365521.2016.1156154","article-title":"Active cytomegalovirus infection diagnosed by real-time PCR in patients with inflammatory bowel disease: a prospective, controlled observational study","volume":"51","author":"M Th\u00f6rn","year":"2016","journal-title":"Scand J Gastroenterol"},{"key":"ref596","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.3748\/wjg.v22.i3.1321","article-title":"Cytomegalovirus in inflammatory bowel disease: A systematic review","volume":"22","author":"T E Romkens","year":"2016","journal-title":"World J Gastroenterol"},{"key":"ref597","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1097\/MIB.0000000000000556","article-title":"Detection of Cytomegalovirus in Patients with Inflammatory Bowel Disease: Where to Biopsy and How Many Biopsies?","volume":"21","author":"J D McCurdy","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"ref598","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1056\/NEJMoa1714283","article-title":"Four Months of Rifampin or Nine Months of Isoniazid for Latent Tuberculosis in Adults","volume":"379","author":"D Menzies","year":"2018","journal-title":"N Engl J Med"},{"key":"ref599","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1056\/NEJMoa1714284","article-title":"Safety and Side Effects of Rifampin versus Isoniazid in Children","volume":"379","author":"T Diallo","year":"2018","journal-title":"N Engl J Med"},{"key":"ref600","doi-asserted-by":"crossref","first-page":"e107","DOI":"10.3346\/jkms.2022.37.e107","article-title":"The Risk of Tuberculosis in Patients With Inflammatory Bowel Disease Treated With Vedolizumab or Ustekinumab in Korea","volume":"37","author":"M G Choi","year":"2022","journal-title":"J Korean Med Sci"},{"key":"ref601","doi-asserted-by":"crossref","first-page":"e34331","DOI":"10.1097\/MD.0000000000034331","article-title":"The safety of vedolizumab in a patient with Crohn\u2019s disease who developed anti-TNF-alpha agent associated latent tuberculosis infection reactivation: A case report","volume":"102","author":"Y Sugiyama","year":"2023","journal-title":"Medicine (Baltimore)"},{"key":"ref602","doi-asserted-by":"crossref","first-page":"251","DOI":"10.12701\/yujm.2020.00878","article-title":"Successful treatment with vedolizumab in an adolescent with Crohn disease who had developed active pulmonary tuberculosis while receiving infliximab","volume":"38","author":"S Choi","year":"2021","journal-title":"Yeungnam Univ J Med"},{"key":"ref603","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jaad.2019.12.033","article-title":"Ustekinumab does not increase tuberculosis risk: Results from a national database in South Korea","volume":"82","author":"S I Cho","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"ref605","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/cid\/ciw778","article-title":"Official American Thoracic Society\/Infectious Diseases Society of America\/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children","volume":"64","author":"D M Lewinsohn","year":"2017","journal-title":"Clin Infect Dis"},{"key":"ref606","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S2468-1253(22)00005-X","article-title":"COVID-19 vaccine-induced antibody responses in immunosuppressed patients with inflammatory bowel disease (VIP): a multicentre, prospective, case-control study","volume":"7","author":"J L Alexander","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref607","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S2468-1253(22)00274-6","article-title":"COVID-19 vaccine-induced antibody and T-cell responses in immunosuppressed patients with inflammatory bowel disease after the third vaccine dose (VIP): a multicentre, prospective, case-control study","volume":"7","author":"J L Alexander","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref608","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1053\/j.gastro.2021.10.029","article-title":"Lower Serologic Response to COVID-19 mRNA Vaccine in Patients With Inflammatory Bowel Diseases Treated With Anti-TNF\u03b1","volume":"162","author":"H Edelman-Klapper","year":"2022","journal-title":"Gastroenterology"},{"key":"ref609","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.dld.2022.08.027","article-title":"Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease: Data from ESCAPE-IBD, an IG-IBD study","volume":"55","author":"F S Macaluso","year":"2023","journal-title":"Dig Liver Dis"},{"key":"ref610","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/jgh.16001","article-title":"Response to COVID-19 vaccine is reduced in patients with inflammatory bowel disease, but improved with additional dose","volume":"38","author":"H Shiga","year":"2023","journal-title":"J Gastroenterol Hepatol"},{"key":"ref611","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1097\/00004836-200609000-00002","article-title":"Quality of life after proctocolectomy with ileoanal anastomosis for patients with ulcerative colitis","volume":"40","author":"G R Lichtenstein","year":"2006","journal-title":"J Clin Gastroenterol"},{"key":"ref612","first-page":"1052","article-title":"[Long-term quality of life after continence-preserving proctocolectomy for ulcerative colitis and familial adenomatous polyposis]","volume":"69","author":"U A Heuschen","year":"1998","journal-title":"Chirurg"},{"key":"ref613","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1093\/ecco-jcc\/jjad021","article-title":"Comparison of Restorative Proctocolectomy with and Without Defunctioning Loop Ileostomy in Patients with Ulcerative Colitis: A Systematic Review and Meta-analysis","volume":"17","author":"M Donnelly","year":"2023","journal-title":"J Crohns Colitis"},{"key":"ref614","doi-asserted-by":"publisher","DOI":"10.1111\/codi.13802","article-title":"Pouch Failures Following Ileal Pouch-anal Anastomosis for Ulcerative Colitis","author":"A Mark-Christensen","year":"2017","journal-title":"Colorectal Dis"},{"key":"ref615","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1001\/archsurg.2010.304","article-title":"To divert or not to divert: A retrospective analysis of variables that influence ileostomy omission in ileal pouch surgery","volume":"146","author":"R E Lovegrove","year":"2011","journal-title":"Arch Surg"},{"key":"ref616","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1007\/s11605-014-2660-8","article-title":"Morbidity of loop ileostomy closure after restorative proctocolectomy for ulcerative colitis and familial adenomatous polyposis: a systematic review","volume":"18","author":"R Mennigen","year":"2014","journal-title":"J Gastrointest Surg"},{"key":"ref617","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/codi.14104","article-title":"A systematic review and meta-analysis comparing adverse events and functional outcomes of different pouch designs after restorative proctocolectomy","volume":"20","author":"C Simillis","year":"2018","journal-title":"Colorectal Dis"},{"key":"ref618","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1463-1318.2006.01093.x","article-title":"Meta-analysis of short-term and long-term outcomes of J, W and S ileal reservoirs for restorative proctocolectomy","volume":"9","author":"R E Lovegrove","year":"2007","journal-title":"Colorectal Dis"},{"key":"ref619","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1097\/DCR.0b013e318270327f","article-title":"The ideal ileal-pouch design: a long-term randomized control trial of J- vs W-pouch construction","volume":"55","author":"P H McCormick","year":"2012","journal-title":"Dis Colon Rectum"},{"key":"ref620","doi-asserted-by":"crossref","first-page":"986","DOI":"10.3109\/00365529008997624","article-title":"A prospective randomized comparison of two different pelvic pouch designs","volume":"25","author":"T Oresland","year":"1990","journal-title":"Scand J Gastroenterol"},{"key":"ref621","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1471-230X-5-39","article-title":"Outcome following emergency surgery for refractory severe ulcerative colitis in a tertiary care centre in India","volume":"5","author":"S Pal","year":"2005","journal-title":"BMC Gastroenterol"},{"key":"ref622","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/BF02555345","article-title":"Toxic megacolon. An analysis of 70\u00a0cases","volume":"29","author":"J Heppell","year":"1986","journal-title":"Dis Colon Rectum"},{"key":"ref623","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1463-1318.2007.01321.x","article-title":"Laparoscopic emergency and elective surgery for ulcerative colitis","volume":"10","author":"L Fowkes","year":"2008","journal-title":"Colorectal Dis"},{"key":"ref624","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1097\/MIB.0000000000000350","article-title":"Systematic Review: Sequential Rescue Therapy in Severe Ulcerative Colitis: Do the Benefits Outweigh the Risks?","volume":"21","author":"N Narula","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"ref625","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/BF02054219","article-title":"Safety of urgent restorative proctocolectomy with ileal pouch-anal anastomosis for fulminant colitis","volume":"38","author":"Y Ziv","year":"1995","journal-title":"Dis Colon Rectum"},{"key":"ref626","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/BF00699416","article-title":"Restorative proctocolectomy in elective and emergency cases of ulcerative colitis","volume":"9","author":"G Heyvaert","year":"1994","journal-title":"Int J Colorectal Dis"},{"key":"ref627","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/00000658-199508000-00003","article-title":"Ileal pouch-anal anastomoses complications and function in 1005 patients","volume":"222","author":"V W Fazio","year":"1995","journal-title":"Ann Surg"},{"key":"ref628","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0140-6736(97)10475-5","article-title":"Toxic megacolon","volume":"351","author":"S G Sheth","year":"1998","journal-title":"Lancet"},{"key":"ref629","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/apt.12375","article-title":"Outcomes of salvage therapy for steroid-refractory acute severe ulcerative colitis: ciclosporin vs. infliximab","volume":"38","author":"A Croft","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"ref630","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1136\/gutjnl-2016-313060","article-title":"Long-term outcome of patients with steroid-refractory acute severe UC treated with ciclosporin or infliximab","volume":"67","author":"D Laharie","year":"2018","journal-title":"Gut"},{"key":"ref631","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1159\/000442676","article-title":"Prolonged Medical Therapy Increases the Risk of Surgical Complications in Patients with Severe Ulcerative Colitis","volume":"33","author":"H Kimura","year":"2016","journal-title":"Dig Surg"},{"key":"ref632","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1097\/DCR.0b013e318251e004","article-title":"Timing of restorative proctocolectomy in patients with medically refractory ulcerative colitis: the patient\u2019s point of view","volume":"55","author":"P A Neumann","year":"2012","journal-title":"Dis Colon Rectum"},{"key":"ref633","first-page":"341","article-title":"Systematic review and meta-analysis of third-line salvage therapy with infliximab or cyclosporine in severe ulcerative colitis","volume":"29","author":"J D Feuerstein","year":"2016","journal-title":"Ann Gastroenterol"},{"key":"ref634","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1093\/ecco-jcc\/jjv134","article-title":"Comparison of Costs and Quality of Life in Ulcerative Colitis Patients with an Ileal Pouch-Anal Anastomosis, Ileostomy and Anti-TNFalpha Therapy","volume":"9","author":"M E van der Valk","year":"2015","journal-title":"J Crohns Colitis"},{"key":"ref635","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s00384-021-04067-6","article-title":"Prevalence of \u201cpouch failure\u201d of the ileoanal pouch in ulcerative colitis: a systematic review and meta-analysis","volume":"37","author":"Z Alsafi","year":"2022","journal-title":"Int J Colorectal Dis"},{"key":"ref636","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/codi.15301","article-title":"A systematic review and meta-analysis of outcomes after elective surgery for ulcerative colitis","volume":"23","author":"D M Baker","year":"2021","journal-title":"Colorectal Dis"},{"key":"ref637","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1007\/s00384-020-03696-7","article-title":"Modified two-stage restorative proctocolectomy with ileal pouch-anal anastomosis for ulcerative colitis: a systematic review and meta-analysis of observational research","volume":"35","author":"W Y Luo","year":"2020","journal-title":"Int J Colorectal Dis"},{"key":"ref638","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.jamcollsurg.2016.12.049","article-title":"Variant Two-Stage Ileal Pouch-Anal Anastomosis: An Innovative and Effective Alternative to Standard Resection in Ulcerative Colitis","volume":"224","author":"J Samples","year":"2017","journal-title":"J Am Coll Surg"},{"key":"ref639","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/BF02553488","article-title":"Restorative proctocolectomy with ileal reservoir. Comparison of two-stage vs. three-stage procedures and analysis of factors that might affect outcome","volume":"32","author":"R J Nicholls","year":"1989","journal-title":"Dis Colon Rectum"},{"key":"ref640","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.jamcollsurg.2006.12.044","article-title":"Effect of infliximab on short-term complications in patients undergoing operation for chronic ulcerative colitis","volume":"204","author":"C R Selvasekar","year":"2007","journal-title":"J Am Coll Surg"},{"key":"ref641","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1463-1318.2008.01579.x","article-title":"Subtotal colectomy for toxic and fulminant colitis in the era of immunosuppressive therapy","volume":"11","author":"D Stewart","year":"2009","journal-title":"Colorectal Dis"},{"key":"ref642","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1002\/ibd.20863","article-title":"Corticosteroids but not infliximab increase short-term postoperative infectious complications in patients with ulcerative colitis","volume":"15","author":"M Ferrante","year":"2009","journal-title":"Inflamm Bowel Dis"},{"key":"ref643","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/ibd.20407","article-title":"Impact of preoperative infliximab use on postoperative infectious complications in ulcerative colitis: the price we have to pay?","volume":"14","author":"B Shen","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"ref644","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1111\/j.1365-2036.2012.05099.x","article-title":"Pre-operative use of anti-TNF-alpha agents and the risk of post-operative complications in patients with ulcerative colitis \u2013 a nationwide cohort study","volume":"35","author":"B M Norgard","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"ref645","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1007\/s10350-008-9364-7","article-title":"Infliximab in ulcerative colitis is associated with an increased risk of postoperative complications after restorative proctocolectomy","volume":"51","author":"I J Mor","year":"2008","journal-title":"Dis Colon Rectum"},{"key":"ref646","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1111\/apt.12060","article-title":"Meta-analysis: effect of preoperative infliximab use on early postoperative complications in patients with ulcerative colitis undergoing abdominal surgery","volume":"36","author":"Z Yang","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"ref647","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/MIB.0000000000000232","article-title":"Effect of preoperative biologic drugs on complications and function after restorative proctocolectomy with primary ileal pouch formation: systematic review and meta-analysis","volume":"21","author":"F Selvaggi","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"ref648","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/SLA.0000000000000757","article-title":"The impact of preoperative serum anti-TNFalpha therapy levels on early postoperative outcomes in inflammatory bowel disease surgery","volume":"261","author":"C Lau","year":"2015","journal-title":"Ann Surg"},{"key":"ref649","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jpedsurg.2006.09.006","article-title":"Pouch outcomes among children with ulcerative colitis treated with calcineurin inhibitors before ileal pouch anal anastomosis surgery","volume":"42","author":"E J Hait","year":"2007","journal-title":"J Pediatr Surg"},{"key":"ref650","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1097\/DCR.0000000000002113","article-title":"Slow and Steady Wins the Race: A Solid Case for a 3-Stage Approach in Ulcerative Colitis","volume":"64","author":"M C Plietz","year":"2021","journal-title":"Dis Colon Rectum"},{"key":"ref651","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/DCR.0b013e3182707682","article-title":"Intraperitoneal or subcutaneous: does location of the (colo)rectal stump influence outcomes after laparoscopic total abdominal colectomy for ulcerative colitis?","volume":"56","author":"J Gu","year":"2013","journal-title":"Dis Colon Rectum"},{"key":"ref652","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1463-1318.2005.00875.x","article-title":"Management of the rectal stump after emergency sub-total colectomy: which surgical option is associated with the lowest morbidity?","volume":"7","author":"J P Trickett","year":"2005","journal-title":"Colorectal Dis"},{"key":"ref653","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/BF02054125","article-title":"Subtotal colectomy with Hartmann\u2019s pouch for inflammatory bowel disease","volume":"38","author":"L A Karch","year":"1995","journal-title":"Dis Colon Rectum"},{"key":"ref654","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s10151-022-02713-x","article-title":"Long-term outcomes after close rectal dissection and total mesorectal excision in ileal pouch-anal anastomosis for ulcerative colitis","volume":"27","author":"M A Reijntjes","year":"2023","journal-title":"Tech Coloproctol"},{"key":"ref655","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/bjs.9701","article-title":"Short-term morbidity and quality of life from a randomized clinical trial of close rectal dissection and total mesorectal excision in ileal pouch-anal anastomosis","volume":"102","author":"S A Bartels","year":"2015","journal-title":"Br J Surg"},{"key":"ref656","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.amjsurg.2014.05.012","article-title":"Does intramesorectal excision for ulcerative colitis impact bowel and sexual function when compared with total mesorectal excision?","volume":"208","author":"C W Hicks","year":"2014","journal-title":"Am J Surg"},{"key":"ref657","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s11605-008-0665-x","article-title":"Does mesorectal preservation protect the ileoanal anastomosis after restorative proctocolectomy?","volume":"13","author":"A D Rink","year":"2009","journal-title":"J Gastrointest Surg"},{"key":"ref658","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1007\/s00595-006-3452-x","article-title":"Adenocarcinoma arising below an ileoanal anastomosis after restorative proctocolectomy for ulcerative colitis: report of a case","volume":"37","author":"H Ota","year":"2007","journal-title":"Surg Today"},{"key":"ref659","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s13304-011-0089-0","article-title":"Adenocarcinoma below stapled ileoanal anastomosis after restorative proctocolectomy for ulcerative colitis","volume":"64","author":"L Alessandroni","year":"2012","journal-title":"Updates Surg"},{"key":"ref660","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1007\/DCR.0b013e3181f222d5","article-title":"Oncologic outcome in patients with ulcerative colitis associated with dyplasia or cancer who underwent stapled or handsewn ileal pouch-anal anastomosis","volume":"53","author":"W Al-Sukhni","year":"2010","journal-title":"Dis Colon Rectum"},{"key":"ref661","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.crohns.2014.08.012","article-title":"European evidence based consensus on surgery for ulcerative colitis","volume":"9","author":"T Oresland","year":"2015","journal-title":"J Crohns Colitis"},{"key":"ref662","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/01.sla.0000225031.15405.a3","article-title":"A comparison of hand-sewn versus stapled ileal pouch anal anastomosis (IPAA) following proctocolectomy: a meta-analysis of 4183 patients","volume":"244","author":"R E Lovegrove","year":"2006","journal-title":"Ann Surg"},{"key":"ref663","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/01.sla.0000152018.99541.f1","article-title":"Evaluation of the learning curve in ileal pouch-anal anastomosis surgery","volume":"241","author":"P P Tekkis","year":"2005","journal-title":"Ann Surg"},{"key":"ref664","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1097\/SLA.0000000000001406","article-title":"Restorative Proctocolectomy and Ileal Pouch-anal Anastomosis","volume":"262","author":"Y Parc","year":"2015","journal-title":"Ann Surg"},{"key":"ref665","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/bjs.7312","article-title":"Volume analysis of outcome following restorative proctocolectomy","volume":"98","author":"E M Burns","year":"2011","journal-title":"Br J Surg"},{"key":"ref666","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1097\/SLA.0b013e31814539b1","article-title":"Improved outcome due to increased experience and individualized management of leaks after ileal pouch-anal anastomosis","volume":"246","author":"M J Raval","year":"2007","journal-title":"Ann Surg"},{"key":"ref667","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/j.dld.2022.06.013","article-title":"Ileoanal pouch cancers in ulcerative colitis and familial adenomatous polyposis: A systematic review and meta-analysis","volume":"54","author":"D Sriranganathan","year":"2022","journal-title":"Dig Liver Dis"},{"key":"ref668","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00423-014-1263-x","article-title":"Residual rectal mucosa after stapled vs. handsewn ileal J-pouch-anal anastomosis in patients with familial adenomatous polyposis coli (FAP) \u2013 a critical issue","volume":"400","author":"P Ganschow","year":"2015","journal-title":"Langenbecks Arch Surg"},{"key":"ref669","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1463-1318.2004.00716.x","article-title":"The risk of dysplasia and cancer in the ileal pouch mucosa after restorative proctocolectomy for ulcerative proctocolitis is low: a long-term term follow-up study","volume":"6","author":"L Borjesson","year":"2004","journal-title":"Colorectal Dis"},{"key":"ref670","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/DCR.0000000000000796","article-title":"Paradoxical Impact of Ileal Pouch-Anal Anastomosis on Male and Female Fertility in Patients With Ulcerative Colitis","volume":"60","author":"F R Pachler","year":"2017","journal-title":"Dis Colon Rectum"},{"key":"ref671","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/SLA.0b013e3182813741","article-title":"A total laparoscopic approach reduces the infertility rate after ileal pouch-anal anastomosis: a 2-center study","volume":"258","author":"L Beyer-Berjot","year":"2013","journal-title":"Ann Surg"},{"key":"ref672","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1097\/SLA.0b013e318250caa9","article-title":"Significantly increased pregnancy rates after laparoscopic restorative proctocolectomy: a cross-sectional study","volume":"256","author":"S A Bartels","year":"2012","journal-title":"Ann Surg"},{"key":"ref673","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1007\/s00384-011-1274-9","article-title":"Impact of ileal pouch-anal anastomosis on female fertility: meta-analysis and systematic review","volume":"26","author":"S G Rajaratnam","year":"2011","journal-title":"Int J Colorectal Dis"},{"key":"ref674","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1097\/SLA.0000000000002022","article-title":"Long-term Follow-up After Ileorectal Anastomosis for Ulcerative Colitis: A GETAID\/GETAID Chirurgie Multicenter Retrospective Cohort of 343 Patients","volume":"266","author":"M Uzzan","year":"2017","journal-title":"Ann Surg"},{"key":"ref675","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s10151-006-0286-x","article-title":"The place for colectomy and ileorectal anastomosis: a valid surgical option for ulcerative colitis?","volume":"10","author":"L Borjesson","year":"2006","journal-title":"Tech Coloproctol"},{"key":"ref676","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/bjs.6809","article-title":"Clinical outcomes of ileorectal anastomosis for ulcerative colitis","volume":"97","author":"A da Luz Moreira","year":"2010","journal-title":"Br J Surg"},{"key":"ref677","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/BF02237099","article-title":"Functional outcome of conversion of ileorectal anastomosis to ileal pouch-anal anastomosis in patients with familial adenomatous polyposis and ulcerative colitis","volume":"42","author":"C Soravia","year":"1999","journal-title":"Dis Colon Rectum"},{"key":"ref678","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12893-023-01984-x","article-title":"Colectomy reconstruction for ulcerative colitis in Sweden and England: a multicenter prospective comparison between ileorectal anastomosis and ileal pouch-anal anastomosis after colectomy in patients with ulcerative colitis. (CRUISE-study)","volume":"23","author":"A Risto","year":"2023","journal-title":"BMC Surg"},{"key":"ref679","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1007\/s11605-021-04913-6","article-title":"Extent of Surgical Resection in Inflammatory Bowel Disease Associated Colorectal Cancer: a Population-Based Study","volume":"25","author":"J Bogach","year":"2021","journal-title":"J Gastrointest Surg"},{"key":"ref680","doi-asserted-by":"publisher","DOI":"10.1097\/DCR.0000000000003311","article-title":"Segmental Colectomy in Ulcerative Colitis","author":"S Yilmaz","year":"2024","journal-title":"Dis Colon Rectum"},{"key":"ref681","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1093\/ecco-jcc\/jjaa107","article-title":"Segmental Colectomy for Ulcerative Colitis: Is There a Place in Selected Patients Without Active Colitis? An International Multicentric Retrospective Study in 72 Patients","volume":"14","author":"A Frontali","year":"2020","journal-title":"J Crohns Colitis"},{"key":"ref682","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s10151-023-02762-w","article-title":"The incidence of malignancy in the residual rectum of IBD patients after colectomy: a systematic review and meta-analysis","volume":"27","author":"I Georganta","year":"2023","journal-title":"Tech Coloproctol"},{"key":"ref683","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1007\/s10350-005-0285-4","article-title":"Long-term outcome and quality of life after continent ileostomy","volume":"49","author":"G Nessar","year":"2006","journal-title":"Dis Colon Rectum"},{"key":"ref684","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/00152192-200509000-00010","article-title":"Thirty years of experience living with a continent ileostomy: bad restrooms--not my reservoir--decide my life","volume":"32","author":"I Berndtsson","year":"2005","journal-title":"J Wound Ostomy Continence Nurs"},{"key":"ref685","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S1091-255X(99)80085-7","article-title":"The continent ileostomy: long-term durability and patient satisfaction","volume":"3","author":"V R Litle","year":"1999","journal-title":"J Gastrointest Surg"},{"key":"ref686","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/DCR.0b013e3181ab586b","article-title":"Outcomes for patients undergoing continent ileostomy after a failed ileal pouch-anal anastomosis","volume":"52","author":"L Lian","year":"2009","journal-title":"Dis Colon Rectum"},{"key":"ref687","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1093\/ecco-jcc\/jjx027","article-title":"Risk of Rectal Neoplasia after Colectomy and Ileorectal Anastomosis for Ulcerative Colitis","volume":"11","author":"M Uzzan","year":"2017","journal-title":"J Crohns Colitis"},{"key":"ref688","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1463-1318.2011.02669.x","article-title":"The prevalence of dysplasia in the ileoanal pouch following restorative proctocolectomy for ulcerative colitis with associated dysplasia","volume":"14","author":"T Kuiper","year":"2012","journal-title":"Colorectal Dis"},{"key":"ref689","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1097\/01.sla.0000145923.03130.1c","article-title":"Hand-assisted laparoscopic versus open restorative proctocolectomy with ileal pouch anal anastomosis: a randomized trial","volume":"240","author":"S Maartense","year":"2004","journal-title":"Ann Surg"},{"key":"ref690","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00384-006-0177-7","article-title":"Comparison of short-term outcomes of laparoscopic vs open approaches to ileal pouch surgery","volume":"22","author":"H S Tilney","year":"2007","journal-title":"Int J Colorectal Dis"},{"key":"ref691","doi-asserted-by":"publisher","first-page":"CD006267","DOI":"10.1002\/14651858.CD006267.pub2","article-title":"Open versus laparoscopic (assisted) ileo pouch anal anastomosis for ulcerative colitis and familial adenomatous polyposis","author":"U Ahmed Ali","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"ref692","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/bjs.9061","article-title":"Systematic review and meta-analysis of laparoscopic versus open colectomy with end ileostomy for non-toxic colitis","volume":"100","author":"S A Bartels","year":"2013","journal-title":"Br J Surg"},{"key":"ref693","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s00384-010-0898-5","article-title":"The role of laparoscopic surgery for ulcerative colitis: systematic review with meta-analysis","volume":"25","author":"X J Wu","year":"2010","journal-title":"Int J Colorectal Dis"},{"key":"ref694","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1007\/s00384-021-03868-z","article-title":"Robotic versus laparoscopic ileal pouch-anal anastomosis (IPAA): a systematic review and meta-analysis","volume":"36","author":"J Flynn","year":"2021","journal-title":"Int J Colorectal Dis"},{"key":"ref695","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s11701-022-01490-x","article-title":"Role of robotic approach in ileal pouch-anal anastomosis (IPAA): A systematic review of the literature","volume":"17","author":"Z Khawaja","year":"2023","journal-title":"J Robot Surg"},{"key":"ref696","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/s00464-011-1880-1","article-title":"Less adhesiolysis and hernia repair during completion proctocolectomy after laparoscopic emergency colectomy for ulcerative colitis","volume":"26","author":"S A Bartels","year":"2012","journal-title":"Surg Endosc"},{"key":"ref697","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s00464-008-0139-y","article-title":"Laparoscopic ileal pouch-anal anastomosis reduces abdominal and pelvic adhesions","volume":"23","author":"A A Indar","year":"2009","journal-title":"Surg Endosc"},{"key":"ref698","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/DCR.0000000000000287","article-title":"Laparoscopic IPAA is not associated with decreased rates of incisional hernia and small-bowel obstruction when compared with open technique: long-term follow-up of a case-matched study","volume":"58","author":"C Benlice","year":"2015","journal-title":"Dis Colon Rectum"},{"key":"ref699","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/DCR.0b013e31819a5cc1","article-title":"Minimally invasive subtotal colectomy and ileal pouch-anal anastomosis for fulminant ulcerative colitis: a reasonable approach?","volume":"52","author":"S D Holubar","year":"2009","journal-title":"Dis Colon Rectum"},{"key":"ref700","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/DCR.0b013e3181975701","article-title":"Laparoscopic vs. open total abdominal colectomy for severe colitis: impact on recovery and subsequent completion restorative proctectomy","volume":"52","author":"T P Chung","year":"2009","journal-title":"Dis Colon Rectum"},{"key":"ref701","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1007\/s00464-009-0819-2","article-title":"Laparoscopic subtotal colectomy for medically refractory ulcerative colitis: the time has come","volume":"24","author":"D A Telem","year":"2010","journal-title":"Surg Endosc"},{"key":"ref702","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1002\/ibd.20361","article-title":"Indeterminate colitis: a review of the concept \u2013 what\u2019s in a name?","volume":"14","author":"K Geboes","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"ref703","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s10350-003-0116-4","article-title":"Outcome of patients with indeterminate colitis undergoing a double-stapled ileal pouch-anal anastomosis","volume":"47","author":"T Pishori","year":"2004","journal-title":"Dis Colon Rectum"},{"key":"ref704","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/00000658-200207000-00008","article-title":"Equivalent function, quality of life and pouch survival rates after ileal pouch-anal anastomosis for indeterminate and ulcerative colitis","volume":"236","author":"C P Delaney","year":"2002","journal-title":"Ann Surg"},{"key":"ref705","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s10350-006-0777-x","article-title":"The effect of Crohn\u2019s disease on outcomes after restorative proctocolectomy","volume":"50","author":"G E Reese","year":"2007","journal-title":"Dis Colon Rectum"},{"key":"ref706","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/MPG.0b013e3181b99baa","article-title":"Rising incidence of inflammatory bowel disease among children: a 12-year study","volume":"50","author":"H M Malaty","year":"2010","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref707","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/00054725-200111000-00004","article-title":"A randomized clinical trial of ciprofloxacin and metronidazole to treat acute pouchitis","volume":"7","author":"B Shen","year":"2001","journal-title":"Inflamm Bowel Dis"},{"key":"ref708","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ajg.2023.01.007","article-title":"A systematic review of outcomes and quality of life after ileorectal anastomosis for ulcerative colitis","volume":"24","author":"M Al-Rashedy","year":"2023","journal-title":"Arab J Gastroenterol"},{"key":"ref709","doi-asserted-by":"publisher","DOI":"10.1177\/10732748241236338","article-title":"Stapled Anastomosis Versus Hand-Sewn Anastomosis With Mucosectomy for Ileal Pouch-Anal Anastomosis: A Systematic Review and Meta-analysis of Postoperative Outcomes, Functional Outcomes, and Oncological Safety","volume":"31","author":"M A Chaouch","year":"2024","journal-title":"Cancer Control"},{"key":"ref710","first-page":"S26","article-title":"Controversies in IPAA for Ulcerative Colitis: A Systematic Review of Different Anastomotic Techniques","volume":"67","author":"P G Kotze","year":"2024","journal-title":"Dis Colon Rectum"},{"key":"ref711","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1111\/codi.16977","article-title":"Transanal ileal pouch-anal anastomosis for inflammatory bowel disease: a systematic review and meta-analysis of short-term outcomes","volume":"26","author":"E P Lincango","year":"2024","journal-title":"Colorectal Dis"},{"key":"ref712","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00423-024-03343-7","article-title":"Transanal ileal pouch-anal anastomosis: A systematic review and meta-analysis of technical approaches and clinical outcomes","volume":"409","author":"I JB Stephens","year":"2024","journal-title":"Langenbecks Arch Surg"},{"key":"ref713","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1111\/codi.16977","article-title":"Transanal ileal pouch\u2013anal anastomosis for inflammatory bowel disease: a systematic review and meta-analysis of short-term outcomes","volume":"26","author":"E P Lincango","year":"2024","journal-title":"Colorectal Disease"},{"key":"ref715","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1097\/DCR.0000000000000418","article-title":"Quality of Life After Total Proctocolectomy With Ileostomy or IPAA: A Systematic Review","volume":"58","author":"P B Murphy","year":"2015","journal-title":"Dis Colon Rectum"},{"key":"ref716","doi-asserted-by":"crossref","first-page":"695","DOI":"10.3109\/00365529309098275","article-title":"Incidence and characteristics of pouchitis in the Kock continent ileostomy and the pelvic pouch","volume":"28","author":"G Svaninger","year":"1993","journal-title":"Scand J Gastroenterol"},{"key":"ref717","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/BF02050351","article-title":"Pouchitis \u2013 is it a wastebasket diagnosis?","volume":"34","author":"S M Rauh","year":"1991","journal-title":"Dis Colon Rectum"},{"key":"ref718","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0025-6196(12)61634-6","article-title":"Pouchitis after ileal pouch-anal anastomosis: a Pouchitis Disease Activity Index","volume":"69","author":"W J Sandborn","year":"1994","journal-title":"Mayo Clin Proc"},{"key":"ref719","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1080\/003655200750056646","article-title":"Long-term clinical outcome and anemia after restorative proctocolectomy for ulcerative colitis","volume":"35","author":"J Tiainen","year":"2000","journal-title":"Scand J Gastroenterol"},{"key":"ref720","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1046\/j.1365-2168.1998.00689.x","article-title":"J ileal pouch-anal anastomosis for chronic ulcerative colitis: complications and long-term outcome in 1310 patients","volume":"85","author":"A P Meagher","year":"1998","journal-title":"Br J Surg"},{"key":"ref721","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/00054725-199811000-00004","article-title":"The implications of acute pouchitis on the long-term functional results after restorative proctocolectomy","volume":"4","author":"R D Hurst","year":"1998","journal-title":"Inflamm Bowel Dis"},{"key":"ref722","first-page":"28","article-title":"Histological and macroscopic changes in the pelvic pouch: long-term follow up after restorative proctocolectomy for ulcerative colitis (UC)","volume":"3","author":"J Tiainen","year":"2001","journal-title":"Colorectal Dis"},{"key":"ref723","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1080\/003655299750026065","article-title":"Health-related quality of life after ileal J-pouch-anal anastomosis for ulcerative colitis: long-term results","volume":"34","author":"J Tiainen","year":"1999","journal-title":"Scand J Gastroenterol"},{"key":"ref724","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1177\/000313489906500110","article-title":"Ileoanal pouch procedures: clinical outcomes and quality-of-life assessment","volume":"65","author":"S A Seidel","year":"1999","journal-title":"Am Surg"},{"key":"ref725","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/BF02234320","article-title":"Long-term follow-up after ileoanal pouch procedure: algorithm for diagnosis, classification, and management of pouchitis","volume":"44","author":"U A Heuschen","year":"2001","journal-title":"Dis Colon Rectum"},{"key":"ref726","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1007\/BF02054692","article-title":"Pouchitis following pelvic pouch operation for ulcerative colitis. Incidence, cumulative risk, and risk factors","volume":"39","author":"D Stahlberg","year":"1996","journal-title":"Dis Colon Rectum"},{"key":"ref727","first-page":"622","article-title":"Pouchitis and extraintestinal manifestations of inflammatory bowel disease after ileal pouch-anal anastomosis","volume":"211","author":"J L Lohmuller","year":"1990","journal-title":"Ann Surg"},{"key":"ref728","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s002689900395","article-title":"Pouchitis: risk factors, etiology, and treatment","volume":"22","author":"R J Nicholls","year":"1998","journal-title":"World J Surg"},{"key":"ref729","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1136\/gut.38.2.234","article-title":"Pouchitis after ileal pouch-anal anastomosis for ulcerative colitis occurs with increased frequency in patients with associated primary sclerosing cholangitis","volume":"38","author":"C Penna","year":"1996","journal-title":"Gut"},{"key":"ref730","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1111\/j.1572-0241.2002.05617.x","article-title":"Irritable pouch syndrome: a new category of diagnosis for symptomatic patients with ileal pouch-anal anastomosis","volume":"97","author":"B Shen","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"ref731","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2214\/ajr.154.1.2104730","article-title":"Ileoanal pouches: comparison of CT, scintigraphy, and contrast enemas for diagnosing postsurgical complications","volume":"154","author":"R F Thoeni","year":"1990","journal-title":"Am J Roentgenol"},{"key":"ref732","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1097\/00004728-199807000-00029","article-title":"MRI of pouch-related fistulas in ulcerative colitis after restorative proctocolectomy","volume":"22","author":"M Libicher","year":"1998","journal-title":"J Comput Assist Tomogr"},{"key":"ref733","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s002619900364","article-title":"Total proctocolectomy and ileoanal pouch: the role of contrast studies for evaluating postoperative leaks","volume":"23","author":"J M Hrung","year":"1998","journal-title":"Abdom Imaging"},{"key":"ref734","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/BF02052448","article-title":"Assessment of peripouch inflammation after ileoanal anastomosis using endoluminal ultrasonography","volume":"38","author":"M J Solomon","year":"1995","journal-title":"Dis Colon Rectum"},{"key":"ref735","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1093\/ibd\/izz005","article-title":"The Incidence and Definition of Crohn\u2019s Disease of the Pouch: A Systematic Review and Meta-analysis","volume":"25","author":"E L Barnes","year":"2019","journal-title":"Inflamm Bowel Dis"},{"key":"ref736","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/apt.13905","article-title":"Systematic review with meta-analysis: the management of chronic refractory pouchitis with an evidence-based treatment algorithm","volume":"45","author":"J P Segal","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"ref737","doi-asserted-by":"publisher","first-page":"CD001176","DOI":"10.1002\/14651858.CD001176","article-title":"Pharmacotherapy for inducing and maintaining remission in pouchitis","author":"W Sandborn","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"ref738","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/00054725-199902000-00005","article-title":"Medical therapy for induction and maintenance of remission in pouchitis: a systematic review","volume":"5","author":"W J Sandborn","year":"1999","journal-title":"Inflamm Bowel Dis"},{"key":"ref739","doi-asserted-by":"publisher","first-page":"CD001176","DOI":"10.1002\/14651858.CD001176.pub3","article-title":"Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis","author":"S Singh","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"ref740","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1046\/j.1365-2036.2002.01203.x","article-title":"Four-week open-label trial of metronidazole and ciprofloxacin for the treatment of recurrent or refractory pouchitis","volume":"16","author":"T Mimura","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"ref741","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1007\/BF02093783","article-title":"Double-blind crossover trial of metronidazole versus placebo in chronic unremitting pouchitis","volume":"39","author":"M V Madden","year":"1994","journal-title":"Dig Dis Sci"},{"key":"ref742","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1001\/archsurg.1996.01430170043007","article-title":"Prospective study of the incidence, timing and treatment of pouchitis in 104 consecutive patients after restorative proctocolectomy","volume":"131","author":"R D Hurst","year":"1996","journal-title":"Arch Surg"},{"key":"ref743","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1007\/s10350-006-0828-3","article-title":"Combined ciprofloxacin and tinidazole therapy in the treatment of chronic refractory pouchitis","volume":"50","author":"B Shen","year":"2007","journal-title":"Dis Colon Rectum"},{"key":"ref744","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1046\/j.1365-2036.1999.00553.x","article-title":"Antibiotic combination therapy in patients with chronic, treatment-resistant pouchitis","volume":"13","author":"P Gionchetti","year":"1999","journal-title":"Aliment Pharmacol Ther"},{"key":"ref745","doi-asserted-by":"crossref","first-page":"462","DOI":"10.3109\/00365529409096839","article-title":"Topical metronidazole treatment in pouchitis","volume":"29","author":"K Nygaard","year":"1994","journal-title":"Scand J Gastroenterol"},{"key":"ref746","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1463-1318.2004.00746.x","article-title":"Rifaximin-ciprofloxacin combination therapy is effective in chronic active refractory pouchitis","volume":"7","author":"A S Abdelrazeq","year":"2005","journal-title":"Colorectal Dis"},{"key":"ref747","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1111\/j.1365-2036.2007.03306.x","article-title":"Oral budesonide in the treatment of chronic refractory pouchitis","volume":"25","author":"P Gionchetti","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"ref748","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1046\/j.1365-2036.2002.01139.x","article-title":"Budesonide enema in pouchitis--a double-blind, double-dummy, controlled trial","volume":"16","author":"A Sambuelli","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"issue":"S 08","key":"ref749","first-page":"531","article-title":"Efficacy and safety of intravenous vedolizumab for treatment of chronic pouchitis: results of the phase 4 earnest trial","volume":"9","author":"S Travis","year":"2021","journal-title":"United european gastroenterology journal"},{"key":"ref750","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1097\/MCG.0000000000000367","article-title":"Use of Biologics in Pouchitis: A Systematic Review","volume":"49","author":"H H Herfarth","year":"2015","journal-title":"J Clin Gastroenterol"},{"key":"ref751","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1093\/ecco-jcc\/jjv225","article-title":"Infliximab to Treat Refractory Inflammation After Pelvic Pouch Surgery for Ulcerative Colitis","volume":"10","author":"O B Kelly","year":"2016","journal-title":"J Crohns Colitis"},{"key":"ref752","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1002\/ibd.22933","article-title":"Adalimumab therapy in Crohn\u2019s disease of the ileal pouch","volume":"18","author":"Y Li","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"ref753","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1097\/MEG.0b013e3283525a7b","article-title":"Efficacy of adalimumab rescue therapy in patients with chronic refractory pouchitis previously treated with infliximab: a case series","volume":"24","author":"M Barreiro-de Acosta","year":"2012","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref754","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1007\/s00384-017-2854-0","article-title":"Successful treatment of chronic refractory pouchitis with vedolizumab","volume":"32","author":"F Mir","year":"2017","journal-title":"Int J Colorectal Dis"},{"key":"ref755","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1093\/ecco-jcc\/jjx018","article-title":"Successful Treatment With Ustekinumab for Chronic Refractory Pouchitis","volume":"11","author":"M L Tran-Minh","year":"2017","journal-title":"J Crohns Colitis"},{"key":"ref756","doi-asserted-by":"crossref","first-page":"701","DOI":"10.3109\/00365529309098276","article-title":"Ciclosporin A retention enemas in refractory distal ulcerative colitis and \u201cpouchitis\u201d","volume":"28","author":"T A Winter","year":"1993","journal-title":"Scand J Gastroenterol"},{"key":"ref757","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1007\/s10620-021-07002-5","article-title":"Is Ustekinumab Effective in Refractory Crohn\u2019s Disease of the Pouch and Chronic Pouchitis? A Systematic Review","volume":"67","author":"C Rocchi","year":"2022","journal-title":"Dig Dis Sci"},{"key":"ref758","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/MCG.0000000000001828","article-title":"Use of Biologics for the Treatment of Inflammatory Conditions of the Pouch: A Systematic Review","volume":"58","author":"G Godoy-Brewer","year":"2024","journal-title":"J Clin Gastroenterol"},{"key":"ref759","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1093\/ecco-jcc\/jjad194","article-title":"Treatment of Antibiotic Refractory Chronic Pouchitis With JAK Inhibitors and S1P Receptor Modulators: An ECCO CONFER Multicentre Case Series","volume":"18","author":"D G Ribaldone","year":"2024","journal-title":"J Crohns Colitis"},{"key":"ref760","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s00384-015-2428-y","article-title":"Successful treatment of chronic Pouchitis utilizing fecal microbiota transplantation (FMT): a case report","volume":"31","author":"S Fang","year":"2016","journal-title":"Int J Colorectal Dis"},{"key":"ref761","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00384-017-2761-4","article-title":"Successful treatment of pouchitis with Vedolizumab, but not fecal microbiota transfer (FMT), after proctocolectomy in ulcerative colitis","volume":"32","author":"M Schmid","year":"2017","journal-title":"Int J Colorectal Dis"},{"key":"ref762","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1093\/ibd\/izab001","article-title":"Fecal Microbiota Transplantation in Chronic Pouchitis: A Randomized, Parallel, Double-Blinded Clinical Trial","volume":"27","author":"E K Karjalainen","year":"2021","journal-title":"Inflamm Bowel Dis"},{"key":"ref763","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.1007\/s00464-013-3054-9","article-title":"Clinical value of surveillance pouchoscopy in asymptomatic ileal pouch patients with underlying inflammatory bowel disease","volume":"27","author":"H Zhu","year":"2013","journal-title":"Surg Endosc"},{"key":"ref764","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s00384-001-0364-5","article-title":"Cancer risk assessment in long-standing pouchitis. DNA aberrations are rare in transformed neoplastic pelvic pouch mucosa","volume":"17","author":"K Gullberg","year":"2002","journal-title":"Int J Colorectal Dis"},{"key":"ref765","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/den.12744","article-title":"Pouchitis after ileal pouch-anal anastomosis in ulcerative colitis: Diagnosis, management, risk factors, and incidence","volume":"29","author":"K Hata","year":"2017","journal-title":"Dig Endosc"},{"key":"ref766","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1007\/s00595-014-0974-5","article-title":"Treatment strategy for preventing pouchitis as a postoperative complication of ulcerative colitis: the significance of the management of cuffitis","volume":"44","author":"T Hashimoto","year":"2014","journal-title":"Surg Today"},{"key":"ref767","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1111\/j.1572-0241.2004.30518.x","article-title":"Treatment of rectal cuff inflammation (cuffitis) in patients with ulcerative colitis following restorative proctocolectomy and ileal pouch-anal anastomosis","volume":"99","author":"B Shen","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"ref768","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1002\/ibd.21412","article-title":"Irritable pouch syndrome is characterized by visceral hypersensitivity","volume":"17","author":"B Shen","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"ref769","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ecco-jcc\/jjad108","article-title":"ECCO Guidelines on Extraintestinal Manifestations in Inflammatory Bowel Disease","volume":"18","author":"H Gordon","year":"2024","journal-title":"J Crohns Colitis"},{"issue":"06","key":"ref770","first-page":"505","article-title":"Rheumatic Manifestations in Chronic Inflammatory Bowel Disease: Clinical Features, Diagnosis and Treatment","volume":"42","author":"M Glaubitz","year":"2017","journal-title":"Aktuelle Rheumatologie"},{"key":"ref771","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1136\/ard.2009.108233","article-title":"The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection","volume":"68","author":"M Rudwaleit","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"S 02","key":"ref772","doi-asserted-by":"crossref","first-page":"ii1","DOI":"10.1136\/ard.2008.104018","article-title":"The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis","volume":"68","author":"J Sieper","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"ref773","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/ecco-jcc\/jjv213","article-title":"The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease","volume":"10","author":"M Harbord","year":"2016","journal-title":"J Crohns Colitis"},{"key":"ref774","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/j.cgh.2018.09.035","article-title":"Retrospective Analysis of Safety of Vedolizumab in Patients With Inflammatory Bowel Diseases","volume":"17","author":"J Meserve","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref775","doi-asserted-by":"publisher","first-page":"CD003113","DOI":"10.1002\/14651858.CD003113.pub3","article-title":"Opioid therapy for treating rheumatoid arthritis pain","author":"S L Whittle","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"ref776","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007744.pub2","article-title":"Tolerability of selective cyclooxygenase 2 inhibitors used for the treatment of rheumatological manifestations of inflammatory bowel disease","author":"X P Miao","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"ref777","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1572-0241.2006.00384.x","article-title":"The gastrointestinal safety and effect on disease activity of etoricoxib, a selective cox-2 inhibitor in inflammatory bowel diseases","volume":"101","author":"Y El Miedany","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"ref778","doi-asserted-by":"crossref","first-page":"e206","DOI":"10.1136\/ard-2023-223937","article-title":"Response to: Correspondence on \u201cASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update\u201d by Braun et al","volume":"82","author":"S Ramiro","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"ref779","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/ueg2.12094","article-title":"The impact of ustekinumab on extraintestinal manifestations of Crohn\u2019s disease: A post hoc analysis of the UNITI studies","volume":"9","author":"N Narula","year":"2021","journal-title":"United European Gastroenterol J"},{"key":"ref780","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1136\/ard-2022-223715","article-title":"Identification of two tofacitinib subpopulations with different relative risk versus TNF inhibitors: an analysis of the open label, randomised controlled study ORAL Surveillance","volume":"82","author":"L E Kristensen","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"ref781","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1093\/ecco-jcc\/jjaa260","article-title":"Ustekinumab for Extra-intestinal Manifestations of Inflammatory Bowel Disease: A Systematic Literature Review","volume":"15","author":"L Guillo","year":"2021","journal-title":"J Crohns Colitis"},{"key":"ref782","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1136\/annrheumdis-2020-219601","article-title":"Tofacitinib for the treatment of ankylosing spondylitis: a phase III, randomised, double-blind, placebo-controlled study","volume":"80","author":"A Deodhar","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"ref783","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1136\/gutjnl-2020-322129","article-title":"Emerging treatment options for extraintestinal manifestations in IBD","volume":"70","author":"T Greuter","year":"2021","journal-title":"Gut"},{"key":"ref784","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1136\/ard.2011.151563","article-title":"2010 Update of the international ASAS recommendations for the use of anti-TNF agents in patients with axial spondyloarthritis","volume":"70","author":"D van der Heijde","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"ref785","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1136\/annrheumdis-2016-210770","article-title":"2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis","volume":"76","author":"D van der Heijde","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"ref786","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.3748\/wjg.v25.i18.2162","article-title":"Inflammatory bowel diseases and spondyloarthropathies: From pathogenesis to treatment","volume":"25","author":"G E Fragoulis","year":"2019","journal-title":"World J Gastroenterol"},{"key":"ref787","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0140-6736(22)01212-0","article-title":"Upadacitinib for the treatment of active non-radiographic axial spondyloarthritis (SELECT-AXIS 2): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"400","author":"A Deodhar","year":"2022","journal-title":"Lancet"},{"key":"ref788","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/ard-2022-223296","article-title":"ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update","volume":"82","author":"S Ramiro","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"ref789","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1016\/S0140-6736(19)32534-6","article-title":"Efficacy and safety of upadacitinib in patients with active ankylosing spondylitis (SELECT-AXIS 1): a multicentre, randomised, double-blind, placebo-controlled, phase 2\/3 trial","volume":"394","author":"D van der Heijde","year":"2019","journal-title":"Lancet"},{"key":"ref790","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1016\/S0140-6736(18)32463-2","article-title":"Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active ankylosing spondylitis (TORTUGA): results from a randomised, placebo-controlled, phase 2 trial","volume":"392","author":"D van der Heijde","year":"2018","journal-title":"Lancet"},{"key":"ref791","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/ecco-jcc\/jjz180","article-title":"ECCO Guidelines on Therapeutics in Crohn\u2019s Disease: Medical Treatment","volume":"14","author":"J Torres","year":"2020","journal-title":"J Crohns Colitis"},{"key":"ref792","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1093\/ecco-jcc\/jjac058","article-title":"The Impact of Vedolizumab and Ustekinumab on Articular Extra-Intestinal Manifestations in Inflammatory Bowel Disease Patients: A Real-Life Multicentre Cohort Study","volume":"16","author":"C De Galan","year":"2022","journal-title":"J Crohns Colitis"},{"key":"ref793","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1136\/annrheumdis-2018-213328","article-title":"Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis: results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 study","volume":"77","author":"D Baeten","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"ref794","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/art.40728","article-title":"Three Multicenter, Randomized, Double-Blind, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Ustekinumab in Axial Spondyloarthritis","volume":"71","author":"A Deodhar","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"ref795","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1136\/annrheumdis-2021-221019","article-title":"Efficacy and safety of risankizumab for active psoriatic arthritis: 24-week results from the randomised, double-blind, phase 3 KEEPsAKE 1 trial","volume":"81","author":"L E Kristensen","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"ref796","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/ecco-jcc\/jjy125","article-title":"Incidence of Arthritis\/Arthralgia in Inflammatory Bowel Disease with Long-term Vedolizumab Treatment: Post Hoc Analyses of the GEMINI Trials","volume":"13","author":"B G Feagan","year":"2019","journal-title":"J Crohns Colitis"},{"key":"ref797","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.1007\/s10067-023-06787-2","article-title":"Are all JAK inhibitors for the treatment of rheumatoid arthritis equivalent? An adjusted indirect comparison of the efficacy of tofacitinib, baricitinib, upadacitinib, and filgotinib","volume":"42","author":"L Vallez-Valero","year":"2023","journal-title":"Clin Rheumatol"},{"key":"ref798","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10020364","article-title":"Dermatological Manifestations in Inflammatory Bowel Diseases","volume":"10","author":"E Antonelli","year":"2021","journal-title":"J Clin Med"},{"key":"ref799","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/MD.0b013e318187cc9c","article-title":"Significance of erythema nodosum and pyoderma gangrenosum in inflammatory bowel diseases: a cohort study of 2402 patients","volume":"87","author":"D Farhi","year":"2008","journal-title":"Medicine (Baltimore)"},{"key":"ref800","doi-asserted-by":"crossref","first-page":"e0210436","DOI":"10.1371\/journal.pone.0210436","article-title":"Occurrence of skin manifestations in patients of the Swiss Inflammatory Bowel Disease Cohort Study","volume":"14","author":"N Roth","year":"2019","journal-title":"PLoS One"},{"key":"ref801","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/jgh.12352","article-title":"Predictive factors for erythema nodosum and pyoderma gangrenosum in inflammatory bowel disease","volume":"29","author":"J Ampuero","year":"2014","journal-title":"J Gastroenterol Hepatol"},{"key":"ref802","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/apt.12431","article-title":"Systematic review: IBD-associated pyoderma gangrenosum in the biologic era, the response to therapy","volume":"38","author":"A Agarwal","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"ref803","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.cgh.2015.04.173","article-title":"Hidradenitis Suppurativa in Patients With Inflammatory Bowel Disease: A Population-Based Cohort Study in Olmsted County, Minnesota","volume":"14","author":"S Yadav","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref804","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jaad.2016.08.031","article-title":"Inflammatory bowel disease is associated with hidradenitis suppurativa: Results from a multicenter cross-sectional study","volume":"76","author":"I E Deckers","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"ref805","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1097\/MIB.0000000000000429","article-title":"Chronological Order of Appearance of Extraintestinal Manifestations Relative to the Time of IBD Diagnosis in the Swiss Inflammatory Bowel Disease Cohort","volume":"21","author":"S R Vavricka","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"ref806","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1177\/000313481107701236","article-title":"A retrospective study of 12 cases of pyoderma gangrenosum: why we should avoid surgical intervention and what therapy to apply","volume":"77","author":"W Baranska-Rybak","year":"2011","journal-title":"Am Surg"},{"key":"ref807","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1001\/jama.2017.16691","article-title":"Hidradenitis Suppurativa: Advances in Diagnosis and Treatment","volume":"318","author":"D ML Saunte","year":"2017","journal-title":"Jama"},{"key":"ref808","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.crohns.2011.10.007","article-title":"Induction of psoriasis with anti-TNF agents in patients with inflammatory bowel disease: a report of 21 cases","volume":"6","author":"I Guerra","year":"2012","journal-title":"J Crohns Colitis"},{"key":"ref809","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1136\/ard.2007.087288","article-title":"Rates of new-onset psoriasis in patients with rheumatoid arthritis receiving anti-tumour necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register","volume":"68","author":"M J Harrison","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"ref810","first-page":"563","article-title":"Erythema nodosum: an evaluation of 100 cases","volume":"25","author":"A Mert","year":"2007","journal-title":"Clin Exp Rheumatol"},{"key":"ref811","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1002\/ibd.21643","article-title":"Frequency, phenotype, outcome, and therapeutic impact of skin reactions following initiation of adalimumab therapy: experience from a consecutive cohort of inflammatory bowel disease patients","volume":"17","author":"D C Baumgart","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"ref812","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1053\/j.gastro.2012.05.004","article-title":"Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease","volume":"143","author":"M D Long","year":"2012","journal-title":"Gastroenterology"},{"key":"ref813","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1093\/ecco-jcc\/jjv232","article-title":"Prevalence and Characteristics of Extra-intestinal Manifestations in a Large Cohort of Greek Patients with Inflammatory Bowel Disease","volume":"10","author":"K Karmiris","year":"2016","journal-title":"J Crohns Colitis"},{"key":"ref814","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1097\/MIB.0000000000001109","article-title":"Anti-TNF Treatment for Extraintestinal Manifestations of Inflammatory Bowel Disease in the Swiss IBD Cohort Study","volume":"23","author":"S R Vavricka","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"ref815","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cgh.2016.06.025","article-title":"Systematic Review of Tumor Necrosis Factor Antagonists in Extraintestinal Manifestations in Inflammatory Bowel Disease","volume":"15","author":"L Peyrin-Biroulet","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref816","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s40257-021-00592-w","article-title":"Erythema Nodosum: A Practical Approach and Diagnostic Algorithm","volume":"22","author":"D M P\u00e9rez-Garza","year":"2021","journal-title":"Am J Clin Dermatol"},{"key":"ref817","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s12016-017-8617-4","article-title":"Skin Manifestations of Inflammatory Bowel Disease","volume":"53","author":"T Greuter","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref818","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1001\/jamadermatol.2017.5980","article-title":"Diagnostic Criteria of Ulcerative Pyoderma Gangrenosum: A Delphi Consensus of International Experts","volume":"154","author":"E Maverakis","year":"2018","journal-title":"JAMA Dermatol"},{"key":"ref819","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1007\/s40265-023-01931-3","article-title":"Pyoderma Gangrenosum: Treatment Options","volume":"83","author":"J Dissemond","year":"2023","journal-title":"Drugs"},{"key":"ref820","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1136\/gut.2005.074815","article-title":"Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial","volume":"55","author":"T N Brooklyn","year":"2006","journal-title":"Gut"},{"key":"ref821","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1080\/09546634.2021.1937475","article-title":"Ustekinumab as adjuvant treatment for all pyoderma gangrenosum subtypes","volume":"33","author":"J S Westerdahl","year":"2022","journal-title":"J Dermatolog Treat"},{"key":"ref822","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1159\/000519320","article-title":"Pyoderma Gangrenosum and Interleukin Inhibitors: A Semi-Systematic Review","volume":"238","author":"Abdallah H Ben","year":"2022","journal-title":"Dermatology"},{"key":"ref823","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/1346-8138.17031","article-title":"New treatment of pyoderma gangrenosum and hidradenitis suppurativa: A review","volume":"51","author":"K Yamanaka","year":"2024","journal-title":"The Journal of Dermatology"},{"key":"ref824","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1111\/ced.14683","article-title":"Tofacitinib for the treatment of refractory pyoderma gangrenosum","volume":"46","author":"V E Orfaly","year":"2021","journal-title":"Clin Exp Dermatol"},{"key":"ref825","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1111\/ijd.16676","article-title":"JAK inhibitors: a novel, safe, and efficacious therapy for pyoderma gangrenosum","volume":"62","author":"L GM Castro","year":"2023","journal-title":"Int J Dermatol"},{"key":"ref826","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1001\/jamadermatol.2015.3903","article-title":"Safety and Efficacy of Anakinra in Severe Hidradenitis Suppurativa: A Randomized Clinical Trial","volume":"152","author":"V Tzanetakou","year":"2016","journal-title":"JAMA Dermatol"},{"key":"ref827","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/bjd.14338","article-title":"Ustekinumab in hidradenitis suppurativa: clinical results and a search for potential biomarkers in serum","volume":"174","author":"J L Blok","year":"2016","journal-title":"Br J Dermatol"},{"key":"ref828","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","article-title":"Psoriasis","volume":"386","author":"W-H Boehncke","year":"2015","journal-title":"The Lancet"},{"key":"ref829","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1111\/jdv.13354","article-title":"European S3-Guidelines on the systemic treatment of psoriasis vulgaris--Update 2015--Short version--EDF in cooperation with EADV and IPC","volume":"29","author":"A Nast","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref830","doi-asserted-by":"crossref","first-page":"83","DOI":"10.14740\/gr990w","article-title":"Hepatobiliary Manifestations and Complications in Inflammatory Bowel Disease: A Review","volume":"11","author":"F S Fousekis","year":"2018","journal-title":"Gastroenterology Res"},{"key":"ref831","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izaa189","article-title":"Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis","author":"A Lin","year":"2020","journal-title":"Inflamm Bowel Dis"},{"key":"ref832","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/apt.12794","article-title":"Systematic review: The epidemiology of the hepatobiliary manifestations in patients with inflammatory bowel disease","volume":"40","author":"E Gizard","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"issue":"S 01","key":"ref834","first-page":"11","article-title":"Ophthalmological aspects of IBD","volume":"13","author":"C Manganelli","year":"2009","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref835","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1002\/ibd.21180","article-title":"Ocular manifestations in a community-based cohort of patients with inflammatory bowel disease","volume":"16","author":"D B Cury","year":"2009","journal-title":"Inflammatory Bowel Diseases"},{"key":"ref836","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1097\/MEG.0000000000001248","article-title":"High frequency of secondary, but not primary ocular manifestations of inflammatory bowel disease in patients treated at a tertiary care center","volume":"30","author":"J Walldorf","year":"2018","journal-title":"European Journal of Gastroenterology & Hepatology"},{"key":"ref837","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.3748\/wjg.v23.i32.5836","article-title":"Ophthalmic manifestations in patients with inflammatory bowel disease: A review","volume":"23","author":"L L Troncoso","year":"2017","journal-title":"World J Gastroenterol"},{"key":"ref838","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1002\/ibd.20285","article-title":"Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases","volume":"13","author":"C Gasche","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"ref839","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1097\/01.MIB.0000442728.74340.fd","article-title":"Prevalence of anemia in inflammatory bowel diseases in european countries: a systematic review and individual patient data meta-analysis","volume":"20","author":"N Filmann","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"ref840","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.3109\/00365521.2013.838605","article-title":"High burden of iron deficiency and different types of anemia in inflammatory bowel disease outpatients in Scandinavia: a longitudinal 2-year follow-up study","volume":"48","author":"P Bager","year":"2013","journal-title":"Scand J Gastroenterol"},{"key":"ref841","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.crohns.2010.07.008","article-title":"Prevalence of anaemia in inflammatory bowel disease in Switzerland: a cross-sectional study in patients from private practices and university hospitals","volume":"4","author":"M Voegtlin","year":"2010","journal-title":"J Crohns Colitis"},{"key":"ref842","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s11938-018-0174-2","article-title":"Management of Anemia in Patients with Inflammatory Bowel Disease (IBD)","volume":"16","author":"D Patel","year":"2018","journal-title":"Curr Treat Options Gastroenterol"},{"key":"ref843","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/17474124.2017.1263566","article-title":"Current evaluation and management of anemia in patients with inflammatory bowel disease","volume":"11","author":"J Martin","year":"2017","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"ref844","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2024.01.176","article-title":"Follow-up evaluation and management of anemia in inflammatory bowel disease: A study by the Italian Group for Inflammatory Bowel Diseases (IG-IBD)","author":"G Bergamaschi","year":"2024","journal-title":"Dig Liver Dis"},{"key":"ref845","doi-asserted-by":"crossref","first-page":"5637","DOI":"10.1007\/s10620-022-07474-z","article-title":"Iron Deficiency in Patients with Inflammatory Bowel Diseases: A Prospective Multicenter Cross-Sectional Study","volume":"67","author":"L Peyrin-Biroulet","year":"2022","journal-title":"Dig Dis Sci"},{"key":"ref846","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/ecco-jcc\/jju009","article-title":"European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases","volume":"9","author":"A U Dignass","year":"2015","journal-title":"J Crohns Colitis"},{"key":"ref847","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/bjh.17900","article-title":"Guideline for the laboratory diagnosis of iron deficiency in adults (excluding pregnancy) and children","volume":"196","author":"A Fletcher","year":"2022","journal-title":"Br J Haematol"},{"key":"ref848","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1093\/ibd\/izad010","article-title":"Hepcidin and Iron Status in Patients With Inflammatory Bowel Disease Undergoing Induction Therapy With Vedolizumab or Infliximab","volume":"29","author":"R Loveikyte","year":"2023","journal-title":"Inflamm Bowel Dis"},{"key":"ref849","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1080\/14656566.2017.1391790","article-title":"Management of inflammatory bowel disease-related anemia and iron deficiency with specific reference to the role of intravenous iron in current practice","volume":"18","author":"J Stein","year":"2017","journal-title":"Expert Opin Pharmacother"},{"key":"ref850","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nrgastro.2010.151","article-title":"Diagnosis and management of iron deficiency anemia in patients with IBD","volume":"7","author":"J Stein","year":"2010","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref851","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/01.MIB.0000199223.27595.e3","article-title":"Ferritin as a simple indicator of iron deficiency in anemic IBD patients","volume":"12","author":"D Guagnozzi","year":"2006","journal-title":"Inflamm Bowel Dis"},{"key":"ref852","doi-asserted-by":"crossref","first-page":"359s","DOI":"10.3945\/ajcn.116.141762","article-title":"Adjusting ferritin concentrations for inflammation: Biomarkers Reflecting Inflammation and Nutritional Determinants of Anemia (BRINDA) project","volume":"106","author":"S M Namaste","year":"2017","journal-title":"Am J Clin Nutr"},{"key":"ref853","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/bjh.16221","article-title":"UK guidelines on the management of iron deficiency in pregnancy","volume":"188","author":"S Pavord","year":"2020","journal-title":"Br J Haematol"},{"issue":"S 01","key":"ref854","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.2215\/CJN.01490506","article-title":"Assessing iron status: beyond serum ferritin and transferrin saturation","volume":"1","author":"J B Wish","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref855","first-page":"9394060","article-title":"Limitations of Serum Ferritin in Diagnosing Iron Deficiency in Inflammatory Conditions","volume":"2018","author":"A Dignass","year":"2018","journal-title":"Int J Chronic Dis"},{"key":"ref856","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/j.1572-0241.2005.41219.x","article-title":"Infliximab for the treatment of chronic anemia in Crohn\u2019s disease","volume":"100","author":"E Dom\u00e8nech","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"ref857","first-page":"Cd013529","article-title":"Interventions for treating iron deficiency anaemia in inflammatory bowel disease","volume":"1","author":"M Gordon","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"ref858","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1053\/j.gastro.2011.06.005","article-title":"FERGIcor, a randomized controlled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease","volume":"141","author":"R Evstatiev","year":"2011","journal-title":"Gastroenterology"},{"key":"ref859","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.immuni.2006.05.001","article-title":"Aging of the immune system: how much can the adaptive immune system adapt?","volume":"24","author":"N P Weng","year":"2006","journal-title":"Immunity"},{"key":"ref860","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1111\/j.1572-0241.2007.01744.x","article-title":"A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (FERINJECT) randomized controlled trial","volume":"103","author":"S Kulnigg","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"ref861","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1038\/ajg.2013.335","article-title":"A randomized, open-label, non-inferiority study of intravenous iron isomaltoside 1,000 (Monofer) compared with oral iron for treatment of anemia in IBD (PROCEED)","volume":"108","author":"W Reinisch","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"ref862","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1080\/00365520902839667","article-title":"Intravenous iron sucrose is superior to oral iron sulphate for correcting anaemia and restoring iron stores in IBD patients: A randomized, controlled, evaluator-blind, multicentre study","volume":"44","author":"S Lindgren","year":"2009","journal-title":"Scand J Gastroenterol"},{"key":"ref863","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1080\/00365520510023198","article-title":"Oral ferrous fumarate or intravenous iron sucrose for patients with inflammatory bowel disease","volume":"40","author":"K Erichsen","year":"2005","journal-title":"Scand J Gastroenterol"},{"key":"ref864","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1111\/j.1572-0241.2005.00250.x","article-title":"Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease--a randomized, controlled, open-label, multicenter study","volume":"100","author":"O Schr\u00f6der","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"ref865","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/01.MIB.0000196646.64615.db","article-title":"Effects of changes in hemoglobin level on quality of life and cognitive function in inflammatory bowel disease patients","volume":"12","author":"C W Wells","year":"2006","journal-title":"Inflamm Bowel Dis"},{"key":"ref866","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11102786","article-title":"Ferric Carboxymaltose Improves the Quality of Life of Patients with Inflammatory Bowel Disease and Iron Deficiency without Anaemia","volume":"11","author":"J M Huguet","year":"2022","journal-title":"J Clin Med"},{"key":"ref867","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1080\/00365520310008818-1","article-title":"Treatment of anaemia in inflammatory bowel disease with iron sucrose","volume":"39","author":"G Bodemar","year":"2004","journal-title":"Scand J Gastroenterol"},{"key":"ref868","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/00042737-200604000-00017","article-title":"Effectiveness of darbepoetin-alfa in combination with intravenous iron sucrose in patients with inflammatory bowel disease and refractory anaemia: a pilot study","volume":"18","author":"I E Koutroubakis","year":"2006","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref869","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1097\/MPG.0000000000001684","article-title":"Intravenous Iron Sucrose for Treatment of Iron Deficiency Anemia in Pediatric Inflammatory Bowel Disease","volume":"66","author":"R E Stein","year":"2018","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref870","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.3109\/00365521.2013.819442","article-title":"Anemia and iron deficiency in inflammatory bowel disease: an open, prospective, observational study on diagnosis, treatment with ferric carboxymaltose and quality of life","volume":"48","author":"R Befrits","year":"2013","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"ref871","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1093\/bja\/aer242","article-title":"A multicentre comparative study on the efficacy of intravenous ferric carboxymaltose and iron sucrose for correcting preoperative anaemia in patients undergoing major elective surgery","volume":"107","author":"E Bisbe","year":"2011","journal-title":"Br J Anaesth"},{"key":"ref872","doi-asserted-by":"crossref","first-page":"e0128156","DOI":"10.1371\/journal.pone.0128156","article-title":"Safety of ferric carboxymaltose immediately after infliximab administration, in a single session, in inflammatory bowel disease patients with iron deficiency: a pilot study","volume":"10","author":"X Cortes","year":"2015","journal-title":"PLoS One"},{"key":"ref873","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.cgh.2012.10.013","article-title":"Ferric carboxymaltose prevents recurrence of anemia in patients with inflammatory bowel disease","volume":"11","author":"R Evstatiev","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref874","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1093\/ecco-jcc\/jjy042","article-title":"Safety and Efficacy of Ferric Carboxymaltose in the Treatment of Iron Deficiency Anaemia in Patients with Inflammatory Bowel Disease, in Routine Daily Practice","volume":"12","author":"J Stein","year":"2018","journal-title":"J Crohns Colitis"},{"key":"ref875","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1136\/gutjnl-2022-327897","article-title":"Hypophosphataemia following ferric derisomaltose and ferric carboxymaltose in patients with iron deficiency anaemia due to inflammatory bowel disease (PHOSPHARE-IBD): a randomised clinical trial","volume":"72","author":"H Zoller","year":"2023","journal-title":"Gut"},{"key":"ref876","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.3109\/00365521.2015.1031168","article-title":"A 1-year trial of repeated high-dose intravenous iron isomaltoside 1000 to maintain stable hemoglobin levels in inflammatory bowel disease","volume":"50","author":"W Reinisch","year":"2015","journal-title":"Scand J Gastroenterol"},{"key":"ref877","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1080\/00365521.2018.1498914","article-title":"Safety and efficacy of intravenous iron isomaltoside for correction of anaemia in patients with inflammatory bowel disease in everyday clinical practice","volume":"53","author":"J Stein","year":"2018","journal-title":"Scand J Gastroenterol"},{"key":"ref878","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1111\/apt.14043","article-title":"Systematic review with network meta-analysis: comparative efficacy and tolerability of different intravenous iron formulations for the treatment of iron deficiency anaemia in patients with inflammatory bowel disease","volume":"45","author":"A Aksan","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"ref879","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1097\/MIB.0000000000000386","article-title":"Iron Replacement in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-analysis","volume":"21","author":"A Abhyankar","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"ref880","doi-asserted-by":"crossref","first-page":"e2308","DOI":"10.1097\/MD.0000000000002308","article-title":"Intravenous Versus Oral Iron for the Treatment of Anemia in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","volume":"95","author":"S Bonovas","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"ref881","doi-asserted-by":"crossref","first-page":"e963","DOI":"10.1097\/MD.0000000000000963","article-title":"Management of Iron-Deficiency Anemia in Inflammatory Bowel Disease: A Systematic Review","volume":"94","author":"O H Nielsen","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"ref882","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.mayocp.2014.10.007","article-title":"The safety of intravenous iron preparations: systematic review and meta-analysis","volume":"90","author":"T Avni","year":"2015","journal-title":"Mayo Clin Proc"},{"key":"ref883","doi-asserted-by":"crossref","first-page":"e318","DOI":"10.1097\/MCG.0000000000001731","article-title":"Same Day Infusion of Iron Therapy Is Associated With No Increased Risk for Adverse Events Among Patients Receiving Biological Infusions for Inflammatory Bowel Disease","volume":"56","author":"S Reddy","year":"2022","journal-title":"J Clin Gastroenterol"},{"key":"ref884","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/apt.15386","article-title":"Incidence of hypophosphatemia in patients with inflammatory bowel disease treated with ferric carboxymaltose or iron isomaltoside","volume":"50","author":"T E Detlie","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"ref885","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.tmrv.2020.07.002","article-title":"Comparative Risk of Hypophosphatemia Following the Administration of Intravenous Iron Formulations: A Network Meta-Analysis","volume":"34","author":"I Bellos","year":"2020","journal-title":"Transfus Med Rev"},{"key":"ref886","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1111\/bcp.14643","article-title":"Hypophosphataemia after treatment of iron deficiency with intravenous ferric carboxymaltose or iron isomaltoside-a systematic review and meta-analysis","volume":"87","author":"B Schaefer","year":"2021","journal-title":"Br J Clin Pharmacol"},{"key":"ref887","doi-asserted-by":"publisher","DOI":"10.1055\/a-2274-1610","article-title":"Eisensupplementation bei Patient*in mit chronisch-entz\u00fcndlicher Darmerkrankung: Empfehlungen zur praxisnahen Vorgehensweise","author":"K Stratmann","year":"2024","journal-title":"Z Gastroenterol"},{"key":"ref888","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/MIB.0000000000000314","article-title":"Ferric maltol is effective in correcting iron deficiency anemia in patients with inflammatory bowel disease: results from a phase-3 clinical trial program","volume":"21","author":"C Gasche","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"ref889","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1016\/S0002-9270(01)02657-0","article-title":"Prediction of response to iron sucrose in inflammatory bowel disease-associated anemia","volume":"96","author":"C Gasche","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"ref890","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/bjh.12959","article-title":"Guidelines for the diagnosis and treatment of cobalamin and folate disorders","volume":"166","author":"V Devalia","year":"2014","journal-title":"Br J Haematol"},{"key":"ref891","first-page":"Cd002042","article-title":"Transfusion thresholds for guiding red blood cell transfusion","volume":"12","author":"J L Carson","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"ref892","doi-asserted-by":"crossref","first-page":"782","DOI":"10.7326\/0003-4819-126-10-199705150-00006","article-title":"Intravenous iron and erythropoietin for anemia associated with Crohn disease. A randomized, controlled trial","volume":"126","author":"C Gasch\u00e9","year":"1997","journal-title":"Ann Intern Med"},{"key":"ref893","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1056\/NEJM199603073341002","article-title":"Recombinant erythropoietin for the treatment of anemia in inflammatory bowel disease","volume":"334","author":"S Schreiber","year":"1996","journal-title":"N Engl J Med"},{"key":"ref894","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1159\/000007667","article-title":"Sequential treatment of anemia in ulcerative colitis with intravenous iron and erythropoietin","volume":"60","author":"C Gasche","year":"1999","journal-title":"Digestion"},{"key":"ref895","doi-asserted-by":"crossref","first-page":"4686","DOI":"10.3748\/wjg.15.4686","article-title":"Blood transfusion for the treatment of acute anaemia in inflammatory bowel disease and other digestive diseases","volume":"15","author":"J A Garc\u00eda-Erce","year":"2009","journal-title":"World J Gastroenterol"},{"key":"ref896","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0140-6736(14)61999-1","article-title":"Restrictive versus liberal blood transfusion for acute upper gastrointestinal bleeding (TRIGGER): a pragmatic, open-label, cluster randomised feasibility trial","volume":"386","author":"V Jairath","year":"2015","journal-title":"Lancet"},{"key":"ref897","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1055\/a-1496-8969","article-title":"Diagnosis and management of acute lower gastrointestinal bleeding: European Society of Gastrointestinal Endoscopy (ESGE) Guideline","volume":"53","author":"K Triantafyllou","year":"2021","journal-title":"Endoscopy"},{"key":"ref898","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.12998\/wjcc.v7.i15.1908","article-title":"Bone alterations in inflammatory bowel diseases","volume":"7","author":"D Sgambato","year":"2019","journal-title":"World journal of clinical cases"},{"key":"ref899","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1136\/gut.51.5.654","article-title":"High prevalence of osteoporotic vertebral fractures in patients with Crohn\u2019s disease","volume":"51","author":"J Klaus","year":"2002","journal-title":"Gut"},{"key":"ref900","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1471-230X-12-47","article-title":"Vertebral fractures in patients with inflammatory bowel disease compared with a healthy population: a prospective case-control study","volume":"12","author":"M A Vazquez","year":"2012","journal-title":"BMC Gastroenterol"},{"key":"ref901","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1186\/s40169-020-00270-0","article-title":"Bone mineral density is negatively correlated with ulcerative colitis: a systematic review and meta-analysis","volume":"9","author":"T Zhou","year":"2020","journal-title":"Clinical and Translational Medicine"},{"key":"ref902","doi-asserted-by":"crossref","first-page":"5362","DOI":"10.3748\/wjg.v26.i35.5362","article-title":"Systematic review of the prevalence and development of osteoporosis or low bone mineral density and its risk factors in patients with inflammatory bowel disease","volume":"26","author":"S K\u00e4rnsund","year":"2020","journal-title":"World J Gastroenterol"},{"key":"ref903","first-page":"e5810","article-title":"Inflammatory Bowel Disease and Risk of Osteoporotic Fractures: A Meta-Analysis","volume":"11","author":"D F Hidalgo","year":"2019","journal-title":"Cureus"},{"key":"ref904","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0000000000001031","article-title":"Risk of Fractures in Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis","volume":"53","author":"Y Komaki","year":"2019","journal-title":"Journal of Clinical Gastroenterology"},{"key":"ref905","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1007\/s00198-018-4586-6","article-title":"Risk of fracture and low bone mineral density in adults with inflammatory bowel diseases. A systematic literature review with meta-analysis","volume":"29","author":"P Szafors","year":"2018","journal-title":"Osteoporosis International"},{"key":"ref906","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jocd.2016.08.010","article-title":"The Use of the Fracture Risk Assessment (FRAX\u00ae) Tool in Predicting Risk of Fractures in Patients With Inflammatory Bowel Disease: A Systematic Review","volume":"20","author":"B Serrano-Montalb\u00e1n","year":"2017","journal-title":"Journal of Clinical Densitometry"},{"key":"ref907","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1053\/j.gastro.2005.06.064","article-title":"A randomized, placebo-controlled trial of certolizumab pegol (CDP870) for treatment of Crohn\u2019s disease","volume":"129","author":"S Schreiber","year":"2005","journal-title":"Gastroenterology"},{"key":"ref908","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.cgh.2020.06.071","article-title":"No Benefit of Concomitant Immunomodulator Therapy on Efficacy of Biologics That Are Not Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Diseases: A Meta-analysis","volume":"19","author":"C Yzet","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref909","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1080\/00365520500217118","article-title":"Clinically active Crohn\u2019s disease in the presence of a low C-reactive protein","volume":"41","author":"T H Florin","year":"2006","journal-title":"Scand J Gastroenterol"},{"key":"ref910","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/S0140-6736(14)61908-5","article-title":"Crohn\u2019s disease management after intestinal resection: a randomised trial","volume":"385","author":"P De Cruz","year":"2015","journal-title":"Lancet"},{"key":"ref911","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1002\/ibd.20927","article-title":"Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohn\u2019s disease","volume":"15","author":"F Schnitzler","year":"2009","journal-title":"Inflamm Bowel Dis"},{"key":"ref912","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1093\/ecco-jcc\/jjaa019","article-title":"Incidence, Risk Factors and Evaluation of Osteoporosis in Patients With Inflammatory Bowel Disease: A Danish Population-Based Inception Cohort With 10 Years of Follow-Up","volume":"14","author":"B Lo","year":"2020","journal-title":"J Crohns Colitis"},{"key":"ref913","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.crohns.2013.10.010","article-title":"Delphi consensus statement: Quality Indicators for Inflammatory Bowel Disease Comprehensive Care Units","volume":"8","author":"X Calvet","year":"2014","journal-title":"J Crohns Colitis"},{"key":"ref914","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1093\/ecco-jcc\/jjx085","article-title":"The 5C Concept and 5S Principles in Inflammatory Bowel Disease Management","volume":"11","author":"T Hibi","year":"2017","journal-title":"J Crohns Colitis"},{"key":"ref917","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1055\/s-0038-1673537","article-title":"DVO Leitlinie 2017 zur Prophylaxe, Diagnostik und Therapie der Osteo- porose bei postmenopausalen Frauen und Ma\u0308nnern","volume":"27","author":"F Thomasius","year":"2018","journal-title":"Osteologie"},{"key":"ref918","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1002\/ibd.21297","article-title":"Risk factors for metabolic bone disease in Crohn\u2019s disease patients","volume":"16","author":"M Cravo","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"ref920","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1007\/s00393-011-0803-9","article-title":"Knochendichtemessungen beim wachsenden Skelett und die klinischen Konsequenzen","volume":"70","author":"S Bechtold-Dalla Pozza","year":"2011","journal-title":"Z Rheumatol"},{"key":"ref922","doi-asserted-by":"crossref","first-page":"547","DOI":"10.3390\/jcm9020547","article-title":"Measuring Vitamin D Status in Chronic Inflammatory Disorders: How does Chronic Inflammation Affect the Reliability of Vitamin D Metabolites in Patients with IBD?","volume":"9","author":"A Aksan","year":"2020","journal-title":"Journal of Clinical Medicine"},{"key":"ref923","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1007\/s10620-010-1544-3","article-title":"Vitamin D deficiency in children with inflammatory bowel disease","volume":"56","author":"A D Levin","year":"2011","journal-title":"Dig Dis Sci"},{"key":"ref924","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1093\/ajcn\/76.5.1077","article-title":"Vitamin D status in children, adolescents, and young adults with Crohn disease","volume":"76","author":"T A Sentongo","year":"2002","journal-title":"Am J Clin Nutr"},{"key":"ref925","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1155\/2003\/391308","article-title":"The frequency of vitamin D deficiency in adults with Crohn\u2019s disease","volume":"17","author":"J S Siffledeen","year":"2003","journal-title":"Can J Gastroenterol"},{"key":"ref926","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/apt.12553","article-title":"Review article: vitamin D and inflammatory bowel diseases","volume":"39","author":"V P Mouli","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"ref927","doi-asserted-by":"crossref","first-page":"327","DOI":"10.17219\/acem\/168684","article-title":"A meta-analysis of the risk of osteoporotic fractures in inflammatory bowel disease","volume":"33","author":"L Hao","year":"2024","journal-title":"Adv Clin Exp Med"},{"key":"ref928","doi-asserted-by":"crossref","first-page":"116958","DOI":"10.1016\/j.bone.2023.116958","article-title":"Risk of fracture in women with glucocorticoid requiring diseases is independent from glucocorticoid use: An analysis on a nation-wide database","volume":"179","author":"G Adami","year":"2024","journal-title":"Bone"},{"key":"ref929","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0016-5085(98)70362-2","article-title":"Effect of a low-impact exercise program on bone mineral density in Crohn\u2019s disease: a randomized controlled trial","volume":"115","author":"R J Robinson","year":"1998","journal-title":"Gastroenterology"},{"key":"ref930","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1056\/NEJMp1608005","article-title":"Vitamin D Deficiency \u2013 Is There Really a Pandemic?","volume":"375","author":"J E Manson","year":"2016","journal-title":"New England Journal of Medicine"},{"key":"ref931","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1210\/jc.2011-0385","article-title":"Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline","volume":"96","author":"M F Holick","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"ref932","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1210\/jc.2010-2704","article-title":"The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know","volume":"96","author":"A C Ross","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"ref933","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.crohns.2012.01.004","article-title":"Risedronate improves bone mineral density in Crohn\u2019s disease: a two year randomized controlled clinical trial","volume":"6","author":"I Soo","year":"2012","journal-title":"J Crohns Colitis"},{"key":"ref934","doi-asserted-by":"crossref","first-page":"693927","DOI":"10.3389\/fmed.2021.693927","article-title":"Risk Factors of Venous Thromboembolism in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis","volume":"8","author":"H Zhang","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"ref935","first-page":"680","article-title":"The risk of venous thromboembolic events in patients with inflammatory bowel disease: a systematic review and meta-analysis","volume":"34","author":"K D Arvanitakis","year":"2021","journal-title":"Ann Gastroenterol"},{"key":"ref936","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/s41424-018-0013-8","article-title":"Risk of thrombosis and mortality in inflammatory bowel disease","volume":"9","author":"A R Andrade","year":"2018","journal-title":"Clin Transl Gastroenterol"},{"key":"ref937","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1055\/s-0040-1710506","article-title":"Inflammatory Bowel Disease and Thrombosis: A National Inpatient Sample Study","volume":"4","author":"J B Cohen","year":"2020","journal-title":"TH Open"},{"key":"ref938","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1111\/apt.15286","article-title":"A clinical predictive model for post-hospitalisation venous thromboembolism in patients with inflammatory bowel disease","volume":"49","author":"J D McCurdy","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"ref939","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1093\/ibd\/izz269","article-title":"Minor Hematochezia Decreases Use of Venous Thromboembolism Prophylaxis in Patients with Inflammatory Bowel Disease","volume":"26","author":"A S Faye","year":"2019","journal-title":"Inflammatory Bowel Diseases"},{"key":"ref940","doi-asserted-by":"crossref","first-page":"e479","DOI":"10.1016\/j.crohns.2013.03.002","article-title":"Predictors and safety of venous thromboembolism prophylaxis among hospitalized inflammatory bowel disease patients","volume":"7","author":"G Ra","year":"2013","journal-title":"Journal of Crohn\u2019s and Colitis"},{"key":"ref941","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1007\/s10620-019-05650-2","article-title":"Increased Transfusion Requirements with Pharmacologic Thromboembolism Prophylaxis During Inflammatory Bowel Disease Exacerbation","volume":"64","author":"K Sultan","year":"2019","journal-title":"Digestive Diseases and Sciences"},{"key":"ref942","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1001\/jamainternmed.2013.122","article-title":"Use of glucocorticoids and risk of venous thromboembolism: a nationwide population-based case-control study","volume":"173","author":"S A Johannesdottir","year":"2013","journal-title":"JAMA Intern Med"},{"key":"ref943","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1007\/s11938-020-00304-z","article-title":"Inflammatory Bowel Disease Therapy and Venous Thromboembolism","volume":"18","author":"T Lambin","year":"2020","journal-title":"Current Treatment Options in Gastroenterology"},{"key":"ref945","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/MEG.0000000000001084","article-title":"Anticoagulant therapy for venous thromboembolism in patients with inflammatory bowel disease","volume":"30","author":"J L Lobo","year":"2018","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref946","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1053\/j.gastro.2019.04.016","article-title":"Environmental Risk Factors for Inflammatory Bowel Diseases: An Umbrella Review of Meta-analyses","volume":"157","author":"D Piovani","year":"2019","journal-title":"Gastroenterology"},{"key":"ref947","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/apt.16703","article-title":"Systematic review with meta-analysis: environmental and dietary differences of inflammatory bowel disease in Eastern and Western populations","volume":"55","author":"M Zhao","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"ref948","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.jpeds.2009.03.017","article-title":"Systematic review: the role of breastfeeding in the development of pediatric inflammatory bowel disease","volume":"155","author":"A R Barclay","year":"2009","journal-title":"J Pediatr"},{"key":"ref949","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1093\/ajcn\/82.2.486","article-title":"Breastfeeding and risk of inflammatory bowel disease","volume":"82","author":"E Klement","year":"2005","journal-title":"Am J Clin Nutr"},{"key":"ref950","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1093\/advances\/nmaa145","article-title":"Association of Dietary Fiber, Fruit, and Vegetable Consumption with Risk of Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis","volume":"12","author":"A Milajerdi","year":"2021","journal-title":"Adv Nutr"},{"key":"ref951","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1053\/j.gastro.2016.10.020","article-title":"Understanding and Preventing the Global Increase of Inflammatory Bowel Disease","volume":"152","author":"G G Kaplan","year":"2017","journal-title":"Gastroenterology"},{"key":"ref952","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1053\/j.gastro.2011.10.001","article-title":"Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review","volume":"142","author":"N A Molodecky","year":"2012","journal-title":"Gastroenterology"},{"key":"ref953","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1136\/gutjnl-2013-305304","article-title":"Long-term intake of dietary fat and risk of ulcerative colitis and Crohn\u2019s disease","volume":"63","author":"A N Ananthakrishnan","year":"2014","journal-title":"Gut"},{"key":"ref954","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/MEG.0000000000000330","article-title":"Consumption of vegetables and fruit and the risk of inflammatory bowel disease: a meta-analysis","volume":"27","author":"F Li","year":"2015","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref956","doi-asserted-by":"crossref","first-page":"492","DOI":"10.5152\/tjg.2015.0106","article-title":"Meat intake and risk of inflammatory bowel disease: A meta-analysis","volume":"26","author":"J Ge","year":"2015","journal-title":"Turk J Gastroenterol"},{"key":"ref957","doi-asserted-by":"crossref","first-page":"e9070","DOI":"10.1097\/MD.0000000000009070","article-title":"Beverage consumption and risk of ulcerative colitis: Systematic review and meta-analysis of epidemiological studies","volume":"96","author":"J Y Nie","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"ref958","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.clnu.2016.10.009","article-title":"Carbohydrate and protein intake and risk of ulcerative colitis: Systematic review and dose-response meta-analysis of epidemiological studies","volume":"36","author":"F Wang","year":"2017","journal-title":"Clin Nutr"},{"key":"ref959","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1093\/jn\/nxac093","article-title":"Therapeutic Potential of the 4 Strategies to SUlfide-REduction (4-SURE) Diet in Adults with Mild to Moderately Active Ulcerative Colitis: An Open-Label Feasibility Study","volume":"152","author":"A S Day","year":"2022","journal-title":"J Nutr"},{"key":"ref960","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izaf177","article-title":"Functional Profiling Demonstrates That a Sulfide-Reducing Diet Achieves Microenvironmental Targets in Ulcerative Colitis","author":"A S Day","year":"2025","journal-title":"Inflamm Bowel Dis"},{"key":"ref961","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1093\/ecco-jcc\/jjac054","article-title":"Meat Intake Is Associated with a Higher Risk of Ulcerative Colitis in a Large European Prospective Cohort Study\u00f8","volume":"16","author":"C Dong","year":"2022","journal-title":"J Crohns Colitis"},{"key":"ref962","doi-asserted-by":"publisher","DOI":"10.3390\/nu15194194","article-title":"Dietary Interventions in Ulcerative Colitis: A Systematic Review of the Evidence with Meta-Analysis","volume":"15","author":"M Herrador-L\u00f3pez","year":"2023","journal-title":"Nutrients"},{"key":"ref963","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1093\/ecco-jcc\/jjac167","article-title":"Intake of Ultra-processed Foods Is Associated with an Increased Risk of Crohn\u2019s Disease: A Cross-sectional and Prospective Analysis of 187 154 Participants in the UK Biobank","volume":"17","author":"J Chen","year":"2023","journal-title":"J Crohns Colitis"},{"key":"ref964","doi-asserted-by":"crossref","first-page":"i540","DOI":"10.1093\/ecco-jcc\/jjae190.0323","article-title":"P0149 Deep functional analysis of a defined sulphide-reducing diet (4-SURE diet) as a novel therapy for ulcerative colitis (UC) demonstrates all specific luminal micro environmental objectives were achieved","volume":"19","author":"A Day","year":"2025","journal-title":"Journal of Crohn\u2019s and Colitis"},{"key":"ref965","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.clnesp.2022.09.019","article-title":"Feasibility and impact of a quality improvement initiative to screen for malnutrition in an Inflammatory Bowel Disease clinic","volume":"52","author":"S L Gold","year":"2022","journal-title":"Clin Nutr ESPEN"},{"key":"ref966","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S2468-1253(23)00011-0","article-title":"Inflammation and malnutrition in inflammatory bowel disease","volume":"8","author":"S Massironi","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref967","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.clnu.2023.03.021","article-title":"Practical guideline on obesity care in patients with gastrointestinal and liver diseases \u2013 Joint ESPEN\/UEG guideline","volume":"42","author":"S C Bischoff","year":"2023","journal-title":"Clin Nutr"},{"key":"ref968","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.clnu.2023.05.002","article-title":"Systematic review of sarcopenia in inflammatory bowel disease","volume":"42","author":"H Fatani","year":"2023","journal-title":"Clin Nutr"},{"key":"ref969","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/ibd\/izac102","article-title":"High Prevalence of Malnutrition and Micronutrient Deficiencies in Patients With Inflammatory Bowel Disease Early in Disease Course","volume":"29","author":"S L Gold","year":"2023","journal-title":"Inflamm Bowel Dis"},{"key":"ref970","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.clnu.2022.12.004","article-title":"ESPEN guideline on Clinical Nutrition in inflammatory bowel disease","volume":"42","author":"S C Bischoff","year":"2023","journal-title":"Clin Nutr"},{"key":"ref971","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1097\/MIB.0000000000000546","article-title":"Association Between Inflammatory Bowel Disease and Vitamin D Deficiency: A Systematic Review and Meta-analysis","volume":"21","author":"R Del Pinto","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"ref972","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1097\/MCG.0000000000000911","article-title":"Fat-soluble Vitamin Deficiencies and Inflammatory Bowel Disease: Systematic Review and Meta-Analysis","volume":"51","author":"N Fabisiak","year":"2017","journal-title":"J Clin Gastroenterol"},{"key":"ref973","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1186\/s12967-019-2070-5","article-title":"Vitamin D deficiency associated with Crohn\u2019s disease and ulcerative colitis: a meta-analysis of 55 observational studies","volume":"17","author":"X X Li","year":"2019","journal-title":"J Transl Med"},{"key":"ref974","doi-asserted-by":"publisher","DOI":"10.3390\/nu9040382","article-title":"Associations between Folate and Vitamin B12 Levels and Inflammatory Bowel Disease: A Meta-Analysis","volume":"9","author":"Y Pan","year":"2017","journal-title":"Nutrients"},{"key":"ref975","doi-asserted-by":"publisher","DOI":"10.3390\/nu14194052","article-title":"Prevalence of Zinc Deficiency in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis","volume":"14","author":"R Zupo","year":"2022","journal-title":"Nutrients"},{"key":"ref976","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.clnu.2013.03.020","article-title":"Nutritional deficiencies in inflammatory bowel disease: therapeutic approaches","volume":"32","author":"S Massironi","year":"2013","journal-title":"Clin Nutr"},{"key":"ref977","doi-asserted-by":"publisher","DOI":"10.5009\/gnl16333","article-title":"Risk Factors for Vitamin D, Zinc, and Selenium Deficiencies in Korean Patients with Inflammatory Bowel Disease","author":"Y M Han","year":"2017","journal-title":"Gut Liver"},{"key":"ref978","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1007\/BF02052601","article-title":"Follow-up results of hematology data before and after restorative proctocolectomy. Clinical outcome","volume":"37","author":"A E M\u2019Koma","year":"1994","journal-title":"Dis Colon Rectum"},{"key":"ref979","doi-asserted-by":"publisher","DOI":"10.3390\/nu14194052","article-title":"Prevalence of Zinc Deficiency in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis","volume":"14","author":"R Zupo","year":"2022","journal-title":"Nutrients"},{"key":"ref980","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10350-006-0752-6","article-title":"Risk factors for anemia in patients with ileal pouch-anal anastomosis","volume":"50","author":"I K Oikonomou","year":"2007","journal-title":"Dis Colon Rectum"},{"key":"ref981","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/01.mcg.0000212641.90477.d0","article-title":"Iron-deficiency anemia as presentation of pouchitis","volume":"41","author":"R J Pastrana","year":"2007","journal-title":"J Clin Gastroenterol"},{"key":"ref982","first-page":"3110","article-title":"Long term metabolic consequences of ileal pouch-anal anastomosis for ulcerative colitis","volume":"96","author":"J Kuisma","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"ref983","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0016-5085(79)80211-5","article-title":"Zinc in total parenteral nutrition: requirements and metabolic effects","volume":"76","author":"S L Wolman","year":"1979","journal-title":"Gastroenterology"},{"key":"ref984","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1053\/j.gastro.2009.08.014","article-title":"Zinc: an essential trace element for parenteral nutrition","volume":"137","author":"K Jeejeebhoy","year":"2009","journal-title":"Gastroenterology"},{"key":"ref985","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1093\/ajcn\/45.6.1480","article-title":"Bioavailability of zinc from zinc-histidine complexes. I. Comparison with zinc sulfate in healthy men","volume":"45","author":"J Sch\u00f6lmerich","year":"1987","journal-title":"Am J Clin Nutr"},{"key":"ref986","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1097\/MEG.0000000000000728","article-title":"The role of dietary supplements in inflammatory bowel disease: a systematic review","volume":"28","author":"R E Rossi","year":"2016","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref987","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1177\/0884533613506596","article-title":"Trace elements in parenteral nutrition: a practical guide for dosage and monitoring for adult patients","volume":"28","author":"T A Fessler","year":"2013","journal-title":"Nutr Clin Pract"},{"key":"ref988","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1016\/j.cgh.2022.11.026","article-title":"Dietary Interventions for the Treatment of Inflammatory Bowel Diseases: An Updated Systematic Review and Meta-analysis","volume":"21","author":"B N Limketkai","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref989","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1016\/j.cgh.2022.11.026","article-title":"Dietary Interventions for the Treatment of Inflammatory Bowel Diseases: An Updated Systematic Review and Meta-analysis","volume":"21","author":"B N Limketkai","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref990","first-page":"Cd008879","article-title":"Preoperative nutrition therapy in people undergoing gastrointestinal surgery","volume":"4","author":"A M Sowerbutts","year":"2024","journal-title":"Cochrane Database Syst Rev"},{"key":"ref991","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjae089","article-title":"ECCO Guidelines on Therapeutics in Crohn\u2019s Disease: Surgical Treatment","author":"M Adamina","year":"2024","journal-title":"J Crohns Colitis"},{"key":"ref992","doi-asserted-by":"crossref","first-page":"4745","DOI":"10.1016\/j.clnu.2021.03.031","article-title":"ESPEN practical guideline: Clinical nutrition in surgery","volume":"40","author":"A Weimann","year":"2021","journal-title":"Clin Nutr"},{"key":"ref993","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1007\/DCR.0b013e31819ed571","article-title":"Prevalence and outcome of anemia after restorative proctocolectomy: a clinical literature review","volume":"52","author":"A E M\u2019Koma","year":"2009","journal-title":"Dis Colon Rectum"},{"key":"ref994","doi-asserted-by":"crossref","first-page":"7908","DOI":"10.3748\/wjg.v22.i35.7908","article-title":"Anemia and iron deficiency in gastrointestinal and liver conditions","volume":"22","author":"J Stein","year":"2016","journal-title":"World J Gastroenterol"},{"key":"ref995","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s00384-005-0076-3","article-title":"Serum biochemical evaluation of patients with functional pouches ten to 20 years after restorative proctocolectomy","volume":"21","author":"A E M\u2019Koma","year":"2006","journal-title":"Int J Colorectal Dis"},{"key":"ref996","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.crohns.2012.08.006","article-title":"Low levels of vitamin D are common in patients with ileal pouches irrespective of pouch inflammation","volume":"7","author":"R Khanna","year":"2013","journal-title":"J Crohns Colitis"},{"key":"ref997","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1093\/ibd\/izac135","article-title":"Efficacy of Fecal Microbiota Transplantation in the Treatment of Active Ulcerative Colitis: A Systematic Review and Meta-Analysis of Double-Blind Randomized Controlled Trials","volume":"29","author":"N El Hage Chehade","year":"2023","journal-title":"Inflamm Bowel Dis"},{"key":"ref998","doi-asserted-by":"crossref","first-page":"14494","DOI":"10.1038\/s41598-023-41182-6","article-title":"Efficacy and safety of fecal microbiota transplantation in the treatment of ulcerative colitis: a systematic review and meta-analysis","volume":"13","author":"J Feng","year":"2023","journal-title":"Sci Rep"},{"key":"ref999","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/ecco-jcc\/jjab165","article-title":"Use of Faecal Transplantation with a Novel Diet for Mild to Moderate Active Ulcerative Colitis: The CRAFT UC Randomised Controlled Trial","volume":"16","author":"C Sarbagili Shabat","year":"2022","journal-title":"J Crohns Colitis"},{"key":"ref1001","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0399-8320(06)73072-X","article-title":"Complementary and alternative medicine use by patients with inflammatory bowel disease: results from a postal survey","volume":"30","author":"M Bensoussan","year":"2006","journal-title":"Gastroenterol Clin Biol"},{"key":"ref1002","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/j.1572-0241.2004.30033.x","article-title":"Predictors of alternative and complementary medicine use in inflammatory bowel disease: do measures of conventional health care utilization relate to use?","volume":"99","author":"T Burgmann","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"ref1003","first-page":"327","article-title":"Complementary and alternative medicine use by patients with inflammatory bowel disease: An Internet survey","volume":"13","author":"R J Hilsden","year":"1999","journal-title":"Can J Gastroenterol"},{"key":"ref1004","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/ibd.21360","article-title":"Use of complementary and alternative medicine by patients with inflammatory bowel disease","volume":"17","author":"R J Hilsden","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"ref1005","first-page":"138","article-title":"The Incidence of self-prescribed oral complementary and alternative medicine use by patients with gastrointestinal diseases","volume":"39","author":"S C Kong","year":"2005","journal-title":"J Clin Gastroenterol"},{"key":"ref1006","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/01.MIB.0000160771.71328.6c","article-title":"Amount of systemic steroid medication is a strong predictor for the use of complementary and alternative medicine in patients with inflammatory bowel disease: results from a German national survey","volume":"11","author":"J Langhorst","year":"2005","journal-title":"Inflamm Bowel Dis"},{"key":"ref1007","doi-asserted-by":"crossref","first-page":"111232","DOI":"10.1016\/j.jpsychores.2023.111232","article-title":"The effectiveness of mindfulness-based interventions in inflammatory bowel disease: A Systematic Review & Meta-Analysis","volume":"169","author":"C Naude","year":"2023","journal-title":"J Psychosom Res"},{"key":"ref1008","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jpsychores.2018.11.010","article-title":"A systematic review and meta-analysis of mindfulness based interventions and yoga in inflammatory bowel disease","volume":"116","author":"T Ewais","year":"2019","journal-title":"J Psychosom Res"},{"key":"ref1009","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1159\/000086318","article-title":"Effects of mind-body therapy on quality of life and neuroendocrine and cellular immune functions in patients with ulcerative colitis","volume":"74","author":"S Elsenbruch","year":"2005","journal-title":"Psychother Psychosom"},{"key":"ref1010","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1080\/00365520601101682","article-title":"Effects of a comprehensive lifestyle modification program on quality-of-life in patients with ulcerative colitis: a twelve-month follow-up","volume":"42","author":"J Langhorst","year":"2007","journal-title":"Scand J Gastroenterol"},{"key":"ref1011","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1093\/ibd\/izac036","article-title":"Mindfulness Intervention Decreases Frequency and Severity of Flares in Inactive Ulcerative Colitis Patients: Results of a Phase II, Randomized, Placebo-Controlled Trial","volume":"28","author":"S Jedel","year":"2022","journal-title":"Inflamm Bowel Dis"},{"key":"ref1012","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9103087","article-title":"Comprehensive Lifestyle-Modification in Patients with Ulcerative Colitis-A Randomized Controlled Trial","volume":"9","author":"J Langhorst","year":"2020","journal-title":"J Clin Med"},{"key":"ref1013","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0304-3959(87)90043-1","article-title":"Relaxation training as a treatment for chronic pain caused by ulcerative colitis","volume":"29","author":"L Shaw","year":"1987","journal-title":"Pain"},{"key":"ref1014","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s00384-023-04437-2","article-title":"A systematic review of the effect of structured exercise on inflammation and body composition in inflammatory bowel disease","volume":"38","author":"N Mc Gettigan","year":"2023","journal-title":"Int J Colorectal Dis"},{"key":"ref1015","doi-asserted-by":"crossref","first-page":"e0278480","DOI":"10.1371\/journal.pone.0278480","article-title":"Effects of structured exercise programmes on physiological and psychological outcomes in adults with inflammatory bowel disease (IBD): A systematic review and meta-analysis","volume":"17","author":"K Jones","year":"2022","journal-title":"PLoS One"},{"key":"ref1016","doi-asserted-by":"crossref","first-page":"101","DOI":"10.17761\/1531-2054-25.1.101","article-title":"Effect of Yoga-Based Intervention in Patients with Inflammatory Bowel Disease","volume":"25","author":"P Sharma","year":"2015","journal-title":"Int J Yoga Therap"},{"key":"ref1017","doi-asserted-by":"crossref","first-page":"102946","DOI":"10.1016\/j.ctim.2023.102946","article-title":"Assessment of anti-inflammatory efficacy of acupuncture in patients with inflammatory bowel disease: A systematic review and meta-analysis","volume":"74","author":"X Yang","year":"2023","journal-title":"Complement Ther Med"},{"key":"ref1018","first-page":"484","article-title":"A Prospective Pilot Randomized Study: Electroacupuncture vs. Sham Procedure for the Treatment of Fatigue in Patients With Quiescent Inflammatory Bowel Disease","volume":"26","author":"D Horta","year":"2020","journal-title":"Inflamm Bowel Dis"},{"key":"ref1019","doi-asserted-by":"publisher","DOI":"10.1111\/apt.14062","article-title":"Randomised clinical trial: yoga vs written self-care advice for ulcerative colitis","author":"H Cramer","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"ref1020","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.3748\/wjg.v13.i25.3417","article-title":"Acupuncture treatment in gastrointestinal diseases: A systematic review","volume":"13","author":"A Schneider","year":"2007","journal-title":"World J Gastroenterol"},{"key":"ref1021","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1093\/ecco-jcc\/jju007","article-title":"Systematic review of complementary and alternative medicine treatments in inflammatory bowel diseases","volume":"9","author":"J Langhorst","year":"2015","journal-title":"J Crohns Colitis"},{"key":"ref1022","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1080\/00365520600580688","article-title":"Acupuncture and moxibustion in the treatment of ulcerative colitis: a randomized controlled study","volume":"41","author":"S Joos","year":"2006","journal-title":"Scand J Gastroenterol"},{"key":"ref1023","first-page":"158352","article-title":"Acupuncture and moxibustion for inflammatory bowel diseases: a systematic review and meta-analysis of randomized controlled trials","volume":"2013","author":"J Ji","year":"2013","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref1024","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1471-230X-10-36","article-title":"Moxibustion for ulcerative colitis: a systematic review and meta-analysis","volume":"10","author":"D H Lee","year":"2010","journal-title":"BMC Gastroenterol"},{"key":"ref1025","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1572-0241.1999.872_a.x","article-title":"Randomized clinical trial of Plantago ovata seeds (dietary fiber) as compared with mesalamine in maintaining remission in ulcerative colitis. Spanish Group for the Study of Crohn\u2019s Disease and Ulcerative Colitis (GETECCU)","volume":"94","author":"F Fernandez-Banares","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"ref1026","doi-asserted-by":"crossref","first-page":"896476","DOI":"10.3389\/fimmu.2022.896476","article-title":"Curcumin and Curcuma longa Extract in the Treatment of 10 Types of Autoimmune Diseases: A Systematic Review and Meta-Analysis of 31 Randomized Controlled Trials","volume":"13","author":"L Zeng","year":"2022","journal-title":"Front Immunol"},{"key":"ref1027","doi-asserted-by":"crossref","first-page":"115041","DOI":"10.1016\/j.jep.2022.115041","article-title":"Efficacy and safety of adjuvant curcumin therapy in ulcerative colitis: A systematic review and meta-analysis","volume":"289","author":"J Yin","year":"2022","journal-title":"J\u00a0Ethnopharmacol"},{"key":"ref1028","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.amjms.2018.06.023","article-title":"Use of Curcumin in Achieving Clinical and Endoscopic Remission in Ulcerative Colitis: A Systematic Review and Meta-analysis","volume":"356","author":"U Iqbal","year":"2018","journal-title":"Am J Med Sci"},{"key":"ref1029","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1080\/17474124.2020.1808460","article-title":"Curcumin therapy for ulcerative colitis remission: systematic review and meta-analysis","volume":"14","author":"R A Goulart","year":"2020","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"ref1030","doi-asserted-by":"crossref","first-page":"102773","DOI":"10.1016\/j.ctim.2021.102773","article-title":"Effects of curcumin supplementation on inflammatory biomarkers in patients with Rheumatoid Arthritis and Ulcerative colitis: A systematic review and meta-analysis","volume":"61","author":"A Ebrahimzadeh","year":"2021","journal-title":"Complement Ther Med"},{"key":"ref1031","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1080\/10408398.2020.1850417","article-title":"Curcumin, autoimmune and inflammatory diseases: going beyond conventional therapy \u2013 a systematic review","volume":"62","author":"L T Marton","year":"2022","journal-title":"Crit Rev Food Sci Nutr"},{"key":"ref1032","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1089\/jmf.2020.0129","article-title":"Effects of the Use of Curcumin on Ulcerative Colitis and Crohn\u2019s Disease: A Systematic Review","volume":"24","author":"R A Goulart","year":"2021","journal-title":"J\u00a0Med Food"},{"key":"ref1033","doi-asserted-by":"publisher","DOI":"10.3390\/nu12082296","article-title":"The Use of Curcumin as a Complementary Therapy in Ulcerative Colitis: A Systematic Review of Randomized Controlled Clinical Trials","volume":"12","author":"M R Coelho","year":"2020","journal-title":"Nutrients"},{"key":"ref1034","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/978-3-030-56153-6_18","article-title":"A Systematic Review of the Clinical Use of Curcumin for the Management of Gastrointestinal Diseases","volume":"1291","author":"M Atefi","year":"2021","journal-title":"Adv Exp Med Biol"},{"key":"ref1035","doi-asserted-by":"publisher","DOI":"10.3390\/nu10111737","article-title":"Oral Adjuvant Curcumin Therapy for Attaining Clinical Remission in Ulcerative Colitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","volume":"10","author":"M G Grammatikopoulou","year":"2018","journal-title":"Nutrients"},{"key":"ref1036","first-page":"363","article-title":"Efficacy of Curcumin as Adjuvant Therapy to Induce or Maintain Remission in Ulcerative Colitis Patients: an Evidence-based Clinical Review","volume":"49","author":"M Simadibrata","year":"2017","journal-title":"Acta Med Indones"},{"key":"ref1037","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.cgh.2006.08.008","article-title":"Curcumin Maintenance Therapy for Ulcerative Colitis: Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial","volume":"4","author":"H Hanai","year":"2006","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"ref1038","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.crohns.2013.08.006","article-title":"Induction with NCB-02 (curcumin) enema for mild-to-moderate distal ulcerative colitis \u2013 a randomized, placebo-controlled, pilot study","volume":"8","author":"V Singla","year":"2014","journal-title":"J Crohns Colitis"},{"key":"ref1039","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.cgh.2015.02.019","article-title":"Curcumin in Combination With Mesalamine Induces Remission in Patients With Mild-to-Moderate Ulcerative Colitis in a Randomized Controlled Trial","volume":"13","author":"A Lang","year":"2015","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"ref1040","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/apt.12397","article-title":"Randomised clinical trial: a herbal preparation of myrrh, chamomile and coffee charcoal compared with mesalazine in maintaining remission in ulcerative colitis--a double-blind, double-dummy study","volume":"38","author":"J Langhorst","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"ref1041","doi-asserted-by":"crossref","first-page":"e000015","DOI":"10.1136\/bmjgast-2014-000015","article-title":"Efficacy and safety of a herbal medicinal product containing myrrh, chamomile and coffee charcoal for the treatment of gastrointestinal disorders: a non-interventional study","volume":"1","author":"U Albrecht","year":"2014","journal-title":"BMJ Open Gastroenterol"},{"key":"ref1042","first-page":"249","article-title":"Myrrhe, Kamille und Kaffeekohle in der Therapie von Patient*in mit Colitis ulcerosa. Eine retrospektive Kohortenstudie mit 5-Jahres-Follow-up","volume":"37","author":"J Langhorst","year":"2016","journal-title":"Zeitschrift f\u00fcr Phytotherapie"},{"key":"ref1043","first-page":"Cd012954","article-title":"Cannabis for the treatment of ulcerative colitis","volume":"11","author":"T S Kafil","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"ref1044","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1097\/MCG.0000000000001393","article-title":"A Systematic Review With Meta-Analysis of the Efficacy of Cannabis and Cannabinoids for Inflammatory Bowel Disease: What Can We Learn From Randomized and Nonrandomized Studies?","volume":"55","author":"B H Doeve","year":"2021","journal-title":"J Clin Gastroenterol"},{"key":"ref1045","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1097\/MEG.0000000000001565","article-title":"Medical cannabis for inflammatory bowel disease: real-life experience of mode of consumption and assessment of side-effects","volume":"31","author":"T Naftali","year":"2019","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref1047","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1055\/s-2001-15802","article-title":"Effects of gum resin of Boswellia serrata in patients with chronic colitis","volume":"67","author":"I Gupta","year":"2001","journal-title":"Planta Med"},{"key":"ref1048","first-page":"37","article-title":"Effects of Boswellia serrata gum resin in patients with ulcerative colitis","volume":"2","author":"I Gupta","year":"1997","journal-title":"Eur J Med Res"},{"key":"ref1049","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1365-2036.2010.04515.x","article-title":"Randomised clinical trial: herbal extract HMPL-004 in active ulcerative colitis \u2013 a double-blind comparison with sustained release mesalazine","volume":"33","author":"T Tang","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"ref1050","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/ajg.2012.340","article-title":"Andrographis paniculata extract (HMPL-004) for active ulcerative colitis","volume":"108","author":"W J Sandborn","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"ref1051","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1056\/NEJM199403243301202","article-title":"Transdermal nicotine for active ulcerative colitis","volume":"330","author":"R D Pullan","year":"1994","journal-title":"N Engl J Med"},{"key":"ref1052","doi-asserted-by":"crossref","first-page":"364","DOI":"10.7326\/0003-4819-126-5-199703010-00004","article-title":"Transdermal nicotine for mildly to moderately active ulcerative colitis. A randomized, double-blind, placebo-controlled trial","volume":"126","author":"W J Sandborn","year":"1997","journal-title":"Ann Intern Med"},{"key":"ref1053","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1056\/NEJM199504133321503","article-title":"Transdermal nicotine as maintenance therapy for ulcerative colitis","volume":"332","author":"G A Thomas","year":"1995","journal-title":"N Engl J Med"},{"key":"ref1054","first-page":"769","article-title":"Transdermal nicotine compared with oral prednisolone therapy for active ulcerative colitis","volume":"8","author":"G A Thomas","year":"1996","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref1055","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1053\/j.gastro.2005.01.005","article-title":"Trichuris suis therapy for active ulcerative colitis: a randomized controlled trial","volume":"128","author":"R W Summers","year":"2005","journal-title":"Gastroenterology"},{"key":"ref1056","doi-asserted-by":"crossref","first-page":"e12087","DOI":"10.1097\/MD.0000000000012087","article-title":"Trichuris suis ova therapy in inflammatory bowel disease: A meta-analysis","volume":"97","author":"X Huang","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"ref1057","first-page":"390","article-title":"A Randomised, Double-blind, Placebo-controlled Trial of Trichuris suis ova in Active Crohn\u2019s Disease","volume":"11","author":"J Scholmerich","year":"2017","journal-title":"J Crohns Colitis"},{"key":"ref1058","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ctcp.2015.03.001","article-title":"Efficacy of the Punica granatum peels aqueous extract for symptom management in ulcerative colitis patients. A randomized, placebo-controlled, clinical trial","volume":"21","author":"M Kamali","year":"2015","journal-title":"Complement Ther Clin Pract"},{"key":"ref1059","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1080\/003655202317316088","article-title":"Wheat grass juice in the treatment of active distal ulcerative colitis: a randomized double-blind placebo-controlled trial","volume":"37","author":"E Ben-Arye","year":"2002","journal-title":"Scand J Gastroenterol"},{"key":"ref1060","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1365-2036.1993.tb00085.x","article-title":"A randomized controlled study of evening primrose oil and fish oil in ulcerative colitis","volume":"7","author":"S M Greenfield","year":"1993","journal-title":"Aliment Pharmacol Ther"},{"key":"ref1061","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/j.1365-2036.2004.01902.x","article-title":"Randomized, double-blind, placebo-controlled trial of oral aloe vera gel for active ulcerative colitis","volume":"19","author":"L Langmead","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"ref1062","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1007\/s11655-012-1026-x","article-title":"A randomized, double blinded, placebo-controlled clinical trial of silymarin in ulcerative colitis","volume":"21","author":"M Rastegarpanah","year":"2015","journal-title":"Chin J Integr Med"},{"key":"ref1063","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s11655-010-0562-5","article-title":"A multi-center, randomized, single-blind, controlled clinical study on the efficacy of composite sophora colon-soluble capsules in treating ulcerative colitis","volume":"16","author":"Z Q Tong","year":"2010","journal-title":"Chin J Integr Med"},{"key":"ref1064","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.crohns.2012.07.010","article-title":"Bilberry ingestion improves disease activity in mild to moderate ulcerative colitis \u2013 an open pilot study","volume":"7","author":"L Biedermann","year":"2013","journal-title":"J Crohns Colitis"},{"key":"ref1065","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.3109\/00365521.2013.819443","article-title":"Hyperbaric oxygen therapy does not improve the effects of standardized treatment in a severe attack of ulcerative colitis: A prospective randomized study","volume":"48","author":"M Pagoldh","year":"2013","journal-title":"Scand J Gastroenterol"},{"key":"ref1066","doi-asserted-by":"crossref","first-page":"101648","DOI":"10.1016\/j.ctcp.2022.101648","article-title":"Effects of aromatherapy on fatigue, quality of sleep and quality of life in patients with inflammatory bowel disease: A feasibility study","volume":"49","author":"L You","year":"2022","journal-title":"Complement Ther Clin Pract"},{"key":"ref1067","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ctim.2018.12.021","article-title":"Zingiber officinale and oxidative stress in patients with ulcerative colitis: A randomized, placebo-controlled, clinical trial","volume":"43","author":"M Nikkhah-Bodaghi","year":"2019","journal-title":"Complement Ther Med"},{"key":"ref1068","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ctim.2019.07.012","article-title":"Effects of flaxseed and flaxseed oil supplement on serum levels of inflammatory markers, metabolic parameters and severity of disease in patients with ulcerative colitis","volume":"46","author":"N Morshedzadeh","year":"2019","journal-title":"Complement Ther Med"},{"key":"ref1069","doi-asserted-by":"crossref","first-page":"e14035","DOI":"10.1111\/ijcp.14035","article-title":"The effects of flaxseed supplementation on gene expression and inflammation in ulcerative colitis patients: An open-labelled randomised controlled trial","volume":"75","author":"N Morshedzadeh","year":"2021","journal-title":"Int J Clin Pract"},{"key":"ref1070","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1002\/ptr.7081","article-title":"The effects of flaxseed supplementation on metabolic syndrome parameters, insulin resistance and inflammation in ulcerative colitis patients: An open-labeled randomized controlled trial","volume":"35","author":"N Morshedzadeh","year":"2021","journal-title":"Phytother Res"},{"key":"ref1071","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1089\/jmf.2022.0116","article-title":"The Effect of Mastic Chios Supplementation in Inflammatory Bowel Disease: A Systematic Literature Review","volume":"26","author":"A Mavroudi","year":"2023","journal-title":"J Med Food"},{"key":"ref1072","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/ptr.6229","article-title":"Regulation of faecal biomarkers in inflammatory bowel disease patients treated with oral mastiha (Pistacia lentiscus) supplement: A double-blind and placebo-controlled randomised trial","volume":"33","author":"E Papada","year":"2019","journal-title":"Phytother Res"},{"key":"ref1073","doi-asserted-by":"publisher","DOI":"10.3390\/nu10111779","article-title":"Antioxidative Efficacy of a Pistacia Lentiscus Supplement and Its Effect on the Plasma Amino Acid Profile in Inflammatory Bowel Disease: A Randomised, Double-Blind, Placebo-Controlled Trial","volume":"10","author":"E Papada","year":"2018","journal-title":"Nutrients"},{"key":"ref1074","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.phymed.2018.08.008","article-title":"Plasma free amino acid profile in quiescent Inflammatory Bowel Disease patients orally administered with Mastiha (Pistacia lentiscus); a randomised clinical trial","volume":"56","author":"E Papada","year":"2019","journal-title":"Phytomedicine"},{"key":"ref1075","doi-asserted-by":"crossref","first-page":"101444","DOI":"10.1016\/j.ctcp.2021.101444","article-title":"Efficacy of Plantago major seed in management of ulcerative colitis symptoms: A randomized, placebo controlled, clinical trial","volume":"44","author":"A Baghizadeh","year":"2021","journal-title":"Complement Ther Clin Pract"},{"key":"ref1076","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/ptr.6848","article-title":"Effects of saffron supplementation on oxidative\/antioxidant status and severity of disease in ulcerative colitis patients: A randomized, double-blind, placebo-controlled study","volume":"35","author":"N Tahvilian","year":"2021","journal-title":"Phytother Res"},{"key":"ref1077","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12906-024-04400-w","article-title":"Effects of Spirulina supplementation in patients with ulcerative colitis: a double-blind, placebo-controlled randomized trial","volume":"24","author":"S Moradi","year":"2024","journal-title":"BMC Complement Med Ther"},{"key":"ref1078","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.clnesp.2023.08.019","article-title":"The effects of spirulina supplementation on serum iron and ferritin, anemia parameters, and fecal occult blood in adults with ulcerative colitis: A randomized, double-blinded, placebo-controlled trial","volume":"57","author":"S Moradi","year":"2023","journal-title":"Clin Nutr ESPEN"},{"key":"ref1079","doi-asserted-by":"crossref","first-page":"e14472","DOI":"10.1111\/ijcp.14472","article-title":"The effects of spirulina (Arthrospira platensis) supplementation on anthropometric indices, blood pressure, sleep quality, mental health, fatigue status and quality of life in patients with ulcerative colitis: A randomised, double-blinded, placebo-controlled trial","volume":"75","author":"S Moradi","year":"2021","journal-title":"Int J Clin Pract"},{"key":"ref1080","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1007\/s10787-022-00991-3","article-title":"Evaluation of the efficacy of Thymus kotschyanus extract as an additive treatment in patients with ulcerative colitis: a randomized double-blind placebo-controlled trial","volume":"30","author":"F Vazirian","year":"2022","journal-title":"Inflammopharmacology"},{"key":"ref1081","doi-asserted-by":"crossref","first-page":"102250","DOI":"10.1016\/j.clinre.2023.102250","article-title":"Indigo naturalis (Qing dai) for inflammatory bowel disease: A systematic review and meta-analysis","volume":"48","author":"R Kakdiya","year":"2024","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"ref1082","first-page":"386","article-title":"Effects of Traditional Chinese Medicine on Serum Cytokines for the Dampness-heat Syndrome of Ulcerative Colitis: A Systematic Review and Meta-analysis","volume":"29","author":"Y Xu","year":"2023","journal-title":"Altern Ther Health Med"},{"key":"ref1083","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s12906-021-03387-y","article-title":"An evidence mapping of systematic reviews and meta-analysis on traditional Chinese medicine for ulcerative colitis","volume":"21","author":"Y X Sun","year":"2021","journal-title":"BMC Complement Med Ther"},{"key":"ref1084","first-page":"1057","article-title":"Efficacy and safety of Weichang\u2019 an pill combined with Western Medicine on gastrointestinal diseases: a systematic review and Meta-analysis","volume":"43","author":"W Jiabao","year":"2023","journal-title":"J Tradit Chin Med"},{"key":"ref1085","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1111\/apt.17202","article-title":"Systematic review: the role of psychological stress in inflammatory bowel disease","volume":"56","author":"J Black","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"ref1086","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1136\/gutjnl-2021-325985","article-title":"Bidirectional brain-gut axis effects influence mood and prognosis in IBD: a systematic review and meta-analysis","volume":"71","author":"K M Fairbrass","year":"2022","journal-title":"Gut"},{"key":"ref1087","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1097\/MEG.0000000000002768","article-title":"Antidepressant treatment in inflammatory bowel disease: a systematic review and meta-analysis","volume":"36","author":"F Weston","year":"2024","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref1088","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S2468-1253(23)00186-3","article-title":"Efficacy of psychological therapies in people with inflammatory bowel disease: a systematic review and meta-analysis","volume":"8","author":"C Riggott","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref1089","doi-asserted-by":"publisher","DOI":"10.3390\/genes12101465","article-title":"Role of Digital Health and Artificial Intelligence in Inflammatory Bowel Disease: A Scoping Review","volume":"12","author":"K Majidova","year":"2021","journal-title":"Genes (Basel)"},{"key":"ref1090","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/nur.22091","article-title":"Telehealth and mobile health interventions in adults with inflammatory bowel disease: A mixed-methods systematic review","volume":"44","author":"S P Davis","year":"2021","journal-title":"Res Nurs Health"},{"key":"ref1091","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.cgh.2021.06.034","article-title":"Prevalence and Risk Factors for Fatigue in Adults With Inflammatory Bowel Disease: A Systematic Review With Meta-Analysis","volume":"20","author":"A D\u2019Silva","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref1092","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/s41575-018-0091-9","article-title":"Fatigue in IBD: epidemiology, pathophysiology and management","volume":"16","author":"N Z Borren","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref1093","first-page":"Cd012005","article-title":"Interventions for fatigue in inflammatory bowel disease","volume":"4","author":"D Farrell","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"ref1094","doi-asserted-by":"crossref","first-page":"101229","DOI":"10.1016\/j.ctcp.2020.101229","article-title":"Non-pharmacological interventions to manage fatigue in adults with inflammatory bowel disease: A systematic review and meta-analysis","volume":"41","author":"S P Davis","year":"2020","journal-title":"Complement Ther Clin Pract"},{"key":"ref1095","doi-asserted-by":"crossref","first-page":"110524","DOI":"10.1016\/j.jpsychores.2021.110524","article-title":"A systematic review of psychological treatments to manage fatigue in patients with inflammatory bowel disease","volume":"147","author":"C Emerson","year":"2021","journal-title":"J Psychosom Res"},{"key":"ref1096","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1136\/gutjnl-2013-305191","article-title":"Fatigue management in patients with IBD: a randomised controlled trial","volume":"63","author":"L Vogelaar","year":"2014","journal-title":"Gut"},{"key":"ref1097","doi-asserted-by":"crossref","first-page":"111949","DOI":"10.1016\/j.jpsychores.2024.111949","article-title":"Long-term treatment outcomes of mindfulness-based cognitive therapy for fatigue in patients with inflammatory bowel disease: Results of a randomized controlled trial","volume":"187","author":"Q M Bredero","year":"2024","journal-title":"J\u00a0Psychosom Res"},{"key":"ref1098","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/ibd\/izy236","article-title":"Association Between IBD Disability and Reduced Work Productivity (Presenteeism): A Population-Based Study in Manitoba, Canada","volume":"25","author":"L A Shafer","year":"2019","journal-title":"Inflamm Bowel Dis"},{"key":"ref1099","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1055\/a-1797-2688","article-title":"Validation of the German Inflammatory Bowel Disease Fatigue (IBD-F) Questionnaire","volume":"61","author":"K AM Scholz","year":"2023","journal-title":"Z Gastroenterol"},{"key":"ref1100","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-023-01888-3","article-title":"The Effect of Biological Treatment on Fatigue in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis","author":"B M Skjellerudsveen","year":"2023","journal-title":"Drugs"},{"key":"ref1101","first-page":"CD012005","article-title":"Interventions for fatigue in inflammatory bowel disease","volume":"4","author":"D Farrell","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"ref1102","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/ecco-jcc\/jjv168","article-title":"Practical Guideline for Fatigue Management in Inflammatory Bowel Disease","volume":"10","author":"J E Kreijne","year":"2016","journal-title":"J Crohns Colitis"},{"key":"ref1103","doi-asserted-by":"crossref","first-page":"101465","DOI":"10.1016\/j.ctcp.2021.101465","article-title":"Effects of yoga in inflammatory bowel diseases and on frequent IBD-associated extraintestinal symptoms like fatigue and depression","volume":"45","author":"E Wilke","year":"2021","journal-title":"Complement Ther Clin Pract"},{"key":"ref1104","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s10620-020-06222-5","article-title":"Improvement of Fatigue and Quality of Life in Patients with Quiescent Inflammatory Bowel Disease Following a Personalized Exercise Program","volume":"66","author":"L W van Erp","year":"2021","journal-title":"Dig Dis Sci"},{"key":"ref1105","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/MPG.0000000000003816","article-title":"Physical Training and Healthy Diet Improved Bowel Symptoms, Quality of Life, and Fatigue in Children With Inflammatory Bowel Disease","volume":"77","author":"L E Scheffers","year":"2023","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref1106","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.crohns.2011.06.001","article-title":"Solution focused therapy: a promising new tool in the management of fatigue in Crohn\u2019s disease patients psychological interventions for the management of fatigue in Crohn\u2019s disease","volume":"5","author":"L Vogelaar","year":"2011","journal-title":"J Crohns Colitis"},{"key":"ref1107","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s12671-022-02057-5","article-title":"Mindfulness-Based Cognitive Therapy for Fatigue in Patients with Inflammatory Bowel Disease: Results of a Randomized Controlled Trial","volume":"14","author":"Q M Bredero","year":"2023","journal-title":"Mindfulness"},{"key":"ref1108","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1053\/j.gastro.2017.11.279","article-title":"Neuromodulators for Functional Gastrointestinal Disorders (Disorders of Gut-Brain Interaction): A Rome Foundation Working Team Report","volume":"154","author":"D A Drossman","year":"2018","journal-title":"Gastroenterology"},{"key":"ref1109","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/s41575-019-0259-y","article-title":"Antidepressants in inflammatory bowel disease","volume":"17","author":"A Mikocka-Walus","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref1110","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/apt.16166","article-title":"Randomised clinical trial: high-dose oral thiamine versus placebo for chronic fatigue in patients with quiescent inflammatory bowel disease","volume":"53","author":"P Bager","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"ref1111","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2023.12.030","article-title":"Modafinil for Severe Fatigue in Inflammatory Bowel Disease: A Prospective Case Series","author":"C D Moulton","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref1112","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1053\/j.gastro.2022.07.052","article-title":"Effect of 5-Hydroxytryptophan on Fatigue in Quiescent Inflammatory Bowel Disease: A Randomized Controlled Trial","volume":"163","author":"M Truyens","year":"2022","journal-title":"Gastroenterology"},{"key":"ref1113","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.clnesp.2017.10.004","article-title":"Surplus vitamin B(12) use does not reduce fatigue in patients with Irritable Bowel Syndrome or inflammatory bowel disease: A randomized double-blind placebo-controlled trial","volume":"23","author":"A M Scholten","year":"2018","journal-title":"Clin Nutr ESPEN"},{"key":"ref1114","first-page":"89","article-title":"The Effectiveness of Actively Induced Medical Rehabilitation in Chronic Inflammatory Bowel Disease","volume":"117","author":"A H\u00fcppe","year":"2020","journal-title":"Dtsch Arztebl Int"},{"key":"ref1115","first-page":"320","article-title":"[Medical Rehabilitation for Inflammatory Bowel Disease: Access, Process, and Results \u2013 Further Analyses of a Randomised Controlled Trial]","volume":"60","author":"H Raspe","year":"2021","journal-title":"Rehabilitation (Stuttg)"},{"key":"ref1116","doi-asserted-by":"publisher","DOI":"10.3238\/arztebl.2020.0089","article-title":"Wirksamkeit und Nutzen einer aktivinduzierten medizinischen Rehabilitation bei chronisch entz\u00fcndlichen Darmerkrankungen Ergebnisse einer randomisierten kontrollierten Studie (MERCED)","volume":"117","author":"A H\u00fcppe","year":"2020","journal-title":"Deutsches \u00c4rzteblatt"},{"key":"ref1117","doi-asserted-by":"publisher","DOI":"10.1055\/a-1392-9531","article-title":"Medizinische Rehabilitation bei chronisch entz\u00fcndlichen Darmerkrankungen: Zugang, Prozess und Ergebnisse: Weitere Analysen einer randomisierten kontrollierten Studie","volume":"60","author":"H Raspe","year":"2021","journal-title":"Die Rehabilitation"},{"key":"ref1118","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s00112-010-2193-5","article-title":"Epidemiologie und klinische Besonderheiten der p\u00e4diatrischen CED","volume":"158","author":"S Buderus","year":"2010","journal-title":"Monatsschrift Kinderheilkunde"},{"key":"ref1119","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1093\/ecco-jcc\/jjaa037","article-title":"A Systematic Review and Meta-analysis of Paediatric Inflammatory Bowel Disease Incidence and Prevalence Across Europe","volume":"14","author":"S E Roberts","year":"2020","journal-title":"J Crohns Colitis"},{"key":"ref1120","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/MPG.0000000000002162","article-title":"Pediatric Chronic Inflammatory Bowel Disease in a German Statutory Health INSURANCE-Incidence Rates From 2009 to 2012","volume":"68","author":"R Wittig","year":"2019","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref1121","first-page":"121","article-title":"Inflammatory bowel disease in pediatric patients: Characteristics of newly diagnosed patients from the CEDATA-GPGE Registry","volume":"112","author":"S Buderus","year":"2015","journal-title":"Dtsch Arztebl Int"},{"key":"ref1122","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1111\/apt.18262","article-title":"Predicting complications in paediatric ulcerative colitis: A longitudinal multicentre cohort study","volume":"60","author":"M Classen","year":"2024","journal-title":"Aliment Pharmacol Ther"},{"key":"ref1123","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nrgastro.2013.240","article-title":"IBD across the age spectrum: is it the same disease?","volume":"11","author":"J Ruel","year":"2014","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref1124","first-page":"100785","article-title":"Updates in diagnosis and management of inflammatory bowel disease","volume":"50","author":"K Sandberg","year":"2020","journal-title":"Curr Probl Pediatr Adolesc Health Care"},{"key":"ref1125","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1001\/jamapediatrics.2015.1982","article-title":"Inflammatory Bowel Disease in Children and Adolescents","volume":"169","author":"M J Rosen","year":"2015","journal-title":"JAMA Pediatr"},{"key":"ref1126","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/MPG.0000000000001455","article-title":"Extraintestinal Manifestations of Pediatric Inflammatory Bowel Disease: Prevalence, Presentation, and Anti-TNF Treatment","volume":"65","author":"T Greuter","year":"2017","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref1127","doi-asserted-by":"crossref","first-page":"e273","DOI":"10.1111\/apa.12215","article-title":"Does cow\u2019s milk protein elimination diet have a role on induction and maintenance of remission in children with ulcerative colitis?","volume":"102","author":"C Strisciuglio","year":"2013","journal-title":"Acta Paediatr"},{"key":"ref1128","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/MPG.0000000000003046","article-title":"The Use of Fecal Calprotectin Testing in Paediatric Disorders: A Position Paper of the European Society for Paediatric Gastroenterology and Nutrition Gastroenterology Committee","volume":"72","author":"C R Koninckx","year":"2021","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref1129","doi-asserted-by":"crossref","first-page":"c3369","DOI":"10.1136\/bmj.c3369","article-title":"Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis","volume":"341","author":"P F van Rheenen","year":"2010","journal-title":"BMJ"},{"key":"ref1130","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1097\/MPG.0b013e31810e75a9","article-title":"Fecal calprotectin: a quantitative marker of colonic inflammation in children with inflammatory bowel disease","volume":"45","author":"U L Fagerberg","year":"2007","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref1131","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1097\/MPG.0b013e3180308d8e","article-title":"Fecal lactoferrin is a sensitive and specific marker of disease activity in children and young adults with inflammatory bowel disease","volume":"44","author":"T R Walker","year":"2007","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref1132","doi-asserted-by":"crossref","first-page":"578527","DOI":"10.1155\/2015\/578527","article-title":"Fecal Lactoferrin: Reliable Biomarker for Intestinal Inflammation in Pediatric IBD","volume":"2015","author":"S Buderus","year":"2015","journal-title":"Gastroenterol Res Pract"},{"key":"ref1133","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1136\/archdischild-2017-314081","article-title":"Predicting inflammatory bowel disease in children with abdominal pain and diarrhoea: calgranulin-C versus calprotectin stool tests","volume":"103","author":"A Heida","year":"2018","journal-title":"Arch Dis Child"},{"key":"ref1134","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1093\/ecco-jcc\/jjad035","article-title":"Accuracy of Transperineal Ultrasonography for Assessing Rectal Lesions in Paediatric Ulcerative Colitis: A Prospective Study","volume":"17","author":"K Jimbo","year":"2023","journal-title":"J Crohns Colitis"},{"key":"ref1135","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s00247-018-4084-1","article-title":"Detecting inflammation in inflammatory bowel disease \u2013 how does ultrasound compare to magnetic resonance enterography using standardised scoring systems?","volume":"48","author":"J L Barber","year":"2018","journal-title":"Pediatr Radiol"},{"key":"ref1136","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1093\/ecco-jcc\/jjz085","article-title":"Diagnostic Accuracy of Transabdominal Ultrasound in Detecting Intestinal Inflammation in Paediatric IBD Patients-a Systematic Review","volume":"13","author":"E A van Wassenaer","year":"2019","journal-title":"J Crohns Colitis"},{"key":"ref1137","first-page":"121","article-title":"Inflammatory bowel disease in pediatric patients: Characteristics of newly diagnosed patients from the CEDATA-GPGE Registry","volume":"112","author":"S Buderus","year":"2015","journal-title":"Dtsch Arztebl Int"},{"key":"ref1138","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/ibd.23013","article-title":"Atypical disease phenotypes in pediatric ulcerative colitis: 5-year analyses of the EUROKIDS Registry","volume":"19","author":"A Levine","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"ref1139","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/MPG.0000000000000239","article-title":"ESPGHAN revised porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents","volume":"58","author":"A Levine","year":"2014","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref1140","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.humpath.2017.06.006","article-title":"Value of upper endoscopic biopsies in predicting medical refractoriness in pediatric patients with ulcerative colitis","volume":"66","author":"K J Sullivan","year":"2017","journal-title":"Hum Pathol"},{"key":"ref1141","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/00000478-200402000-00006","article-title":"Pediatric patients with untreated ulcerative colitis may present initially with unusual morphologic findings","volume":"28","author":"J N Glickman","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"ref1142","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/00000478-200402000-00005","article-title":"Patterns of inflammation in mucosal biopsies of ulcerative colitis: perceived differences in pediatric populations are limited to children younger than 10 years","volume":"28","author":"M E Robert","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"ref1143","first-page":"2034","article-title":"Atypical rectosigmoid histology in children with newly diagnosed ulcerative colitis","volume":"88","author":"J Markowitz","year":"1993","journal-title":"Am J Gastroenterol"},{"key":"ref1144","doi-asserted-by":"crossref","first-page":"39","DOI":"10.32074\/1591-951X-235","article-title":"Histopathology of IBD Colitis. A practical approach from the pathologists of the Italian Group for the study of the gastrointestinal tract (GIPAD)","volume":"113","author":"V Villanacci","year":"2021","journal-title":"Pathologica"},{"key":"ref1145","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/MPG.0b013e31805563f3","article-title":"Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn\u2019s and Colitis Foundation of America","volume":"44","author":"North American Society for Pediatric Gastroenterology H, Nutrition, Colitis Foundation of A","year":"2007","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref1146","first-page":"519","article-title":"Incidence and Phenotype at Diagnosis of Very-early-onset Compared with Later-onset Paediatric Inflammatory Bowel Disease: A Population-based Study [1988-2011]","volume":"11","author":"E Bequet","year":"2017","journal-title":"J Crohns Colitis"},{"key":"ref1147","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1093\/ecco-jcc\/jjy068","article-title":"Diagnostic Yield of Next-generation Sequencing in Very Early-onset Inflammatory Bowel Diseases: A Multicentre Study","volume":"12","author":"F Charbit-Henrion","year":"2018","journal-title":"J Crohns Colitis"},{"key":"ref1148","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1007\/s00112-024-02004-9","article-title":"Darm au\u00dfer Kontrolle \u2013 wenn das Immunsystem andere Wege geht","volume":"172","author":"C Posovszky","year":"2024","journal-title":"Monatsschrift Kinderheilkunde"},{"key":"ref1149","first-page":"519","article-title":"Incidence and Phenotype at Diagnosis of Very-early-onset Compared with Later-onset Paediatric Inflammatory Bowel Disease: A Population-based Study [1988-2011]","volume":"11","author":"E Bequet","year":"2017","journal-title":"J Crohns Colitis"},{"key":"ref1150","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15030969","article-title":"Pharmacologic Management of Monogenic and Very Early Onset Inflammatory Bowel Diseases","volume":"15","author":"A E Levine","year":"2023","journal-title":"Pharmaceutics"},{"key":"ref1151","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1093\/ibd\/izz259","article-title":"Very Early Onset Inflammatory Bowel Disease: A Clinical Approach With a Focus on the Role of Genetics and Underlying Immune Deficiencies","volume":"26","author":"J Ouahed","year":"2020","journal-title":"Inflamm Bowel Dis"},{"key":"ref1152","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S2468-1253(22)00337-5","article-title":"Genomic diagnosis and care co-ordination for monogenic inflammatory bowel disease in children and adults: consensus guideline on behalf of the British Society of Gastroenterology and British Society of Paediatric Gastroenterology, Hepatology and Nutrition","volume":"8","author":"J Kammermeier","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref1153","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/MPG.0000000000002035","article-title":"Management of Paediatric Ulcerative Colitis, Part 1: Ambulatory Care-An Evidence-based Guideline From European Crohn\u2019s and Colitis Organization and European Society of Paediatric Gastroenterology, Hepatology and Nutrition","volume":"67","author":"D Turner","year":"2018","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref1154","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/MPG.0000000000002036","article-title":"Management of Paediatric Ulcerative Colitis, Part 2: Acute Severe Colitis-An Evidence-based Consensus Guideline From the European Crohn\u2019s and Colitis Organization and the European Society of Paediatric Gastroenterology, Hepatology and Nutrition","volume":"67","author":"D Turner","year":"2018","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref1155","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S2468-1253(17)30252-2","article-title":"Factors associated with early outcomes following standardised therapy in children with ulcerative colitis (PROTECT): a multicentre inception cohort study","volume":"2","author":"J S Hyams","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref1156","first-page":"527","article-title":"Once- Versus Twice-daily Mesalazine to Induce Remission in Paediatric Ulcerative Colitis: A Randomised Controlled Trial","volume":"11","author":"D Turner","year":"2017","journal-title":"J Crohns Colitis"},{"key":"ref1157","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1016\/S0140-6736(18)32592-3","article-title":"Clinical and biological predictors of response to standardised paediatric colitis therapy (PROTECT): a multicentre inception cohort study","volume":"393","author":"J S Hyams","year":"2019","journal-title":"Lancet"},{"key":"ref1158","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1093\/ecco-jcc\/jjx042","article-title":"Mesalamine Enemas for Induction of Remission in Oral Mesalamine-refractory Pediatric Ulcerative Colitis: A Prospective Cohort Study","volume":"11","author":"A Levine","year":"2017","journal-title":"J Crohns Colitis"},{"key":"ref1159","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/MPG.0000000000000530","article-title":"High- and low-dose oral delayed-release mesalamine in children with mild-to-moderately active ulcerative colitis","volume":"59","author":"H S Winter","year":"2014","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref1160","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/MPG.0000000000003698","article-title":"Efficacy and Safety of Sulfasalazine Suspension in Children With Ulcerative Colitis","volume":"76","author":"I Mansuri","year":"2023","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref1161","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/MPG.0b013e31826ac41a","article-title":"Outcome following aminosalicylate therapy in children newly diagnosed as having ulcerative colitis","volume":"56","author":"B Zeisler","year":"2013","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref1162","doi-asserted-by":"crossref","first-page":"635","DOI":"10.5217\/ir.2018.00015","article-title":"5-Aminosalicylic acid aggravates colitis mimicking exacerbation of ulcerative colitis","volume":"16","author":"J Miyoshi","year":"2018","journal-title":"Intest Res"},{"key":"ref1163","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1530\/EJE-08-0429","article-title":"Bone turnover and metabolism in paediatric patients with inflammatory bowel disease treated with systemic glucocorticoids","volume":"159","author":"M K Vihinen","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"ref1164","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1471-230X-14-51","article-title":"Screening for adrenal suppression in children with inflammatory bowel disease discontinuing glucocorticoid therapy","volume":"14","author":"M Sidoroff","year":"2014","journal-title":"BMC Gastroenterol"},{"key":"ref1165","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1365-2036.2010.04373.x","article-title":"Systematic review: steroid withdrawal in anti-TNF-treated patients with inflammatory bowel disease","volume":"32","author":"E Bultman","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"ref1166","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s10350-005-0213-7","article-title":"Preoperative steroid-related complications in Japanese pediatric patients with ulcerative colitis","volume":"49","author":"K Uchida","year":"2006","journal-title":"Dis Colon Rectum"},{"key":"ref1167","doi-asserted-by":"crossref","first-page":"745","DOI":"10.3109\/00365521.2012.679681","article-title":"Glucocorticoids in pediatric inflammatory bowel disease","volume":"47","author":"M Sidoroff","year":"2012","journal-title":"Scand J Gastroenterol"},{"key":"ref1168","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1530\/EJE-08-0429","article-title":"Bone turnover and metabolism in paediatric patients with inflammatory bowel disease treated with systemic glucocorticoids","volume":"159","author":"M K Vihinen","year":"2008","journal-title":"European journal of endocrinology"},{"key":"ref1169","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S2468-1253(21)00142-4","article-title":"Efficacy and safety of adalimumab in paediatric patients with moderate-to-severe ulcerative colitis (ENVISION I): a randomised, controlled, phase 3 study","volume":"6","author":"N M Croft","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref1170","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.cgh.2011.11.026","article-title":"Induction and maintenance therapy with infliximab for children with moderate to severe ulcerative colitis","volume":"10","author":"J Hyams","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref1171","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1111\/jcpt.13239","article-title":"Biosimilar infliximab in paediatric inflammatory bowel disease: Efficacy, immunogenicity and safety","volume":"45","author":"V Dipasquale","year":"2020","journal-title":"J Clin Pharm Ther"},{"key":"ref1172","doi-asserted-by":"crossref","first-page":"461","DOI":"10.5223\/pghn.2022.25.6.461","article-title":"Long-Term Efficacy and Safety of Golimumab for Ulcerative Colitis in a Pediatric Inflammatory Bowel Disease Center in Japan","volume":"25","author":"K Tokita","year":"2022","journal-title":"Pediatr Gastroenterol Hepatol Nutr"},{"key":"ref1173","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.cgh.2011.11.026","article-title":"Induction and Maintenance Therapy With Infliximab for Children With Moderate to Severe Ulcerative Colitis","volume":"10","author":"J Hyams","year":"2012","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"ref1174","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1093\/ecco-jcc\/jjz019","article-title":"Intensified Infliximab Induction is Associated with Improved Response and Decreased Colectomy in Steroid-Refractory Paediatric Ulcerative Colitis","volume":"13","author":"P C Church","year":"2019","journal-title":"J Crohns Colitis"},{"key":"ref1175","doi-asserted-by":"crossref","first-page":"903677","DOI":"10.3389\/fped.2022.903677","article-title":"Significant advantages for first line treatment with TNF-alpha inhibitors in pediatric patients with inflammatory bowel disease \u2013 Data from the multicenter CEDATA-GPGE registry study","volume":"10","author":"M Classen","year":"2022","journal-title":"Front Pediatr"},{"key":"ref1176","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20102529","article-title":"A Review on the Use of Anti-TNF in Children and Adolescents with Inflammatory Bowel Disease","volume":"20","author":"M A Aardoom","year":"2019","journal-title":"Int J Mol Sci"},{"key":"ref1177","doi-asserted-by":"crossref","first-page":"10654","DOI":"10.3748\/wjg.v21.i37.10654","article-title":"Histological healing after infliximab induction therapy in children with ulcerative colitis","volume":"21","author":"A Wiernicka","year":"2015","journal-title":"World J Gastroenterol"},{"key":"ref1178","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/MPG.0000000000002141","article-title":"Use of Biosimilars in Pediatric Inflammatory Bowel Disease: An Updated Position Statement of the Pediatric IBD Porto Group of ESPGHAN","volume":"68","author":"L de Ridder","year":"2019","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref1179","first-page":"57","article-title":"Biosimilars in Pediatric IBD: Updated Considerations for Disease Management","volume":"16","author":"V Dipasquale","year":"2022","journal-title":"Biologics"},{"key":"ref1180","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1038\/ajg.2009.759","article-title":"Outcome following infliximab therapy in children with ulcerative colitis","volume":"105","author":"J S Hyams","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"ref1181","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1093\/ecco-jcc\/jjad009","article-title":"A Model-Based Tool for Guiding Infliximab Induction Dosing to Maximize Long-term Deep Remission in Children with Inflammatory Bowel Diseases","volume":"17","author":"W Kantasiripitak","year":"2023","journal-title":"J Crohns Colitis"},{"key":"ref1182","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1097\/MPG.0000000000002566","article-title":"Role of Thiopurines in Pediatric Inflammatory Bowel Diseases: A Real-Life Prospective Cohort Study","volume":"70","author":"O Atia","year":"2020","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref1183","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/MPG.0000000000003899","article-title":"Thiopurines Maintenance Therapy in Children With Ulcerative Colitis: A Multicenter Retrospective Study","volume":"77","author":"F Abu Hanna","year":"2023","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref1184","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1097\/MPG.0b013e31820ba46c","article-title":"Do children with IBD really respond better than adults to thiopurines?","volume":"52","author":"J R Goodhand","year":"2011","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref1185","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0016-5085(98)70251-3","article-title":"Safety of azathioprine and 6-mercaptopurine in pediatric patients with inflammatory bowel disease","volume":"115","author":"B S Kirschner","year":"1998","journal-title":"Gastroenterology"},{"key":"ref1186","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/MPG.0000000000002802","article-title":"Safety of Thiopurine Use in Paediatric Gastrointestinal Disease","volume":"71","author":"E Miele","year":"2020","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref1187","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/MPG.0000000000003197","article-title":"Epstein-Barr Virus Status and Subsequent Thiopurine Exposure Within a Paediatric Inflammatory Bowel Disease Population","volume":"73","author":"R E Harris","year":"2021","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref1188","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S2352-4642(24)00078-6","article-title":"Rare and severe adverse events in children with inflammatory bowel disease: analysis of data from the PIBD-SETQuality Safety Registry","volume":"8","author":"R CW Klomberg","year":"2024","journal-title":"Lancet Child Adolesc Health"},{"key":"ref1189","first-page":"S151","article-title":"Use of methotrexate in patients with inflammatory bowel diseases","volume":"28","author":"J C Preiss","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"ref1190","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/j.1365-2036.2010.04433.x","article-title":"Methotrexate in paediatric ulcerative colitis: a retrospective survey at a single tertiary referral centre","volume":"32","author":"M Aloi","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"ref1191","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1002\/ibd.21653","article-title":"Methotrexate in the treatment of inflammatory bowel disease: an 8-year retrospective study in a Canadian pediatric IBD center","volume":"17","author":"S Willot","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"ref1192","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/ibd.21418","article-title":"Outcomes and adverse events in children and young adults undergoing tacrolimus therapy for steroid-refractory colitis","volume":"17","author":"S Watson","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"ref1193","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.crohns.2013.03.006","article-title":"Oral tacrolimus for pediatric steroid-resistant ulcerative colitis","volume":"8","author":"V M Navas-L\u00f3pez","year":"2014","journal-title":"J Crohns Colitis"},{"key":"ref1194","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/apt.13181","article-title":"Systematic review: thalidomide and thalidomide analogues for treatment of inflammatory bowel disease","volume":"41","author":"C Yang","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"ref1195","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1111\/jcpt.13422","article-title":"Quality assessment of clinical guidelines on probiotics therapy in children with IBD using the AGREE II instrument","volume":"46","author":"H Cheng","year":"2021","journal-title":"J Clin Pharm Ther"},{"issue":"S 01","key":"ref1196","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1097\/MCG.0000000000001095","article-title":"Probiotics in Pediatric Gastroenterology: Emerging Indications: Inflammatory Bowel Diseases","volume":"52","author":"E Scarpato","year":"2018","journal-title":"J Clin Gastroenterol"},{"key":"ref1197","first-page":"Cd005573","article-title":"Probiotics for induction of remission in ulcerative colitis","volume":"3","author":"L Kaur","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"ref1198","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/apt.15445","article-title":"Longitudinal non-adherence predicts treatment escalation in paediatric ulcerative colitis","volume":"50","author":"J K Carmody","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"ref1199","doi-asserted-by":"crossref","first-page":"9562192","DOI":"10.1155\/2020\/9562192","article-title":"Adherence to Azathioprine\/6-Mercaptopurine in Children and Adolescents with Inflammatory Bowel Diseases: A Multimethod Study","volume":"2020","author":"M M Alsous","year":"2020","journal-title":"Can J Gastroenterol Hepatol"},{"key":"ref1200","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1002\/jgh3.12791","article-title":"Prevalence of irritable bowel syndrome and functional abdominal pain disorders in children with inflammatory bowel disease in remission","volume":"6","author":"L F Limbri","year":"2022","journal-title":"JGH Open"},{"key":"ref1201","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1097\/MPG.0000000000001877","article-title":"Prevalence of Anti-tissue Transglutaminase Antibodies and Celiac Disease in Children With Inflammatory Bowel Disease","volume":"66","author":"A Alper","year":"2018","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref1202","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/s11894-023-00890-9","article-title":"Clostridioides difficile Infection in Pediatric Inflammatory Bowel Disease","volume":"25","author":"S A Reasoner","year":"2023","journal-title":"Curr Gastroenterol Rep"},{"key":"ref1203","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/MPG.0000000000001941","article-title":"Early Treatment Response Predicts Outcome in Paediatric Ulcerative Colitis: GASTROENTEROLOGY: INFLAMMATORY BOWEL DISEASE","volume":"67","author":"M Gasparetto","year":"2018","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref1204","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1111\/apt.17217","article-title":"The inexorable increase of biologic exposure in paediatric inflammatory bowel disease: a Scottish, population-based, longitudinal study","volume":"56","author":"C J Burgess","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"ref1205","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/ibd\/izad064","article-title":"Dual Biologic or Small Molecule Therapy in Refractory Pediatric Inflammatory Bowel Disease (DOUBLE-PIBD): A Multicenter Study from the Pediatric IBD Porto Group of ESPGHAN","volume":"30","author":"A Yerushalmy-Feler","year":"2024","journal-title":"Inflamm Bowel Dis"},{"key":"ref1206","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/ecco-jcc\/jjac135","article-title":"Paediatric Inflammatory Bowel Disease: A Multi-Stakeholder Perspective to Improve Development of Drugs for Children and Adolescents","volume":"17","author":"N M Croft","year":"2023","journal-title":"J Crohns Colitis"},{"key":"ref1207","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/jpc.16519","article-title":"Novel pharmacological developments in the management of paediatric inflammatory bowel disease: Time for guideline update \u2013 A narrative review","volume":"60","author":"R B Lee","year":"2024","journal-title":"J Paediatr Child Health"},{"key":"ref1208","first-page":"255","article-title":"[Position paper of the Society for Paediatric Gastroenterology and Nutrition (GPGE) on the off-label use of biologics and signal inhibitors in children and adolescents with IBD that have already been approved for adults]","volume":"63","author":"J D\u00e4britz","year":"2025","journal-title":"Z Gastroenterol"},{"key":"ref1209","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjaa161","article-title":"The Medical Management of Paediatric Crohn\u2019s Disease: an ECCO-ESPGHAN Guideline Update","author":"P F van Rheenen","year":"2020","journal-title":"J Crohns Colitis"},{"key":"ref1210","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1093\/ecco-jcc\/jjac036","article-title":"Pharmacokinetics, Safety and Efficacy of Intravenous Vedolizumab in Paediatric Patients with Ulcerative Colitis or Crohn\u2019s Disease: Results from the Phase 2 HUBBLE Study","volume":"16","author":"J S Hyams","year":"2022","journal-title":"J\u00a0Crohns Colitis"},{"key":"ref1211","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/MPG.0000000000002362","article-title":"Real World Experience With Ustekinumab in Children and Young Adults at a Tertiary Care Pediatric Inflammatory Bowel Disease Center","volume":"69","author":"J R Dayan","year":"2019","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref1212","doi-asserted-by":"crossref","first-page":"otab039","DOI":"10.1093\/crocol\/otab039","article-title":"Vedolizumab Experience in Children and Adolescents With Inflammatory Bowel Disease: A Multicenter Observational Study","volume":"3","author":"T M Hajjat","year":"2021","journal-title":"Crohns Colitis 360"},{"key":"ref1213","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjx082","article-title":"Vedolizumab in pediatric inflammatory bowel disease: a retrospective multi-center experience from the Paediatric IBD Porto group of ESPGHAN","author":"O Ledder","year":"2017","journal-title":"J Crohns Colitis"},{"key":"ref1214","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S2468-1253(22)00307-7","article-title":"Outcomes, dosing, and predictors of vedolizumab treatment in children with inflammatory bowel disease (VEDOKIDS): a prospective, multicentre cohort study","volume":"8","author":"O Atia","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref1215","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1111\/jgh.16246","article-title":"Safety and efficacy of vedolizumab in pediatric patients with ulcerative colitis: multicenter study in Japan","volume":"38","author":"K Yokoyama","year":"2023","journal-title":"J Gastroenterol Hepatol"},{"key":"ref1216","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1097\/MPG.0000000000003758","article-title":"Ustekinumab Use in Pediatric Inflammatory Bowel Disease: A French Multicenter Study From the Pediatric GETAID","volume":"76","author":"M Koudsi","year":"2023","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref1217","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s40272-023-00586-7","article-title":"Effectiveness and Safety of Ustekinumab for Pediatric Inflammatory Bowel Disease: A Systematic Review","volume":"25","author":"S Fang","year":"2023","journal-title":"Paediatr Drugs"},{"key":"ref1218","doi-asserted-by":"publisher","DOI":"10.1055\/a-2474-3104","article-title":"[Position paper of the Society for Paediatric Gastroenterology and Nutrition (GPGE) on the off-label use of biologics and signal inhibitors in children and adolescents with IBD that have already been approved for adults]","author":"J Dabritz","year":"2025","journal-title":"Z Gastroenterol"},{"key":"ref1219","first-page":"8","article-title":"PK, Efficacy, and Safety of Mirikizumab as Induction Therapy in Pediatric Patients With Moderately to Severely Active Ulcerative Colitis: Results From the Phase 2 SHINE-1 Study","volume":"19","year":"2023","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"ref1220","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1093\/jcag\/gwad042","article-title":"The Role of Tofacitinib in the Treatment of Acute Severe Colitis in Children","volume":"7","author":"G A Costaguta","year":"2024","journal-title":"J Can Assoc Gastroenterol"},{"key":"ref1221","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1097\/MPG.0000000000003616","article-title":"Tofacitinib Salvage Therapy for Children Hospitalized for Corticosteroid- and Biologic-Refractory Ulcerative Colitis","volume":"75","author":"B D Constant","year":"2022","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref1222","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1097\/MPG.0000000000003190","article-title":"Tofacitinib Therapy in Children and Young Adults With Pediatric-onset Medically Refractory Inflammatory Bowel Disease","volume":"73","author":"H Moore","year":"2021","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref1223","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izae112","article-title":"Tofacitinib in Pediatric Ulcerative Colitis: A Retrospective Multicenter Experience","author":"O Ledder","year":"2024","journal-title":"Inflamm Bowel Dis"},{"key":"ref1224","doi-asserted-by":"publisher","DOI":"10.1002\/jpn3.12408","article-title":"Upadacitinib is associated with clinical response and steroid-free remission for children and adolescents with inflammatory bowel disease","author":"J Runde","year":"2024","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref1225","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1093\/ibd\/izad300","article-title":"Single-center Experience With Upadacitinib for Adolescents With Refractory Inflammatory Bowel Disease","volume":"30","author":"E A Spencer","year":"2024","journal-title":"Inflamm Bowel Dis"},{"key":"ref1226","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/MPG.0000000000003510","article-title":"The Influence of the Introduction of Biologic Agents on Surgical Intervention in Paediatric Inflammatory Bowel Disease","volume":"75","author":"G S Bethell","year":"2022","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref1227","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1093\/ecco-jcc\/jjab210","article-title":"Colectomy Rates did not Decrease in Paediatric- and Adult-Onset Ulcerative Colitis During the Biologics Era: A Nationwide Study From the epi-IIRN","volume":"16","author":"O Atia","year":"2022","journal-title":"J Crohns Colitis"},{"key":"ref1228","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/j.jpedsurg.2023.02.042","article-title":"Surgical Management of Ulcerative Colitis in Children and Adolescents: A Systematic Review from the APSA Outcomes and Evidence-Based Practice Committee","volume":"58","author":"R M Rentea","year":"2023","journal-title":"J Pediatr Surg"},{"key":"ref1229","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1053\/j.gastro.2020.07.066","article-title":"Predicting Outcomes in Pediatric Ulcerative Colitis for Management Optimization: Systematic Review and Consensus Statements From the Pediatric Inflammatory Bowel Disease-Ahead Program","volume":"160","author":"E Orlanski-Meyer","year":"2021","journal-title":"Gastroenterology"},{"key":"ref1230","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/j.jpedsurg.2023.02.042","article-title":"Surgical Management of Ulcerative Colitis in Children and Adolescents: A Systematic Review from the APSA Outcomes and Evidence-Based Practice Committee","volume":"58","author":"R M Rentea","year":"2023","journal-title":"Journal of Pediatric Surgery"},{"key":"ref1231","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.gtc.2023.06.001","article-title":"When and Where Should Surgery Be Positioned in Pediatric Inflammatory Bowel Disease?","volume":"52","author":"A M Lipskar","year":"2023","journal-title":"Gastroenterol Clin North Am"},{"key":"ref1232","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1002\/ibd.20378","article-title":"Guidelines for the management of growth failure in childhood inflammatory bowel disease","volume":"14","author":"R Heuschkel","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"ref1233","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1002\/bjs.10678","article-title":"Outcome after restorative proctocolectomy and ileal pouch-anal anastomosis in children and adults","volume":"104","author":"K Diederen","year":"2017","journal-title":"Br J Surg"},{"key":"ref1234","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1093\/ibd\/izab319","article-title":"Outcomes of Ileoanal Pouch Anastomosis in Pediatric Ulcerative Colitis Are Worse in the Modern Era: A Time Trend Analysis Outcomes Following Ileal Pouch-Anal Anastomosis in Pediatric Ulcerative Colitis","volume":"28","author":"J Runde","year":"2022","journal-title":"Inflamm Bowel Dis"},{"key":"ref1235","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/978-3-662-65248-0_8","volume-title":"Chronisch entz\u00fcndliche Darmerkrankungen. Gastroenterologie\u2013Hepatologie\u2013Ern\u00e4hrung\u2013Nephrologie\u2013Urologie","author":"J D\u00e4britz","year":"2024"},{"key":"ref1236","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1053\/j.gastro.2007.05.029","article-title":"Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study","volume":"133","author":"D Turner","year":"2007","journal-title":"Gastroenterology"},{"key":"ref1237","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.3748\/wjg.v23.i18.3322","article-title":"Correlation of endoscopic disease severity with pediatric ulcerative colitis activity index score in children and young adults with ulcerative colitis","volume":"23","author":"B Kerur","year":"2017","journal-title":"World J Gastroenterol"},{"key":"ref1238","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1136\/gut.2010.211755","article-title":"Faecal calprotectin, lactoferrin, M2-pyruvate kinase and S100A12 in severe ulcerative colitis: a prospective multicentre comparison of predicting outcomes and monitoring response","volume":"59","author":"D Turner","year":"2010","journal-title":"Gut"},{"key":"ref1239","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/MEG.0000000000001550","article-title":"Combining faecal calprotectin and sigmoidoscopy can predict mucosal healing in paediatric ulcerative colitis","volume":"32","author":"S Kim","year":"2020","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref1240","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1002\/ibd.20472","article-title":"Clinical role of calprotectin assay in determining histological relapses in children affected by inflammatory bowel diseases","volume":"14","author":"A Diamanti","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"ref1241","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/ibd.20376","article-title":"Fecal calprotectin is useful in predicting disease relapse in pediatric inflammatory bowel disease","volume":"14","author":"D Walkiewicz","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"ref1242","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1111\/apt.18262","article-title":"Predicting complications in paediatric ulcerative colitis: A longitudinal multicentre cohort study","volume":"60","author":"M Cla\u00dfen","year":"2024","journal-title":"Aliment Pharmacol Ther"},{"key":"ref1243","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.advms.2020.03.004","article-title":"Correlation between biomarkers (calprotectin, seromucoid, metalloproteinase-3 and CRP) and clinical and endoscopic activity of ulcerative colitis in children","volume":"65","author":"B Iwanczak","year":"2020","journal-title":"Adv Med Sci"},{"key":"ref1244","doi-asserted-by":"crossref","first-page":"11469","DOI":"10.3748\/wjg.v21.i40.11469","article-title":"Are faecal markers good indicators of mucosal healing in inflammatory bowel disease?","volume":"21","author":"G J Boon","year":"2015","journal-title":"World J Gastroenterol"},{"key":"ref1245","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/MPG.0000000000003574","article-title":"Colorectal Cancer in Childhood-onset Inflammatory Bowel Disease: A Scandinavian Register-based Cohort Study, 1969-2017","volume":"75","author":"\u00c5 H Everhov","year":"2022","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref1246","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1097\/MPG.0000000000002092","article-title":"Endoscopy in Pediatric Inflammatory Bowel Disease: A Position Paper on Behalf of the Porto IBD Group of the European Society for Pediatric Gastroenterology, Hepatology and Nutrition","volume":"67","author":"S Oliva","year":"2018","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref1247","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/MPG.0000000000003574","article-title":"Colorectal Cancer in Childhood-onset Inflammatory Bowel Disease: A Scandinavian Register-based Cohort Study, 1969-2017","volume":"75","author":"A H Everhov","year":"2022","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref1248","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.3748\/wjg.v19.i15.2437","article-title":"Fifteen-year-old colon cancer patient with a 10-year history of ulcerative colitis","volume":"19","author":"S Y Noh","year":"2013","journal-title":"World J Gastroenterol"},{"key":"ref1249","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1186\/s12887-021-02966-9","article-title":"Colorectal Cancer associated with pediatric inflammatory bowel disease: a case series","volume":"21","author":"M J Kim","year":"2021","journal-title":"BMC Pediatr"},{"key":"ref1250","doi-asserted-by":"crossref","first-page":"e341","DOI":"10.1097\/PG9.0000000000000341","article-title":"Endoscopic Surveillance for Colorectal Cancer in Pediatric Ulcerative Colitis: A Survey Among Dutch Pediatric Gastroenterologists","volume":"4","author":"J Z Jagt","year":"2023","journal-title":"JPGN Rep"},{"key":"ref1251","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/MPG.0000000000002399","article-title":"Impact of Paediatric Versus Adult Care Setting on Health Care Utilization in Adolescents With Inflammatory Bowel Disease","volume":"69","author":"R WB Bottema","year":"2019","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref1252","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.gastha.2023.06.009","article-title":"Healthcare Utilization Patterns and Excessive Steroid Use in Late Adolescence Age and Young Adults With Crohn\u2019s Disease and Ulcerative Colitis","volume":"2","author":"F S Hussain","year":"2023","journal-title":"Gastro Hep Adv"},{"key":"ref1253","first-page":"331","article-title":"Inflammatory Bowel Disease in Childhood and Adolescence","volume":"114","author":"J Dabritz","year":"2017","journal-title":"Dtsch Arztebl Int"},{"key":"ref1254","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/apt.13218","article-title":"Systematic review: Body composition in children with inflammatory bowel disease","volume":"42","author":"D Thangarajah","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"ref1255","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/ecco-jcc\/jjad145","article-title":"Short-term Psychodynamic Psychotherapy in Addition to Standard Medical Therapy Increases Clinical Remission in Adolescents and Young Adults with Inflammatory Bowel Disease: a Randomised Controlled Trial","volume":"18","author":"F Milo","year":"2024","journal-title":"J Crohns Colitis"},{"key":"ref1256","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.jpeds.2007.04.004","article-title":"Body mass index in children with newly diagnosed inflammatory bowel disease: observations from two multicenter North American inception cohorts","volume":"151","author":"S Kugathasan","year":"2007","journal-title":"J Pediatr"},{"key":"ref1257","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/01.mpg.0000228105.91240.80","article-title":"Osteoporosis in pediatric patients suffering from chronic inflammatory bowel disease with and without steroid treatment","volume":"43","author":"F Walther","year":"2006","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref1258","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1093\/ibd\/izz264","article-title":"Vaccinations and Immunization Status in Pediatric Inflammatory Bowel Disease: A Multicenter Study From the Pediatric IBD Porto Group of the ESPGHAN","volume":"26","author":"M Martinelli","year":"2020","journal-title":"Inflamm Bowel Dis"},{"key":"ref1259","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1002\/mnfr.200700156","article-title":"Nutritional concerns in pediatric inflammatory bowel disease patients","volume":"52","author":"M D Kappelman","year":"2008","journal-title":"Mol Nutr Food Res"},{"key":"ref1260","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1097\/MPG.0000000000001896","article-title":"Nutrition in Pediatric Inflammatory Bowel Disease: A Position Paper on Behalf of the Porto Inflammatory Bowel Disease Group of the European Society of Pediatric Gastroenterology, Hepatology and Nutrition","volume":"66","author":"E Miele","year":"2018","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref1261","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.jpeds.2007.04.004","article-title":"Body mass index in children with newly diagnosed inflammatory bowel disease: observations from two multicenter North American inception cohorts","volume":"151","author":"S Kugathasan","year":"2007","journal-title":"J Pediatr"},{"key":"ref1262","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/nrgastro.2014.102","article-title":"Growth problems in children with IBD","volume":"11","author":"I R Sanderson","year":"2014","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref1263","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izz264","article-title":"Vaccinations and Immunization Status in Pediatric Inflammatory Bowel Disease: A Multicenter Study From the Pediatric IBD Porto Group of the ESPGHAN","author":"M Martinelli","year":"2019","journal-title":"Inflamm Bowel Dis"},{"key":"ref1264","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1016\/j.vaccine.2019.12.024","article-title":"Vaccination rate and immunity of children and adolescents with inflammatory bowel disease or autoimmune hepatitis in Germany","volume":"38","author":"L Cagol","year":"2020","journal-title":"Vaccine"},{"key":"ref1265","first-page":"Cd014821","article-title":"Remote care through telehealth for people with inflammatory bowel disease","volume":"5","author":"M Gordon","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"key":"ref1266","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1186\/s12876-023-03021-w","article-title":"Healthcare service use in paediatric inflammatory bowel disease: a questionnaire on patient and parent care experiences in Germany","volume":"23","author":"A Boerkoel","year":"2023","journal-title":"BMC Gastroenterol"},{"key":"ref1267","doi-asserted-by":"publisher","DOI":"10.3390\/children10121904","article-title":"A Nationwide Survey on Patient Empowerment in Pediatric Inflammatory Bowel Disease in Germany","volume":"10","author":"K Kaul","year":"2023","journal-title":"Children (Basel)"},{"key":"ref1268","doi-asserted-by":"publisher","DOI":"10.3390\/children11040481","article-title":"Health Literacy of Children and Adolescents with Inflammatory Bowel Disease (IBD) and Parents of IBD Patients-Coping and Information Needs","volume":"11","author":"K Kaul","year":"2024","journal-title":"Children (Basel)"},{"key":"ref1269","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1186\/s12876-023-03021-w","article-title":"Healthcare service use in paediatric inflammatory bowel disease: a questionnaire on patient and parent care experiences in Germany","volume":"23","author":"A Boerkoel","year":"2023","journal-title":"BMC Gastroenterol"},{"key":"ref1270","first-page":"627","article-title":"The Care of Children and Adolescents with Chronic Inflammatory Bowel Disease: A Cluster-Randomized Trial on Improving the Guideline Conformity of Treatment by the Use of the CEDATA-GPGE Patient Registry","volume":"121","author":"L Tischler","year":"2024","journal-title":"Dtsch Arztebl Int"},{"key":"ref1271","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/ibd.21394","article-title":"ImproveCareNow: The development of a pediatric inflammatory bowel disease improvement network","volume":"17","author":"W Crandall","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"ref1272","doi-asserted-by":"crossref","first-page":"e1030","DOI":"10.1542\/peds.2011-1700","article-title":"Improved outcomes in a quality improvement collaborative for pediatric inflammatory bowel disease","volume":"129","author":"W V Crandall","year":"2012","journal-title":"Pediatrics"},{"key":"ref1273","doi-asserted-by":"publisher","DOI":"10.3238\/arztebl.m2024.0168","article-title":"The Care of Children and Adolescents With Chronic Inflammatory Bowel Disease: A Cluster-Randomized Trial on Improving the Guideline Conformity of Treatment by the Use of the CEDATA-GPGE Patient Registry","author":"L Tischler","year":"2024","journal-title":"Dtsch Arztebl Int"},{"key":"ref1274","doi-asserted-by":"crossref","first-page":"e1030","DOI":"10.1542\/peds.2011-1700","article-title":"Improved outcomes in a quality improvement collaborative for pediatric inflammatory bowel disease","volume":"129","author":"W V Crandall","year":"2012","journal-title":"Pediatrics"},{"issue":"S 02","key":"ref1275","first-page":"275","article-title":"Parental quality of life in the framework of paediatric chronic gastrointestinal disease","volume":"35","author":"R Knez","year":"2011","journal-title":"Coll Antropol"},{"key":"ref1276","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1093\/ecco-jcc\/jjac095","article-title":"Psychiatric Disorders in Adult and Paediatric Patients With Inflammatory Bowel Diseases \u2013 A Systematic Review and Meta-Analysis","volume":"16","author":"L Arp","year":"2022","journal-title":"J Crohns Colitis"},{"key":"ref1277","doi-asserted-by":"crossref","first-page":"e080408","DOI":"10.1136\/bmjopen-2023-080408","article-title":"Impact of mental health comorbidity in children and young adults with inflammatory bowel disease: a UK population-based cohort study","volume":"14","author":"R Cooney","year":"2024","journal-title":"BMJ Open"},{"key":"ref1278","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1590\/s0004-2803.202100000-96","article-title":"HEALTH-RELATED QUALITY OF LIFE IN ADOLESCENTS AND YOUNG ADULTS WITH INFLAMMATORY BOWEL DISEASE IS ASSOCIATED WITH REDUCTION IN SCHOOL AND WORK PRODUCTIVITY RATHER THAN PHYSICAL IMPAIRMENT: A MULTIDISCIPLINARY STUDY","volume":"58","author":"J Oba","year":"2021","journal-title":"Arq Gastroenterol"},{"key":"ref1279","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1111\/j.1440-1754.2011.02034.x","article-title":"Health-related quality of life in paediatric patients with inflammatory bowel disease related to disease activity","volume":"47","author":"J Haapam\u00e4ki","year":"2011","journal-title":"J Paediatr Child Health"},{"key":"ref1280","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1093\/jpepsy\/jsp120","article-title":"A meta-analytic review of the psychosocial adjustment of youth with inflammatory bowel disease","volume":"35","author":"R N Greenley","year":"2010","journal-title":"J Pediatr Psychol"},{"key":"ref1281","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.crohns.2012.01.010","article-title":"The requirements and barriers to successful transition of adolescents with inflammatory bowel disease: differing perceptions from a survey of adult and paediatric gastroenterologists","volume":"6","author":"S Sebastian","year":"2012","journal-title":"J Crohns Colitis"},{"key":"ref1282","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/imj.12402","article-title":"Perspectives of paediatric and adult gastroenterologists on transfer and transition care of adolescents with inflammatory bowel disease","volume":"44","author":"E K Wright","year":"2014","journal-title":"Intern Med J"},{"key":"ref1283","doi-asserted-by":"crossref","first-page":"e033535","DOI":"10.1136\/bmjopen-2019-033535","article-title":"Value of an outpatient transition clinic for young people with inflammatory bowel disease: a mixed-methods evaluation","volume":"10","author":"J NT Sattoe","year":"2020","journal-title":"BMJ Open"},{"key":"ref1284","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/MPG.0000000000000555","article-title":"Transition readiness in pediatric patients with inflammatory bowel disease: patient survey of self-management skills","volume":"60","author":"E P Whitfield","year":"2015","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref1285","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s12876-019-1046-5","article-title":"Long-term implications of structured transition of adolescents with inflammatory bowel disease into adult health care: a retrospective study","volume":"19","author":"L Sch\u00fctz","year":"2019","journal-title":"BMC Gastroenterol"},{"key":"ref1286","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jadohealth.2015.04.012","article-title":"Evaluation of Outcomes in Adolescent Inflammatory Bowel Disease Patients Following Transfer From Pediatric to Adult Health Care Services: Case for Transition","volume":"57","author":"R Cole","year":"2015","journal-title":"J Adolesc Health"},{"key":"ref1287","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/MPG.0000000000003013","article-title":"Predicting Suboptimal Transitions in Adolescents With Inflammatory Bowel Disease","volume":"72","author":"H Pearlstein","year":"2021","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref1288","doi-asserted-by":"crossref","first-page":"e206","DOI":"10.1016\/j.crohns.2012.09.010","article-title":"Inflammatory bowel disease and pregnancy: lack of knowledge is associated with negative views","volume":"7","author":"C P Selinger","year":"2013","journal-title":"J Crohns Colitis"},{"key":"ref1289","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.cgh.2016.03.018","article-title":"Preconception Care Reduces Relapse of Inflammatory Bowel Disease During Pregnancy","volume":"14","author":"A de Lima","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref1290","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/apt.12417","article-title":"Meta-analysis: the impact of disease activity at conception on disease activity during pregnancy in patients with inflammatory bowel disease","volume":"38","author":"A Abhyankar","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"ref1291","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/apt.17348","article-title":"Predictors of disease activity during pregnancy in women with inflammatory bowel disease-a Danish cohort study","volume":"57","author":"T Vestergaard","year":"2023","journal-title":"Aliment Pharmacol Ther"},{"key":"ref1292","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1136\/gutjnl-2021-325317","article-title":"Exposure to corticosteroids in pregnancy is associated with adverse perinatal outcomes among infants of mothers with inflammatory bowel disease: results from the PIANO registry","volume":"71","author":"F D Odufalu","year":"2022","journal-title":"Gut"},{"key":"ref1293","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1503\/cmaj.101063","article-title":"Corticosteroid use during pregnancy and risk of orofacial clefts","volume":"183","author":"A Hviid","year":"2011","journal-title":"Cmaj"},{"key":"ref1294","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1136\/bmj.38313.624352.8F","article-title":"Use of inhaled corticosteroids during pregnancy and risk of pregnancy induced hypertension: nested case-control study","volume":"330","author":"M J Martel","year":"2005","journal-title":"Bmj"},{"key":"ref1295","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1053\/j.gastro.2020.11.038","article-title":"Pregnancy and Neonatal Outcomes After Fetal Exposure to Biologics and Thiopurines Among Women With Inflammatory Bowel Disease","volume":"160","author":"U Mahadevan","year":"2021","journal-title":"Gastroenterology"},{"key":"ref1296","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1053\/j.gastro.2018.05.040","article-title":"Exposure Concentrations of Infants Breastfed by Women Receiving Biologic Therapies for Inflammatory Bowel Diseases and Effects of Breastfeeding on Infections and Development","volume":"155","author":"R Matro","year":"2018","journal-title":"Gastroenterology"},{"key":"ref1297","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/ajg.2017.501","article-title":"Long-Term Safety of In Utero Exposure to Anti-TNF\u03b1 Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study","volume":"113","author":"M Chaparro","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"ref1298","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1097\/MIB.0000000000001234","article-title":"Anti-TNF-\u03b1 Use During the Third Trimester of Pregnancy in Women with Moderate-severe Inflammatory Bowel Disease and the Risk of Preterm Birth and Low Birth Weight","volume":"23","author":"H Kammerlander","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"ref1299","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.cgh.2020.09.021","article-title":"Biologics for Inflammatory Bowel Disease and Their Safety in Pregnancy: A Systematic Review and Meta-analysis","volume":"20","author":"O H Nielsen","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref1300","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/apt.16192","article-title":"Safety of ustekinumab or vedolizumab in pregnant inflammatory bowel disease patients: a multicentre cohort study","volume":"53","author":"P Wils","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"ref1301","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/cplu.201600512","article-title":"A Synthetic, X-ray, NMR Spectroscopy and DFT Study of \u03b2-Naphthil Dihydrazone, Di(\u03b2-naphthyl)acetylene, Tetra(\u03b2-naphthyl)cyclopentadienone, and Hexa(\u03b2-naphthyl)-benzene: C(6) (C(10) H(7))(6) Is a Disordered Molecular Propeller","volume":"82","author":"L E Harrington","year":"2017","journal-title":"Chempluschem"},{"key":"ref1302","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1111\/apt.16593","article-title":"Vedolizumab clearance in neonates, susceptibility to infections and developmental milestones: a prospective multicentre population-based cohort study","volume":"54","author":"M Julsgaard","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"ref1303","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/apt.15539","article-title":"Pregnancy outcomes in inflammatory bowel disease patients treated with vedolizumab, anti-TNF or conventional therapy: results of the European CONCEIVE study","volume":"51","author":"A Moens","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"ref1304","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.cgh.2023.12.029","article-title":"Safety of Vedolizumab and Ustekinumab Compared With Anti-TNF in Pregnant Women With Inflammatory Bowel Disease","volume":"23","author":"A Meyer","year":"2025","journal-title":"Clinical Gastroenterology and Hepatology"},{"issue":"01","key":"ref1305","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ecco-jcc\/jjac115","article-title":"European Crohn\u2019s and Colitis Guidelines on Sexuality, Fertility, Pregnancy, and Lactation","volume":"17","author":"J Torres","year":"2023","journal-title":"J Crohn\u2019s Colitis"},{"key":"ref1306","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.ard.2025.02.023","article-title":"EULAR recommendations for use of antirheumatic drugs in reproduction, pregnancy, and lactation: 2024 update","volume":"84","author":"L R\u00fcegg","year":"2025","journal-title":"Ann Rheum Dis"},{"key":"ref1307","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1572-0241.2005.40785.x","article-title":"The role of breastfeeding in postpartum disease activity in women with inflammatory bowel disease","volume":"100","author":"S Kane","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"ref1308","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1016\/S0016-5085(17)30634-0","article-title":"Exposure to Biologic Therapy and Childhood Development among Offspring of Women with Inflammatory Bowel Disease: Results from the Piano Registry","volume":"152","author":"A Roy","year":"2017","journal-title":"Gastroenterology"},{"key":"ref1309","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S2468-1253(23)00158-9","article-title":"Tofacitinib concentrations in plasma and breastmilk of a lactating woman with ulcerative colitis","volume":"8","author":"M Julsgaard","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref1310","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1053\/j.gastro.2018.12.022","article-title":"Inflammatory Bowel Disease in Pregnancy Clinical Care Pathway: A Report From the American Gastroenterological Association IBD Parenthood Project Working Group","volume":"156","author":"U Mahadevan","year":"2019","journal-title":"Gastroenterology"},{"key":"ref1311","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s10350-004-0569-0","article-title":"Pregnancy and delivery before and after ileal pouch-anal anastomosis for inflammatory bowel disease: immediate and long-term consequences and outcomes","volume":"47","author":"D Hahnloser","year":"2004","journal-title":"Dis Colon Rectum"},{"key":"ref1312","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1007\/s10350-007-0240-7","article-title":"The effect of restorative proctocolectomy on sexual function, urinary function, fertility, pregnancy and delivery: a systematic review","volume":"50","author":"J A Cornish","year":"2007","journal-title":"Dis Colon Rectum"},{"key":"ref1313","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1097\/MIB.0000000000001112","article-title":"Defining the Most Appropriate Delivery Mode in Women with Inflammatory Bowel Disease: A Systematic Review","volume":"23","author":"A Foulon","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"ref1314","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1007\/s10350-005-0124-7","article-title":"Vaginal delivery after ileal pouch-anal anastomosis: a word of caution","volume":"48","author":"F H Remzi","year":"2005","journal-title":"Dis Colon Rectum"},{"key":"ref1315","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1136\/flgastro-2019-101371","article-title":"IBD in pregnancy: recent advances, practical management","volume":"12","author":"C P Selinger","year":"2021","journal-title":"Frontline Gastroenterol"},{"key":"ref1316","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.cgh.2012.08.018","article-title":"Complications from inflammatory bowel disease during pregnancy and delivery","volume":"10","author":"G Br\u00f6ms","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref1317","doi-asserted-by":"crossref","first-page":"e17309","DOI":"10.1097\/MD.0000000000017309","article-title":"The risk of venous thromboembolism in women with inflammatory bowel disease during pregnancy and the postpartum period: A systematic review and meta-analysis","volume":"98","author":"Y H Kim","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"ref1318","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.cgh.2008.10.022","article-title":"Outcomes of obstetric hospitalizations among women with inflammatory bowel disease in the United States","volume":"7","author":"G C Nguyen","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref1319","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1093\/ecco-jcc\/jjy053","article-title":"Hepatitis B Vaccination Effective in Children Exposed to Anti-Tumour Necrosis Factor Alpha in Utero","volume":"12","author":"A de Lima","year":"2018","journal-title":"Journal of Crohn\u2019s and Colitis"},{"key":"ref1320","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/ibd\/izy294","article-title":"Safety of Anti-TNF-Alpha Therapy During Pregnancy on Long-term Outcome of Exposed Children: A Controlled, Multicenter Observation","volume":"25","author":"D Duricova","year":"2019","journal-title":"Inflamm Bowel Dis"},{"key":"ref1321","doi-asserted-by":"crossref","first-page":"935034","DOI":"10.3389\/fped.2022.935034","article-title":"Immune function in newborns with in-utero exposure to anti-TNF\u03b1 therapy","volume":"10","author":"B Weiss","year":"2022","journal-title":"Front Pediatr"},{"key":"ref1322","doi-asserted-by":"crossref","first-page":"102676","DOI":"10.1016\/j.jaut.2021.102676","article-title":"Pregnancy and neonatal outcomes in women with immune mediated inflammatory diseases exposed to anti-tumor necrosis factor-\u03b1 during pregnancy: A systemic review and meta-analysis","volume":"122","author":"L Barenbrug","year":"2021","journal-title":"J Autoimmun"},{"key":"ref1323","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.cgh.2017.08.041","article-title":"Use of Biologic Therapy by Pregnant Women With Inflammatory Bowel Disease Does Not Affect Infant Response to Vaccines","volume":"16","author":"D B Beaulieu","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref1324","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.crohns.2010.05.001","article-title":"Case Report: Fatal case of disseminated BCG infection in an infant born to a mother taking infliximab for Crohn\u2019s disease","volume":"4","author":"K Cheent","year":"2010","journal-title":"J Crohns Colitis"},{"key":"ref1325","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1093\/rheumatology\/keac141","article-title":"A systematic review of live vaccine outcomes in infants exposed to biologic disease modifying anti-rheumatic drugs in utero","volume":"61","author":"B Goulden","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"ref1326","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1053\/j.gastro.2016.04.002","article-title":"Concentrations of Adalimumab and Infliximab in Mothers and Newborns, and Effects on Infection","volume":"151","author":"M Julsgaard","year":"2016","journal-title":"Gastroenterology"},{"key":"ref1327","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1093\/ecco-jcc\/jjx034","article-title":"Immunoglobulin and Infliximab Concentrations in Dichorionic Twins Exposed to Infliximab in Utero","volume":"11","author":"T Vestergaard","year":"2017","journal-title":"J Crohns Colitis"},{"key":"ref1328","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/S2352-4642(23)00136-0","article-title":"Immunological effects and safety of live rotavirus vaccination after antenatal exposure to immunomodulatory biologic agents: a prospective cohort study from the Canadian Immunization Research Network","volume":"7","author":"T Fitzpatrick","year":"2023","journal-title":"Lancet Child Adolesc Health"},{"key":"ref1329","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1093\/ecco-jcc\/jjad005","article-title":"Vaccines in Children Exposed to Biological Agents In Utero and\/or During Breastfeeding: Are They Effective and Safe?","volume":"17","author":"J P Gisbert","year":"2023","journal-title":"J Crohns Colitis"},{"key":"ref1330","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.cgh.2024.07.007","article-title":"Live Rotavirus Vaccination Appears Low-risk in Infants Born to Mothers With Inflammatory Bowel Disease on Biologics","volume":"23","author":"K Ernest-Suarez","year":"2025","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref1331","doi-asserted-by":"publisher","first-page":"izae220","DOI":"10.1093\/ibd\/izae220","article-title":"Safety of Rotavirus Vaccination in Infants That Were Exposed to Biologics In Utero: A Systematic Review","author":"T L Schell","year":"2024","journal-title":"Inflammatory Bowel Diseases"},{"key":"ref1332","first-page":"263","article-title":"European Crohn\u2019s and Colitis Organisation Topical Review on IBD in the Elderly","volume":"11","author":"A Sturm","year":"2017","journal-title":"J Crohns Colitis"},{"issue":"S 01","key":"ref1333","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1159\/000503099","article-title":"Management of the Elderly Inflammatory Bowel Disease Patient","volume":"101","author":"P Hruz","year":"2020","journal-title":"Digestion"},{"key":"ref1334","first-page":"462","article-title":"Risk of Infection and Types of Infection Among Elderly Patients With Inflammatory Bowel Disease: A Retrospective Database Analysis","volume":"26","author":"N Khan","year":"2020","journal-title":"Inflamm Bowel Dis"},{"key":"ref1335","first-page":"461","article-title":"Corticosteroid-associated complications in elderly Crohn\u2019s disease patients","volume":"92","author":"G A Akerkar","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"ref1336","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1056\/NEJMra0707500","article-title":"Clostridium difficile \u2013 more difficult than ever","volume":"359","author":"C P Kelly","year":"2008","journal-title":"N Engl J Med"},{"key":"ref1337","doi-asserted-by":"publisher","DOI":"10.1111\/apt.18106","article-title":"Treatment of inflammatory bowel disease with steroid-sparing medications is age-dependent \u2013 Results from a Danish nationwide cohort study, 2000\u20132018","author":"R LM Nordestgaard","year":"2024","journal-title":"Aliment Pharmacol Ther"},{"key":"ref1338","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1136\/annrheumdis-2019-216761","article-title":"Incidence of venous and arterial thromboembolic events reported in the tofacitinib rheumatoid arthritis, psoriasis and psoriatic arthritis development programmes and from real-world data","volume":"79","author":"P Mease","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"ref1339","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1136\/gut.2004.049460","article-title":"Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine","volume":"54","author":"A Kandiel","year":"2005","journal-title":"Gut"},{"key":"ref1340","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1053\/j.gastro.2012.05.004","article-title":"Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease","volume":"143","author":"M D Long","year":"2012","journal-title":"Gastroenterology"},{"key":"ref1341","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1053\/j.gastro.2003.10.047","article-title":"The safety profile of infliximab in patients with Crohn\u2019s disease: the Mayo clinic experience in 500 patients","volume":"126","author":"J F Colombel","year":"2004","journal-title":"Gastroenterology"},{"key":"ref1342","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/ibd.23026","article-title":"Older age is associated with higher rate of discontinuation of anti-TNF therapy in patients with inflammatory bowel disease","volume":"19","author":"A Desai","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"ref1343","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.cgh.2010.09.026","article-title":"Advanced age is an independent risk factor for severe infections and mortality in patients given anti-tumor necrosis factor therapy for inflammatory bowel disease","volume":"9","author":"M Cottone","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref1344","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/apt.15692","article-title":"Systematic review with meta-analysis: biologics and risk of infection or cancer in elderly patients with inflammatory bowel disease","volume":"51","author":"D Piovani","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"ref1345","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1161\/01.CIR.0000077913.60364.D2","article-title":"Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial","volume":"107","author":"E S Chung","year":"2003","journal-title":"Circulation"},{"key":"ref1346","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s40264-023-01383-4","article-title":"Drug-Induced Progressive Multifocal Leukoencephalopathy (PML): A Systematic Review and Meta-Analysis","volume":"47","author":"L V Rindi","year":"2024","journal-title":"Drug Saf"},{"key":"ref1347","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1093\/ibd\/izy133","article-title":"Outcomes of Treatment for Latent Tuberculosis Infection in Patients With Inflammatory Bowel Disease Receiving Biologic Therapy","volume":"24","author":"G P Ramos","year":"2018","journal-title":"Inflamm Bowel Dis"},{"key":"ref1348","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1093\/ibd\/izy153","article-title":"Low Frequency of Opportunistic Infections in Patients Receiving Vedolizumab in Clinical Trials and Post-Marketing Setting","volume":"24","author":"S C Ng","year":"2018","journal-title":"Inflamm Bowel Dis"},{"key":"ref1349","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1007\/s10620-021-07073-4","article-title":"Risk of Malignancy with Vedolizumab Versus Tumor Necrosis Factor-alpha Antagonists in Patients with Inflammatory Bowel Diseases","volume":"67","author":"S Singh","year":"2022","journal-title":"Dig Dis Sci"},{"key":"ref1350","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/apt.15538","article-title":"Vedolizumab use is not associated with increased malignancy incidence: GEMINI LTS study results and post-marketing data","volume":"51","author":"T Card","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"ref1351","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1007\/s12325-021-01713-x","article-title":"Incidence of Infections and Malignancy Among Elderly Male Patients with IBD Exposed to Vedolizumab, Prednisone, and 5-ASA Medications: A Nationwide Retrospective Cohort Study","volume":"38","author":"N Khan","year":"2021","journal-title":"Adv Ther"},{"key":"ref1352","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s11894-023-00874-9","article-title":"Indications and safety of newer IBD treatments in the older patient","volume":"25","author":"B Clement","year":"2023","journal-title":"Curr Gastroenterol Rep"},{"key":"ref1353","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12155014","article-title":"Efficacy and Safety of S1P1 Receptor Modulator Drugs for Patients with Moderate-to-Severe Ulcerative Colitis","volume":"12","author":"S Bencardino","year":"2023","journal-title":"J Clin Med"},{"key":"ref1354","doi-asserted-by":"publisher","first-page":"jjaf106","DOI":"10.1093\/ecco-jcc\/jjaf106","article-title":"ECCO-ESGAR-ESP-IBUS Guideline on Diagnostics and Monitoring of Patients with Inflammatory Bowel Disease: Part 1: initial diagnosis, monitoring of known inflammatory bowel disease, detection of complications Free","volume":"19","author":"T Kucharzik","year":"2025","journal-title":"Journal of Crohn\u2019s and Colitis"},{"key":"ref1355","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1055\/s-0043-105954","article-title":"S2k-Leitlinie \u201eTuberkulose im Erwachsenenalter\u201c","volume":"71","year":"2017","journal-title":"Pneumologie"},{"key":"ref1356","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1055\/a-2309-6123","article-title":"Aktualisierte S3-Leitlinie \u201eDiagnostik und Therapie des Morbus Crohn\u201c der Deutschen Gesellschaft f\u00fcr Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) (Version 4.1) \u2013 living guideline.\nSturm A, Atreya R, Bettenworth D, Bokemeyer B, Dignass A, Ehehalt R, Germer CT, Grunert PC, Helwig U, Horisberger K, Herrlinger K, Kienle P, Kucharzik T, Langhorst J, Maaser C, Ockenga J, Ott C, Siegmund B, Zei\u00dfig S, Stallmach A; Collaborators","volume":"62","year":"2024","journal-title":"Z Gastroenterol"},{"key":"ref1357","first-page":"1323","article-title":"Update S3-Leitlinie Reizdarmsyndrom\u2026","volume":"59","author":"P Layer","year":"2021","journal-title":"Z Gastroenterol"}],"container-title":["Zeitschrift f\u00fcr Gastroenterologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2769-2192.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T23:43:42Z","timestamp":1782258222000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2769-2192"}},"subtitle":["Stand November 2025 \u2013 AWMF-Registriernummer: 021-009"],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":1343,"journal-issue":{"issue":"06","published-online":{"date-parts":[[2026,6,22]]},"published-print":{"date-parts":[[2026,6]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2769-2192","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0044-2771","1439-7803"],"issn-type":[{"value":"0044-2771","type":"print"},{"value":"1439-7803","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6]]}}}